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“I’ve got to stop somewhere… 
I’ll leave you something to imagine (laughs)” 
Richard Feynman 
 
A quote fitting for discussions on the origin of life  
and… PhD research and dissertation writing 
  
  
 
SUMMARY 
I 
Summary 
The propagation and translation of molecular information is vital towards 
sustaining life as we know it. Several parallel trends in designing systems 
holding molecular information are found in literature. Supramolecular 
chemists developed molecular ‘receptors’ to accommodate various substrates 
ranging from simple ions to more complex molecules and polymers. A more 
specialist approach has been developed by chemists working with self-
replicating nucleic acids and even proteins, but not without setbacks such as 
product inhibition. To counter such setbacks we plan to promote the leaving 
group (LG) as an information carrier. So far, in conventional chemistry an 
LG is mostly optimized to obtain high yield and a fast substitution reaction. 
Inspired by the chemical simplification of tRNA as LG and information carrier 
during protein synthesis, developing LGs based on nucleobases or other self-
recognizing structures is a new way to develop ‘molecular genetics’.  
This PhD work sets out to grasp the complex dynamics when using an 
Informational LG (ILG) in mimics of biochemical systems. Of particular 
interest are the non-enzymatic replication and translation of oligonucleotides 
as they hold important clues to the emergence of organized systems from a 
prebiotic environment. The chemical origin of life cannot be simply uncovered 
and thus remains to this day an inspiring mystery leading to discussion and 
conflict among scientists. Recent discoveries lead us to believe that RNA 
played a pivotal role in ensuring continuity of genetic information in prebiotic 
times. The evidence, shortcomings and alternatives of a RNA-world are 
summarized and discussed in the introductory part of this dissertation. 
Chemical replication of oligonucleotides brought forth the minimal replicator 
theory which still is the theoretical foundation to categorize and evaluate all 
molecular replicating systems. Chapter 3 elaborates further by introducing 
the ILG approach; followed by a detailed, theoretical comparison of both the 
expanded and the original theory. Despite a slight reservation towards the 
thermodynamic data used to translate this model into a working example, the 
ILG model lives up to its expectations and outperforms the minimal replicator 
theory. Furthermore, an attempt to obtain a monomer that could introduce 
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the ILG strategy in non-enzymatic, templated oligonucleotide synthesis is 
reported while uncovering a novel synthetic route for a medicinally interesting 
compound. 
In Chapter 4, our ILG inspiration is reduced to its base components. A library 
of tRNA mimics was constructed according to an envisaged model, allowing 
for single stranded oligonucleotides to template peptide bond formation after 
uncaging the precursor by UV irradiation. Several synthetic difficulties were 
addressed and overcome. Furthermore, although first suspected, control 
experiments ruled out any significant contribution of catalysis by introducing 
the ILG in the absence of template. Preliminary experimental issues aside, 
the catalytic effect of oligonucleotides was proven and further investigated.  
 
SAMENVATTING 
III 
Samenvatting 
Het behoud en vertalen van moleculaire informatie is essentieel voor het 
onderhouden van levende systemen. Verscheidene parallelle trends in 
programmeren moleculaire informatie bevatten zijn terug te vinden in de 
literatuur. Zo ontwikkelen supramoleculaire chemici moleculaire ‘receptoren’ 
voor verscheidene substraten gaande van simpele ionen tot meer complexe 
moleculen en polymeren. Een meer gespecialiseerde aanpak komt van chemici 
die werken met zelf-replicerende nucleïnezuren en zelfs eiwitten, maar niet 
zonder tegenslagen zoals product inhibitie. Om zulke tegenslagen tegen te 
gaan, stellen we voor om de ‘leaving group’ (LG) te promoveren tot informatie 
drager. Dus ver, in conventionele scheikunde, wordt een LG vooral 
geoptimaliseerd om hoge opbrengsten en snelle substitutie reacties te 
bekomen. Geïnspireerd door de chemische simplificatie van tRNA als LG én 
informatie drager in eiwit synthese, is het ontwikkelen van LGs op basis van 
nucleobasen of andere zelf-herkennende structuren een nieuwe manier om 
‘moleculaire genetica’ te ontwikkelen. 
Dit doctoraatsonderzoek poogt de complexe dynamica te begrijpen van een 
informatie-houdende LG (ILG) in nabootsingen van biochemische systemen. 
Bijzonder interessant zijn de niet-enzymatische replicatie en translatie van 
oligonucleotiden, want zij bevatten belangrijke hints voor het ontstaan van 
georganiseerde systemen vanuit een prebiotische omgeving. De chemische 
oorsprong van het leven kan niet simpelweg ontdekt worden en blijft als 
inspirerend mysterie voer voor discussie en conflict. Recent onderzoek brengt 
RNA naar voren als belangrijke speler in het behoud van genetische informatie 
in prebiotische tijden. De argumenten, tekortkomingen en alternatieven van 
een RNA-wereld worden samengevat en bediscussieerd in de inleiding van 
deze doctoraatsthesis. 
Chemische replicatie van oligonucleotiden bracht het theoretisch fundament 
voor de evaluatie van alle moleculaire replicerende systemen. Hoofdstuk 3 gaat 
verder door het introduceren van de ILG aanpak, gevolgd door een 
gedetailleerde, theoretische vergelijking van zowel de uitgebreide als de 
originele theorie. Ondanks een kritische noot betreffende de gebruikte 
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thermodynamische gegevens gebruikt om dit model in een werkend voorbeeld 
te gieten, voldoet het ILG model aan de verwachtingen en geeft het betere 
resultaten dan de originele theorie. Verder wordt een poging gerapporteerd 
om de ILG strategie in niet-enzymatische oligonucleotide synthese met 
templaat te introduceren waarbij een nieuwe synthetische route voor een 
medicinaal interessant molecule gevonden werd.  
In het vierde hoofdstuk gaat onze ILG inspiratie terug naar de oorsprong. Een 
verzameling van tRNA analogen werd opgebouwd volgens een model waarin 
een enkele strand oligonucleotide zou kunnen dienen als templaat voor peptide 
synthese na het ontschermen van de precursor met UV belichting. 
Verscheidene moeilijkheden werden aangepakt en overwonnen. Hoewel eerst 
vermoed, werd door middel van controle experimenten de katalytische invloed 
van de ILG zonder templaat uitgesloten. Voorbij de eerste experimentele 
uitdagingen, werd het katalytisch effect van oligonucleotiden bewezen en 
verder onderzocht. 
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AcCoA Acetyl coenzyme A 
ACN Acetonitrile 
ADP Adenosine diphosphate 
AICA 4-Aminoimidazole-5-carboxamide 
AICN 4-Aminoimidazole-5-carbonitrile 
AMN Aminomalonodinitrile 
AMP Adenosine monophosphate 
ATP Adenosine triphosphate 
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1.1 The RNA world 
1.1.1 Conception and Confirmation 
Despite all controversy, it is generally accepted that RNA ensured continuity 
of genetic information at some point during the prebiotic era. This concept 
has been dubbed “the RNA world” by Walter Gilbert in 19861 who, 
encouraged by the first discovery of enzymatic activity of RNA2, envisaged 
an abiotic world where RNA would perform the cellular functions of both 
DNA and proteins. The reversible transposition of self-splicing introns would 
result in genetic diversity, with an unfolded sequence acting as a template for 
direct replication, later replaced by the more stable DNA. Folding into a 
three-dimensional structure would then result in ribozymic activity, succeeded 
by  more diverse and efficient structures, i.e. amino acid-based enzymes.  
Since the advent of RNA as answer to an age-old* “chicken-and-egg paradox”, 
according to which DNA encodes for proteins needed for its own replication, 
many discoveries have either strengthened this hypothesis, led to amendments 
or proposed alternatives to counter the flaws of this theory. One remarkable 
example is the ribosome.5 This complex structure composed of RNA and 
proteins represents the current biological link between information and 
function, and exerts his catalytic function through the rRNA segments. 
Certain protein parts were identified as structural elements contributing to 
its efficiency but not as being essential.5 Furthermore, a plethora of RNAs 
was discovered bearing a non-genetic function. These so-called “non-coding 
RNAs” or ncRNAs include ribozymes and self-splicing introns but also 
regulatory elements for gene expression on various downstream levels and 
exert other supporting roles for DNA and proteins alike.6 However, there are 
also smaller clues in modern biochemistry that indicate the origin was through 
RNA, such as universally conserved cofactors (ATP, AcCoA, NAD, FAD), 
DNA synthesis from RNA precursors and RNA viruses. 
                                      
* Closely linked to researching the origin of the genetic code. Woese, Crick and Orgel already proposed 
nucleic acids as answer to the paradox in the late 1960s; due to the specific nature of Watson-Crick 
base pairing, able to catalyse replication via its complement.3 An unknown feat for proteins by the 
time.4  
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The above strengthens the belief in the versatility of RNA to function in a 
prebiotic environment. The emphasis on ribozymic activity has led to research 
abiotic formation, propagation and selection of oligonucleotides necessary to 
obtain such activity (Chapter 1.2.1). Later, that catalytic power would have 
been increased and eventually replaced by proteins (Chapter 1.2.2). But first 
of all, there is a need to fuel the RNA world with feedstock material and 
energy, either chemical or physical.  
What follows is a selection of important milestones and discussion points 
regarding the origin of life and derived complex systems, from which this 
dissertation finds its inspiration in this rapidly growing field. 
1.1.2 Prebiotic chemistry* 
The quest for the origin of life has been, and now more than ever is, 
multidisciplinary due to the many facets that interplay in achieving a viable 
answer. However, a single answer will probably never suffice; as life’s abiotic 
origin cannot be uncovered, but only reinvented. Answers should come from 
both chemistry and physics; as this endeavour can only be achieved by 
assuming that the current thermodynamic and kinetic parameters describing 
molecule formation and interaction, governed the prebiotic age albeit under 
different circumstances. Deciphering the latter information is the 
responsibility of earth and planetary sciences. 
Thus, prebiotic chemistry was born from the classic electric discharge 
experiment by Stanley Miller in 1953.8 Although the efforts of 19th  and early 
20th century chemists (Wöhler, Butlerov and Löb9) can be counted as 
contributions to this field, Millers’ experiment is the first arising from the 
motivation to uncover the origin of life. He was inspired by the works of 
Haldane10 and Oparin11,12 suggesting that primary organisms must have been 
                                      
* For an introductory overview in prebiotic chemistry and the systems approach.7  Structural similarities 
between the comprehensive review and the introduction on the RNA world in Chapter 1, are due 
to the vast amount of literature that has been collected. The purpose of the introduction is not to 
be complete but to introduce the subjects and concepts that influenced this research. 
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heterotrophic, using prebiotically available monomers to form biopolymers.* 
Oparin also described the increase of complexity of such organic networks 
before the advent of cellular organisms and proposed a prebiotic environment 
rich in methane. The idea of a reducing atmosphere was supported by Urey 
in 195214 and gave rise to the experimental conditions of the famous Miller-
Urey experiment. Afterwards, the reducing nature of the prebiotic world was 
contested15 but analogous experiments with a CO2-rich atmosphere gave 
similar results.16 This benchmark experiment, its supposed flaws and 
adaptations show that prebiotic chemistry is not black and white, but a 
moving field subject to constant improvement, hypes, and discussion (Table 
1.1).3 
  
                                      
* Current biology obtains building blocks by multi-step synthesis from feedstock material and energy. 
Thus, producing many intermediates, some useful for other pathways but some only used for one in 
specific. The Heterotrophic Hypothesis13 states that this pathway originated by retrograde evolution: 
after depletion of the primary, prebiotically available building block; only the organism, who had 
meanwhile obtained another enzyme (by mutation) which could produce the primary building block 
from a slightly simpler precursor, would have survived. The process would repeat itself until steady 
state was obtained with a precursor who would not run out, resulting in a multi-step pathway. 
Table 1.1. The criteria for prebiotic chemistry inspired by reference3  
Plausible synthesis In respect to plausible circumstances, founded by either 
geological or planetary observationsa 
Using equally plausible starting materials 
in water Proceeding from the assumption that life as we know it contains 
an inherent chemical nature, common to its origin  
or absence of solvent  e.g. on dry/drying land, by geological processes or in the gas 
phase 
with “significant” yield Enough to accumulate or fast enough to off-set degradation 
a the conclusion could be drawn the other way around, when many good syntheses have common 
circumstances, the latter could be considered plausible. 
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1.1.3 Prebiotic ribonucleotide formation 
RNA consists of a ribose (pentose) backbone, linked together by 3’-5’ 
phosphodiester bonds, and functionalised by glycosidic bonds between the 
anomeric carbons (1’) and the nitrogen of a nucleobase (adenine, uracil, 
guanine, and cytosine). Historically, the synthesis of ribonucleotides under 
prebiotic conditions consisted of synthesizing each component separately and 
subsequently linking them (Scheme 1.3A).3 
The complex network of sugars 
The formose reaction (Butlerow, 1861)17 still remains the primary source of 
sugars in prebiotic chemistry. It consists of a series of aldol reactions taking 
place in an alkaline environment with the help of multivalent cations (Scheme 
1.1A).18 However, the reaction affords a complicated mixture and is poorly 
understood. For example, the mechanism of the first step, the base-catalysed 
condensation of two formaldehyde molecules, is still a source for discussion. 
Furthermore ribose is a minor product19 and rather unstable,20 although this 
might be circumvented by accumulation into vesicle compartments as ribose 
exerts higher membrane permeability.21 A different approach attempted to 
simplify the reaction mixture by preventing enolisation of the aldoses to the 
ketose (Scheme 1.1B). Eschenmoser acknowledged the role of sugar 
phosphates during glycolysis and added a phosphate group on the first 
intermediate of the formose reaction (glycolaldehyde).22 The resulting mixture 
was an enormous simplification consisting of 66% pentose-2,4-diphosphate 
(33% ribose) and 20% hexose-2,4,6-triphosphate. Despite being an interesting 
discovery, the question how to obtain 5’-monophosphates still remains 
unanswered (See Phosphorylation). Later, it was shown that borates23,24 
stabilize the formation of pentoses and silicates the formation of tetroses and 
hexoses.25 From the resulting discussion on experimental conditions26,27*, an 
important caveat arose stating that the resulting complexes might be too 
stable for further use. But there is more to the formose reaction than at first 
                                      
* A recent publication favours the results of Ricardo et al’s over those of Lambert et al’s, with added 
silicates and added phosphates not acting as complexing agents but as means to precipitate bivalent 
cations (Ca2+) out of solution, thus disfavouring the continuation of the formose reaction.28  
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glance, a source of sugar. First of all, it is autocatalytic* and it also provides 
feedstock material for pre-RNA nucleic acid analogues (See Chapter 1.3). 
 
 
Scheme 1.1. The simplified formose reaction (A) and the adaptations (B): a series of 
(retro)aldolreactions starting from simple aldehydes such as glycolaldehyde and formaldehyde, and 
subsequent keto-enol tautomerizations result in a complicated mixture of sugars. Preventing the 
isomerisation by phosphate diesters or borate complexes results in shifting the equilibrium to the more 
desired pentoses and hexoses. 
Purines and pyrimidines: asymmetric efficiency 
More than 50 years have passed since Oró, inspired by Miller, reported the 
formation of purines by oligomerization of hydrogen cyanide (HCN)29 and 
many have followed in his footsteps providing ample data on prebiotic 
nucleobase formation under various circumstances. A detailed explanation of 
Scheme 1.2 goes beyond the scope of this introduction, but a few key features 
should be pointed out. Although the first suggested route to purines, based 
on the condensation of aminomalononitrile (AMN) with formamidine was very 
                                      
*  For example, retroaldol reaction of tetroses gives 2 molecules of glycolaldehyde, which can 
subsequently again react with (form)aldehyde forming trioses and tetroses. But any retroaldol 
reaction of higher sugars can amount to the same effect. For more on autocatalysis, see Chapter 4. 
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slow, Ferris and Orgel30,31 solved this problem with the aid of photochemistry 
(DAMN to DAFM conversion, Scheme 1.2). The spontaneous formation of 
pyrimidines is less robust than that of purines, as can also be deduced from 
their lower prevalence in meteorites.32 Cyanoacetylene has been indicated as 
key starting material33, but has also been contested due to its instability and 
the need of high concentrations of reagents.34 An alternative pathway using 
cyanoacetaldehyde is therefore more promising.34 
 
 
Scheme 1.2. The core pathways to prebiotic nucleobase synthesis: (A) oligomerization of HCN to 
obtain purines, (B) the cyanoacetylene/cyanoacetaldehyde route to pyrimidines, (C) The possible 
central role of formamide as prebiotic source of nucleobases and feedstock material for synthesis thereof. 
Primary feedstock material in red; key intermediates denoted in green: AMN, aminomalonodinitrile; 
DAMN, Diaminomaleodinitrile; DAFM, diaminofumarodinitrile; AICN, 4-aminoimidazole-5-
carbonitrile; AICA, 4-aminoimidazole-5-carboxamide. Final products of interest are shown in blue. PI: 
Proton Irridiation (in space), ∆T: high temperature, ∆p: high pressure (terrestrial conditions), hν: 
irridiation by light. Figure adapted from references3,35,36 
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The central role of HCN in obtaining purines and other reagents needed for 
nucleobase synthesis (e.g. formamide, formamidine, urea, guanidine) has also 
been controversial due to its volatility and proclivity to hydrolysis.36 A frozen 
prebiotic world has been proposed to counter this, but maybe the rediscovered 
hydrolysis product, formamide, might have played a bigger role (Scheme 1.2, 
C).37,38 It is easily formed under (extra)terrestrial conditions, can reversibly be 
converted to other feedstock materials, and has proven to afford nucleobases 
under a variety of circumstances (heat, UV irradiation) and catalysts 
(montmorillonite, borate and TiO2). 
The nucleosidic bond 
The optimism for obtaining these nucleotide building blocks is soon assessed 
to be premature when trying to combine them into a nucleoside, waiting to 
be phosphorylated (Scheme 1.3A). The glycosidic bond formation between 
sugar and heterocycle is another thermodynamic uphill barrier to be 
overcome. The addition of Mg2+ and inorganic phosphate as catalysts affords 
purine nucleosides in low yield*, while much higher amounts of isomers† were 
obtained.39 This embodies a kinetic problem: the multiple nucleophilic centres 
of these heterocycles hamper the formation of the required product. 
Furthermore, pyrimidines have failed to produce any nucleotide probably due 
to a decreased nucleophilicity by resonance stabilisation of the deprotonated 
species.40 2-Pyrimidinone is currently the only reported species that is capable 
of glycosidic bond formation, the resulting nucleoside (zebularine) supposed 
to be converted post hoc to the more stable uridine (by oxidation) or cytosine 
(by amination).41 
The systems chemistry solution (?) 
A radical solution to the combinatorial approach might be the de novo 
synthesis of the entire nucleoside/tide at once, thus avoiding the formation of 
the glycosidic bond. The first experiments were conducted by synthetizing the 
nucleobase precursor already attached to the sugar and, although efficient, 
                                      
* 5-9% of adenine, guanine and inosine nucleosides, xanthine (uracil mimic) did not react  
† 20% monosubstitution on the 6-NH2 group of adenine, 40% of disubstitution (6,9-diribosyl), similar 
results for the guanine with the 2-NH2 group. 
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they yielded the wrong isomers.40,42 The mirrored strategy was employed by 
Saladino and co-workers using the formylated nucleobases that could also be 
obtained by formamide condensation (Scheme 1.2C).43 But the sugar chain 
“growing” progressed slowly and no products larger than trioses were 
obtained. Furthermore the acyclonucleosides could only cyclize after reduction 
of the C1’-carbonyl, and the resulting hemi-aminal is prone to hydrolysis (or 
exchange), and thus reverting back to the same issues connected with 
glycosidic bond formation. One step further was the simultaneous formation 
of the sugar and nucleobase moiety as can be seen in Scheme 1.3B for 
pyrimidine44 and purine45,46 nucleotides. Although for the latter this synthetic 
pathway is currently not complete, the usage of the same precursors to reach 
this far is still worth mentioning. This is the actual strength of the system 
suggested by Sutherland; featuring universal precursors; derived from known 
prebiotic systems; which also feed the synthesis of other biomolecules such as 
amino acids and lipid precursors.47 Furthermore, the multipurpose role of 
phosphate is described, not only as a building block, but also as buffer for 
reactions, stability and supressing side-reactions. Recently, Carell and 
coworkers reported the use of formylated aminopyrimidines as purine 
precursors to prebiotically obtain nucleosides (FaPy pathway, Scheme 1.3C).48 
Starting from reported aminopyrimidines, a regioselective formylation was 
confirmed on the amine located on the 5 position.* Incubating the formylated 
aminopyrimidine with ribose in the presence of base results in β-adenosine in 
up to 20% yield. The desired nucleoside is also obtained when feeding the 
precursors to formose-type reactions, although in lesser yield as it suffers from 
the same problems as the formose reaction itself (as discussed previously). 
Although more efficient than prior reported methods for purine nucleoside 
formation, the FaPy pathway is far from perfect. The aminopyrimidines are 
quite robust in absence of oxygen, but the formylation was carried out in high 
concentrations of formic acid, conditions incompatible with the subsequent 
formose-type chemistry. 
  
                                      
* The charge resulting from protonating the N1 or N3 of pyrimidine ring is stabilised by amine moieties 
on C2, C4 or C6. A C5 amine is spared from participating in the resonance structures as confirmed 
by the sp3-charcateristics determined by crystallographic structures. 
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Phosphorylation 
The Sutherland-type synthesis results in 2’,3’-phosphodiesters, for which 
oligomerisation is described but inefficient49-51 due to thermodynamic 
constraints.52 More work has been carried out on phosphorylation reactions of 
ready-made nucleosides. The use of inorganic phosphate salts53 and catalysts 
such as urea54 or formamide55 is needed. Also polyphosphates work56,57, but the 
most abundant source of phosphate are insoluble minerals, initially believed 
to be ineffective.58 Later some * were identified as active phosphorylating 
agents55 and others† believed to be sources of free phosphate.59 
 
Scheme 1.3. Current state of affairs regarding prebiotic nucleoside formation: (A) Classical 
combinatorial approach: inefficient for purines and ineffective for pyrimidines. (B) Systems approach to 
nucleotide synthesis, avoiding glycosidic bond formation: effective for cytosine and uracil, ineffective for 
purines (dashed bonds are theorised reactions). (C) The FaPy pathway recently discovered using 
formylated aminopyrimidines. Colour scheme: precursors from formose reactions (red); HCN-derived 
                                      
*  Copper (II) phosphates such as pseudomalachite (Cu5(PO4)2(OH)4), and hydroxylapatite 
(Ca5(PO4)3(OH)). 
† Other transition metal phosphates such as vivianite (Fe3(PO4)2(H2O)8). The affinity of prebiotic 
cyanide for the transition metal is believed to be the driving force to break up the crystal structure 
and achieve phosphate in solute, along with generating a line of interesting metallocyano catalysts.59 
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precursors (blue), either from electron discharge or polymerization experiments; Pi, inorganic phosphate 
(orange), used as buffer and reagent. 
1.1.4 Oligonucleotide formation 
If a steady source of nucleotides was present on prebiotic earth, the next issue 
would be the generation of a pool of oligonucleotides where emergent 
ribozymes could be selected and evolve beyond the need of prebiotic 
chemistry. Non-enzymatic nucleic acid condensations comprise of monomer 
self-condensation, template-directed monomer condensation, and ligation of 
shorter fragments. Since researchers started condensing nucleotides into 
oligomers, a wide range of reactions conditions has been reported.* 
Chemistry of backbone formation 
Non-enzymatic oligonucleotide synthesis has seen much diversity in backbone 
formation. While some might fall in the category of alternative genetic 
systems (Chapter 1.1.5), others were more aimed at materials chemistry63,64,  
reaction control65 or other applications.66 The state of the art discussed below 
regards the formation of a phosphoribose backbone. The amount of 
nucleophilic centers in mononucleotides is quite large (nucleobase nitrogens, 
phosphate, and sugar hydroxyl groups) for what has to be a very specific 
reaction in order to reach large oligomers. The use of RNA instead of DNA 
provides us with hydroxyl groups with higher nucleophilicity67, but introduces 
the problem of regiochemistry.62†,68 Both reactivity and regiochemistry can be 
manipulated by the use of bivalent cations, that shield the negative charge of 
the phosphate groups, promoting vicinity between monomers which can be 
further augmented by chelating effects.69 Furthermore, the hydroxyl groups 
are rendered more active and the 2’/3’-preference is influenced by different 
Lewis acids.70 Another strategy to increase efficiency of oligomer formation, 
utilises 3’- or 2’-amino derivatives.71-73 The amino group is a stronger 
nucleophile in aqueous environment, but at the 3’-end it might result in cyclic 
                                      
* For further reading the reader is referred to some excellent reviews60-62, although inspirational the 
concise literature overview presented here incorporates new elements, either more recent or from 
related fields of study. 
† As discussed in this review the mix of 2’-5’ and 3’-5’ phosphodiester bonds RNA might be evolutionary 
beneficial by reducing template interactions. (See also “Template inhibition”, Chapter 3) 
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mononucleotides.74,75 Nevertheless, this reaction has recently been proven to 
be slower when competing with templated primer extension.75 
Activation of monomers 
The activation of mononucleotides is a concern to be recognised. The 
biological triphosphates are optimised for enzyme-catalysed reactions76 and 
react too slowly (or hydrolyse too fast) to be studied in a laboratory context.3 
A new leaving group besides pyrophosphate was needed.77 One of the pioneers 
in this research field, Leslie Orgel, proposed 5’-phosphorimidazolides as 
reactive species for their prebiotic plausibility, ease of synthesis and relative 
stability.78 These reactive species still remain the benchmark for comparison. 
Analogues, such as alkyl substituted systems79 or larger aromatic systems80,81, 
also showed promise (Scheme 1.4A, left).82 Ferris investigated the leaving 
group pKa but failed to draw a correlation with reactivity.80 However, the 
presence of conjugated systems and other basic nitrogens seems to be 
important to stabilise the formation of a positive charge produced by either 
monomer formation or subsequent protonation, thus, slowing down the rate 
of hydrolysis in favour of oligomer formation.80 The prebiotic relevance of 
phosphoramidates has been questioned, and 1-methyladenine might be a 
plausible species although relatively unstable.81  
1-Hydroxy-7-azabenzotriazole esters (OAt-esters) of nucleotides deserve 
mentioning due to their efficiency in genetic copying (Scheme 1.4A, left in 
gray).83,84 The hydrolytic stability in alkaline environment (pH 8.9) is probably 
their main advantage. Furthermore, the reactivity of the system is high 
enough to perform reactions at -20 °C, enabling the use of weakly pairing 
templates.85 The OAt-esters might not have a place in prebiotic chemistry but 
they do embody the characteristics currently lacking in the origin of life 
research. 
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Scheme 1.4. Activation (A) and condensation (B) of ribonucleotides: activation (blue) by leaving 
groups (LG) based on either pre-activation or in situ activation. The N-heterocycles used, have been 
found to increase the efficiency of EDC-catalysed reactions (as co-factor). The interplay of activation 
and hydrolysis (red) is also illustrated. For condensation, the main pathways (bold) include self-
condensation and template-directed condensation and ligation; resulting in a mixture of 2’-5’ and 3’-5’ 
phosphodiesterbonds. Minor (investigated) pathways include the usage of cyclic or pyrophosphate 
monomers (hypothesis, dashed line). Figure inspired on references60,61 
The alternative to pre-activated nucleotides is in situ activation (Scheme 
1.4A, right). This strategy precedes the phosphorimidazolides as it was used 
by Orgel in his very first oligomerization experiments.86-88 Carbodiimides and 
especially water soluble EDC, are suitable activating agents. They act as the 
lab friendly analogues of cyanamide, a supposed prebiotic condensing agent.89 
Recently, in situ activation has been rediscovered by Richert and co-workers 
in efforts to increase efficiency in genetic copying experiments.90 The same 
circumstances that hamper origin of life simulations also prevent from 
achieving a reliable non-enzymatic copying system. The main issue identified 
here, is the hydrolysis of pre-activated monomers; this not only reduces the 
amount of reactants, but also produces hydrolysis products acting as 
competitive inhibitors of templated reactions.91 Further optimisation of non-
INTRODUCTION 
| 15 
enzymatic copying has identified additives (heterocyclic species) acting as 
organocatalysts during EDC-mediated condensation reactions of 
mononucleotides.90 The interesting aspect here was the superiority of 1-
methylimidazole (1-MeIm) over the previously used 2-methylimidazole (2-
MeIm). The suggested mechanism proceeds via an imidazolium intermediate, 
as was also reported previously in experiments by Orgel.92 
Monomer self-condensation 
The formation of a phosphodiester bond from inactivated mononucleotides 
involves the elimination of water. The first experiments were thus conducted 
under heating and drying conditions* and afforded low yields (< 10%) of 
short oligomers (n ≤ 6).51,94 Using EDC-activated species, mostly 
pyrophosphates were observed.87,95 Molar concentrations of reagents yielded 
similar results.96 Dehydrating conditions were found to be more effective when 
introducing a scaffold to improve monomer stacking. Phospholipid bilayers 
were introduced by Deamer and co-workers to provide such a scaffold, as 
liposomes form layered structures when collapsing under dehydrative stress.97 
Multiple cycles of evaporation and rehydration produced large oligomers (n ≤ 
100), in low yields with a size dependent on the nucleobase used. Another way 
to concentrate aqueous solutions is by eutectic freezing.98,99 Ionic solutes past 
freezing point form increasing amounts of pure water ice crystals, resulting in 
channels of liquid brines and eventually saturated compartmentalized sections 
upon further cooling.98 Despite slowing down the reaction rates, under 
optimized conditions high yields of oligomers were observed, (20-30% of 
dimers, 50-60% of n = 3-22)98,100 with an almost stochastic distribution when 
using mixtures of nucleotide 5’-phosporimidazolides.101 Both self-assembled 
bilayers and eutectic water-ice provide interesting micro-environments but 
more studies are to be expected as they also introduce many different 
parameters to the chemistry of oligonucleotide formation. Examples may 
include but are not limited to the concentration of lipid/salt, temperature, 
the rate of change, and the influence of other co-solutes (e.g. counteranions). 
                                      
* Hydrothermal vents, volcanic drying pools and ‘black’ rock heating are all scenarios used to explain 
heat-dry or wet-dry reaction conditions on prebiotic earth.93 and references therein 
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Self-condensation of mononucleotides in aqueous solutions using activated 
monomers or condensing agents has not been more efficient than the first 
heat-dry experiments (Scheme 1.4B).68,102 The interesting information derived 
from aqueous bulk experiments can be summarized into three points. Firstly, 
a large amount of pyrophosphates is formed95, even suspected to be a reactive 
species in condensation reactions.103 Secondly, the important role of 
multivalent cations was determined (as discussed previously). And last but 
not least, the phosphate activator contributes to regioselectivity. 2-MeIm 
favours 3’-5’ linkage79 over the otherwise dominating 2’-5’ species.68 
Furthermore, critical remarks should be made regarding the usage of cyclic 
mononucleotides. As mentioned before, 2’-3’ cyclophosphates are 
thermodynamically stable52 resulting in very short chains.49,51 Di Mauro 
reported similar but improved results with 3’-5’ analogues (n ≤ 25).49 
However, some controversy arose due to irreproducibility of the aqueous 
polymerisation (Nick Hud personal communication). Similar results as Di 
Mauro’s can be obtained by reactions in the dry state and certain commercial 
sources of 3’-5’ mononucleotides contain polymerized impurities accounted to 
drying during synthesis.50 
Clays and other minerals have proven their merit in prebiotic chemistry. 
Besides being a source of feedstock materials (See 1.1.3 Phosphorylation) and 
multivalent cations, the absorption of reagents on a solid surface would result 
in localized concentration and stabilise specific conformations.104,105 The 
electrostatic affinity of nucleic acids for the mineral increases as the polymer 
grows, protecting it from hydrolysis and favouring longer chain growth. The 
extensive investigation of montmorillonites by Ferris and co-workers has been 
the bulk of this field.106 In solutions containing Mg2+ ions, suspected to be 
absorbed by the montmorillonite, oligomers up to 50 nucleotides in length 
were obtained by frequent replenishment of the supernatant, ensuring the 
steady flow of activated monomers and removal of the inactivated ones.107 The 
usage of 1-methyladenine over imidazoles as activating agents increases 
reaction speed and eliminates any bias towards any of the four canonical 
nucleobases.108 Montmorillonite-catalysed polymerisations favour 3’-5’ 
linkages.106,108 Other investigated minerals include but are not limited to 
kaolinite109, hydroxyapatite110 and ferric hydroxide111. However, besides Ferris’ 
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systematic research on homoionic montmorillonites, one must account for 
many different parameters when using minerals, such as surface area and 
treatment, metallic impurities and mineral structure.109 
Template-directed monomer condensation and ligation* 
The template may be used solely, but primers and downstream elements 
increase efficiency.112 †  Hairpin forming oligonucleotides act similarly.91 
Increasing template length contributes positively to product formation.114 
However, templating strength depends foremost on duplex formation, where 
an A-helix would result in better positioning of reacting intermediates.115 The 
conformational change of activated ribonucleotides from 2’-endo to 3’-endo 
upon binding has been confirmed by NMR spectroscopy.116 The importance of 
the A-helix confirms the superiority of RNA over DNA in templated 
oligomerisation experiments.115 Furthermore, to achieve optimal duplex 
formation, high ionic strength and low temperatures are favourable but the 
formation of secondary structures is to be avoided.117 Guanosine-rich 
fragments are especially difficult due to quadruplex formation, but this can 
be suppressed by addition of Li+ ions.118  
The templated polymerisation reaction competes with oligomerisation in the 
aqueous solution and the formation of other species such as cyclic 
mononucleotides and pyrophosphates (Scheme 1.4B).74,95 The dimers and 
trimers in bulk could in fact still participate and ligate on template119 
especially when using in situ-activation and forming homopolymers. The 
sequence dependent nature of these reactions is a large concern. Despite 
several efforts, addition of oligoadenosine does not catalyse the formation of 
activated uridines and analogues efficiently.120,121 Even worse, Orgel’s 
experiments refined the sequence requirements such as the need for 60% 
cytosine residues and the identification of sequence fragments that inhibit 
                                      
* Non-enzymatic, template directed oligomerization reactions of mononucleotides have been the subject 
of much research and previously discussed aspects of oligonucleotide formation influence this system. 
Therefore, templating efficiency is the primary parameter discussed here, followed by some 
overlapping remarks. 
† The concept by Richert and co-workers has recently been proven to work on phosphorimidazolides 
(instead of OAt-esters) by Szostak. The system improves when the downstream binding elements 
are also activated species.113 
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polymerization.3,122 All of this has been overcome in non-enzymatic genetic 
copying84 but there still remains a gap between the differently aimed 
strategies. 
Also here, the influence of micro-environments has been investigated. But 
neither dehydrating liposomes nor eutectic freezing resulted in large changes. 
The first did result in higher fidelity copying97 and the latter gave adenosine 
incorporation on oligothymidine albeit after 1 year of cyclic incubation.123 
Besides being suspected to aid templated oligonucleotide synthesis, ligation of 
smaller oligonucleotides has mostly been used in experiments outside of 
prebiotic context such as investigating self-replication.124-126 However, the 
investigation of templated ligation fidelity makes it doubtful for achieving 
robust discrimination between closely related oligonucleotides.127-130 
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1.2 Towards Functionality 
The propagation of molecular information is vital towards sustaining life as 
we know it, and prebiotic earth must have had mechanisms in order to 
preserve useful information with a margin for error to allow for molecular 
evolution.* 
1.2.1 Origin of replication 
The first clue lies in the experiments regarding templated oligonucleotide 
formation (Chapter 1.1.4). The second was a derivative thereof; namely the 
conception of self-replicating oligonucleotides.125,126 The series of non-
enzymatic, template-directed condensations reactions132,133 were simplified by 
reducing it to the ligation of two monomers resulting in a palindromic 
sequence. The product formed would then act as a template, increasing the 
efficiency of replication. However, the duplex dissociation remains the rate-
determining step and hampers efficient replication.134 Since then, this concept† 
has been expanded to self-replicating small molecules135, peptides4 and 
ribozymes136. (Figure 1.1) Some systems are aimed at understanding complex 
networks137, while others are posed as prebiotical means of amplification and 
selection.131 
Going back to oligonucleotide formation: if a pool of oligonucleotides was 
present on prebiotic earth, sustained by oligomerization and template 
catalysed condensation and ligation, then ribozymic activity could emerge. 
Researching the selection of replicase activity has been the focal point of 
theoretical and experimental research, regarding the emergence and selection 
of replicase ribozymes. Eigen and Schuster defined the “quasi-species” as 
stationary distribution of closely related oligonucleotides (or other 
informational molecules), determined by the rate constants of replication, 
degradation and mutation frequencies.138,139 
                                      
* This has been dubbed “Unnatural Selection” in analogy with Darwinism but on a suborganismal 
level131 
† For a full explanation of the minimal replicator theory, the reader is referred to Chapter 3  
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Figure 1.1. An overview of self-replicating molecules (A) Von Kiedrowski’s palindromic hexanucleotide125, 
phosphodiester formed by EDC reagent; (B) Prototypical small molecule replicator by Philp135, the use of Dynamic 
Combinatorial Chemistry adds a new dimension; (C) Paul and Joyce’s ribozyme136, the first truly autocatalytic 
system (p = 1), phosphodiester bond formed by ligation of triphosphates by the ribozyme, A and B fragments form 
together T (template); (D) The self-replicating peptides by Ghadiri and co-workers140, the peptide sequence in top-
down view (left), schematic representation of the templated reaction (right), one should note the lack of specific 
interaction in this system (hydrophobic interactions between V(aline) and L(eucine)), the bond formed here is an 
amide bond starting from thioester and amine. Colour scheme: crucial bond and formation (red), complementary 
interactions (blue, green).   
This sets important threshold values for fidelity, genome size and replication 
speed in which molecular evolution could proceed. The experimental evidence 
is found in viral RNA polymerases. Spiegelman pioneered by incubating 
bacteriophage Qβ’s RNA genome with RNA-dependent RNA polymerase* and 
this resulted in deletion of genomic redundancy in respect to replication. The 
ability to form viral particles was lost in the process.141 Recently, directed 
nucleic acid evolution has led to investigate ribozymes as catalysts of 
                                      
* a protein, not a ribozyme 
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oligonucleotide formation.142 Such RNA polymerases have reached high 
accuracy; however, they remain limited to introducing a dozen nucleotides in 
primer extension experiments.143,144 The most interesting result came from 
ribozyme catalyzed ligation experiments, in fact a replicator was made by 
ligating precursors of a ribozyme.136 The previously mentioned minimal 
replicator based on a ribozyme was in fact the very first truly exponential 
growing system developed (p = 1, see Chapter 3). 
1.2.2 Origin of translation* 
Introduction: Refining the RNA world 
Many of the flaws regarding the RNA world are related to achieving the end 
goal of the abiotic generation of a self-replicating ribozyme. The combination 
of oligomerization and ligation experiments still falls short of obtaining a pool 
of oligonucleotides long enough to exert polymerase activity.144 The nature of 
the catalytic entity is sequence dependent and limited to the subunits used.138 
Thus, optimizing the activity comes either from sequence, length, post-hoc 
modification or using other subunits. Although alternate genetic systems 
which might evolve into a catalytic one are possible (Chapter 1.3), the 
simplest solution is to increase the amount of monomers. Here lies the strength 
of proteins, with 20 chemically different monomers which reduces the amount 
of condensations reactions needed to select for activity.† 
The advent of proteins has been posed as an evolutionary advantage, not only 
by the ease by which they are formed (Chapter 4.1) but especially by 
increasing the catalytic efficiency.146 The first scenario would be peptide 
fragments acting in cohort with ribozymes, later completely replacing them. 
Following this logic, the ribosome has been considered as a prebiotic relic 
(Chapter 1.1.1).5,147 However the question still remains how the transition 
between nucleotide and amino acids occurred. The act of RNA amino 
acylation must have provided an advantage such as protection from 
                                      
* This chapter is dedicated to the transfer of information between oligonucleotides and peptides and the 
evolution of the translational machinery, for more on prebiotic peptide formation see Chapter 4.1. 
† Also being one of the main arguments to advocate the “Protein-world”145 instead of the “RNA-world” 
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degradation148 or anchoring in a suitable environment148 before any 
translational machinery or processes could evolve.  
Genetic code’s origin: Accident or Evolution? 
The discovery of the genetic code is an interesting story in itself, culminating 
in 2 Nobel prizes, one for the RNA (bio)chemistry needed (Ochoa and 
Kornberg, 1959) and one for its actual discovery (Holley, Khorana and 
Nirenberg, 1968). Although a detailed account of this research falls beyond 
the scope of this dissertation, some of the discussions remain relevant to the 
still unknown origin. The first theories revolved around the numbers game on 
how to reconcile 20 amino acids with only 4 nucleobases. Gamow proposed 
triplets resulting in 64 codons, as duplexes would only result in encoding 16 
amino acids.149 Although the latter could fit in simplified genetic system as 
posed in Chapter 1.3, the genetic code itself could have been operating with 
less redundancy, when looking at the system in current mammalian 
mitochondrial cells (Appendix A).150 Gamow’s ideas fuelled those from 
Crick151,152 and Orgel.152,153 Crick stated the genetic code as result of a ‘frozen 
accident’ as the genetic code was universal* and any change would result in 
lethality by significant alterations of protein sequences and functionality. 
Although he did not oppose to some type of “stereochemical” order according 
to Woese.151 This theory related the codons to amino acid through physico-
chemical qualities. A paper by Orgel153 in 1972 carefully stated the link 
between peptide hydrophilicity/hydrophobicity and the ratio of pyrimidines 
and purines. 
Current theories regarding chemical selection of amino acids are fueled by 
recent aptamer research.155 Direct RNA Templating (DRT) by Yarus156 
describes an oligonucleotide with different amino acid binding sites and 
multiple codons, facilitating peptide formation by proximity. Efficiency and 
selection would lead to the advent of the genetic code. Another angle came 
from Szathmary, according to whom the genetic code preceded peptide 
synthesis with a focus on the advent of tRNA.157 Oligonucleotides would select 
for amino acid conjugates and subsequently act as cofactors by base pairing 
                                      
* Small exceptions are currently known throughout the nature154  
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with ribozymes. This would imply an anti-codon selected for amino-acids in 
contrast to DRT. However,  research has indicated the separate evolution of 
the two main regions of tRNA, which segregate the amino acid attachment 
site from the anticodon.158 The segment containing the latter has been proven 
to be unnecessary for successful enzymatic amino acylation.159 In this light, it 
was proposed that the mini-helix159 (with acceptor stem) came first, exercising 
a chemical selectivity on amino acid side chains. The anti-codon segment then 
led to more efficiency, by supramolecular assembly and was later covalently 
integrated in a complete tRNA molecule.159  
Experimental evidence of the spontaneous formation of anti-codon-like amino 
acylation might be found in the recent publications of Richert and co-workers 
on the simultaneous formation of peptides, RNA oligomers and peptidyl RNA 
while copying RNA sequences (Figure 1.2).160,161 Not only is the concurrent 
and compatible establishment of these processes interesting, selectivity in 
forming peptidyl RNA may give important clues as to what preceded the 
genetic code. The key peptide-RNA hybrid is a  5’-phosphoramidate*, instead 
of the biological 2’/3’-aminoacyl species. The latter has been previously 
reported as the suspected intermediate in prebiotic peptide synthesis163, and 
the former also identified as a more stable species in these systems164, although 
no in-depth evidence (e.g. NMR over TLC) for structural characterization 
were provided.163,164 The stability of the 5’-phosphoramidates in aqueous 
solution would yield a prebiotic advantage over the aminoacyl adenylates 
requiring in situ formation or solid state conditions.163,164 
                                      
* 5’-phosporamidates of amino acids and mononucleotides can also be used as oligonucleotide building 
block by viral polymerases162 
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Figure 1.2. The spontaneous formation of RNA Strands, peptidyl RNA, cofactors and copying of 
RNA Sequences with in situ activation: Experiments A-D are all separate, but are conducted in the 
same condensation buffer (0.8 M EDC, 0.15 M 1-ethylimidazole, 0.08 M MgCl2, 0.5 M HEPES pH 7.5). 
Experiment A: double stranded sequence on beads with downstream element, mononucleotides, Ac-Gly 
and Phe-OEt result in oligonucleotides, peptide bond  and primer elongation. Experiment B-C: peptide 
bond formation with AMP results in (oligo)peptidyl RNA, Experiment D: pyrophosphate bond 
formation for synthesis of co-factors. Figure adapted from reference160 
Although the evidence for an evolved genetic code increases, the ‘frozen 
accident’ has not been put on ice. Recent research165 has shown that if 
evolution of the code aimed at decreasing the stereochemical distance between 
codons of related amino acids, there might remain some distance to cross.* 
The lack of obtaining a completely optimized system points towards a 
grayscale situation were some evolution got frozen in time. 
  
                                      
* Yet again there is a lively discussion on the feasibility of these assumption-driven calculations in the 
community, as touched upon in the cited review  
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1.3 Alternative genetic systems: The “Pre-RNA” world 
1.3.1 Keeping the faith in a genetic-first approach 
Although several issues have been dealt with when researching the advent of 
a genetic system on earth, some problems remain for the RNA-world 
hypothesis. First of all, the conversion of cytosine to uracil is relatively fast 
on a geological time scale166; which poses problems for achieving a chemical 
system dependent on all four current nucleobases. Also the multitude of 
analogues obtained by the pathways of Scheme 1.2 and the difference in 
efficiency, poses the question whether a different genetic system was present 
on prebiotic earth. The previously discussed issues regarding the formation of 
oligonucleotides and transfer of information also contribute to this idea, 
together with RNA’s inherent sensitivity to hydrolysis.167 This “pre-RNA 
world” has been roughly divided into two research fields, the ones looking at 
nucleobase analogues and those researching alternate backbone systems to 
counter the difficulties of nucleotide formation.  
1.3.2 Alternative genetic backbones* 
The problems regarding templated phosphodiester formation (Chapter 1.1.4) 
have resulted in the introduction of alternative ways to link ribonucleotides, 
among them are triazoles63,66, disulfides169, imines170, esters171 and amides72,73. 
But more of prebiotic interest are the nucleic acid analogues and linkers with 
potential roots in the synthetic pathways proposed for abiotic formation of 
sugars, amino acid and lipids (Figure 1.3). One condition remains important, 
namely the ability to hybridize with itself or other nucleic acids in order to 
transfer information.  
                                      
* Cairns-Smith166 proposed mineral defects as the first “genetic code”. Difference in selectivity in these 
defects would result in bias towards the sequences made by absorbing on minerals (See 1.1.4, 
“Clays”). 
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Figure 1.3. Overview of prebiotic plausible genetic backbones mentioned: repeating monomeric unit 
depicted (black). LNA is not considered to be prebiotic (completely grey structure). B = nucleobase. 
Based on reference172 
The chemical simplification173 of RNA gave glycerol-derived (GNA) and 
threose nucleic acid (TNA). The first, an acyclic RNA-like system partakes in 
non-enzymatic oligomerisation experiments when templated174 and its 
triphosphates can be used by DNA polymerases.175 However, the need for 
reducing the glyceraldehyde hemi-aminal actually increases the complexity of 
a plausible prebiotic synthesis.176 TNA consists of an α-L-threofuranosyl 2’-3’ 
phosphodiester backbone, in fact the simplest sugar scaffold that could be 
used without resorting to ring strained species.177 It hybridizes with RNA and 
DNA, is a possible substrate for DNA polymerases178 and folds in three-
dimensional structures with aptameric properties.179 Further investigation of 
pentoses, hexoses and sugar analogues resulted in the advent of artificial 
genetic polymers.180 Some might be prebiotically relevant181, meanwhile some 
might interact with pre-existing biological processes while others could take 
part in a genetic system completely orthogonal* to the current one.182 Two 
classical examples are the pyranose isomer of RNA (pRNA) and locked nucleic 
acid (LNA). Both pRNA and LNA have performed in non-enzymatic 
oligonucleotide synthesis and the higher duplex stability, especially from 
pRNA and other pentopyranoses, show that RNA was not the evolutionary 
product of maximizing base-pairing strength.181 
                                      
* The search for orthogonal genetic systems and their polymers (XNA) currently resides in the field of 
synthetic biology.  
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Alongside some sugar analogues, the most important alternative genetic 
backbone might be a peptide. Before the advent of Nielsen’s peptide nucleic 
acids (PNA)183, Orgel tried templated oligomerization of amino acids with a 
nucleobase side-chain, albeit unsuccessfully.184 PNA was discovered as gene-
targeting entity with therapeutic applications in mind183; but its flexibility, 
stability and affinity for natural nucleic acids boosted the research for other 
applications.185-188 Since then, the original N-(2-aminoethyl)glycine backbone 
has seen several analogues such as using proline for conformational restriction 
and other amino acids for chirality and side-chain interactions.187 Despite the 
discovery of the original achiral backbone in prebiotic experiments189, abiotic 
knowledge of monomer synthesis and polymerization still lacks.186 The latter 
has been done on both PNA and RNA templates with PNA dimers185, as the 
monomers tend to cyclize into piperazinones upon chemical activation. 
Although, the lack of chemical background has not hampered the use of PNA 
as complementary strand in ligation or polymerization experiments.188,190,191* 
In those many examples, one other property is revealed. The achiral backbone 
easily adopts the chirality of the opposing strand or is influenced by the 
chirality of only a few monomers.192 However, chiral cross-inhibition with a 
racemic mixture of building blocks still occurs.193,194 Nevertheless, the creation 
of PNAzymes adds to the interesting properties of PNA, even though it was 
through the covalent addition of a Cu2+ complex.195 
1.3.3 Non-canonical nucleobases†  
Moving beyond the nucleobases used in RNA and DNA, is not unnatural as 
the present-day genetic and translational system already uses more 
heterocyclic species. Besides intermediates formed during biosynthesis; 
posttranscriptional modifications197 are an interesting inspiration for non-
canonical nucleobases. The large variety of purine and pyrimidine heterocycles 
                                      
* And many more 
† An interesting review on possible prebiotic purines and pyrimidines can be found in a recent text by 
Cafferty and Hud.193 The reader is especially directed to Figure 3 discussing the chemical space of 
nucleobases in regard to qualities currently addressed to canonical nucleobases, such as hydrogen 
bonding and self-assembly. The discussion of alternate nucleobases here will comprise of classical 
examples used and obtained by chemistry with a prebiotic goal. 
INTRODUCTION 
28 |  
“prebiotically” obtained, fuel the need to consider their inevitable 
introduction in the earliest genetic systems, be it useful or not.  
Figure 1.4. Overview of prebiotic plausible non-canonical base pairs mentioned A = adenosine, U 
= uridine, I = inosine, D = diaminopurine, s2U = 2-thiouridine, 3-isoA = 3-isoadenosine. R = glycosidic 
bond 
The purine hypoxanthine, analogous to uracil, has already been proposed to 
complement adenosine in an all-purine RNA by Crick in 1968.151 This 
hypothesis finds support in the favourable synthetic pathways and increased 
stacking interactions for purines. It would also simplify the advent of RNA to 
a binary system, without much implications toward the genetic code due to 
the wobble position in codons.151 However, the helix formation between 
inosine-adenosine oligomers under prebiotic conditions remains to be 
observed.198 The poor incorporation of uridine in template directed 
oligomerisation experiments kept scientists searching for alternatives.120,121 The 
first strategy was using 1,3-diaminopurine as complementary base for 
increased hydrogen bonding.199 However, this was only completely successful 
when replacing uracil by 5-(1-propynyl)uracil200, probably due to increased 
dipolar and stacking interactions. The same might also count for 6-
ethynylpyridone, the respective C5 nucleotide found to pair adenine in similar 
strength as the G-C couple.201 An alternate strategy to improve the A-U base 
pairing is the use of 2-thiouridine, proven to express increased incorporation 
rate and fidelity of non-enzymatic RNA primer extension experiments.202 2-
Thiouracil has the added advantage of prebiotic plausibility in a sulfur rich 
environment. Hoogsteen base pairing can also been used to influence 
templated reactions, examples include the polymerisation of activated 
adenosines on polyuridine templates in a triple helix203 and the use of 3-
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isoadenosine.199 Besides the above mentioned alternate basepairs, more 
synthetic additions to the genetic alphabet are known; mostly finding their 
application in synthetic biology but not in prebiotic chemistry.204  
 
 
Figure 1.5. Modified uracils obtained by prebiotic plausible means: All except for thymine (grey), 
the reduction of 5-hydroxymethyluracil (HMU) by formate requires high concentrations205. General 
reaction conditions as reported by Miller: 1.10-3 M 5-hydroxymethyluracil, 0.1 M nucleophile, pH 7, 100 
°C, 1 d. Yields > 90% except for guanidine (2%), glycine (56%), ammonia (31%). Figure adapted from 
reference206 
Besides high strength and fidelity base pairing, another goal for modified 
nucleobases is to add functionality. Transfer RNA (tRNA) acts as biological 
inspiration source. Its extensive post-transcriptional ribonucleotide 
modifications are essential to folding, secondary and tertiary structure, and 
thus function.207 Among the modifications are functional groups of present-
day amino acids, potentially increasing the catalytic functionality of early 
nucleobases and nucleic acids.146,197 Continuing in the spirit of Nielsen’s 
research (PNA) on peptide-nucleic acid hybrids, Robertson and Miller proved 
the prebiotic viability of RNA-peptide hybrids derived from uracil (Figure 
1.5).206  
To summarize, pre-RNAs might support starting up the RNA world by 
reducing synthetic complexity or increasing genomic stability. Adhering to 
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this theory, the transition of informative systems would have been gradual by 
heteroduplex formation and early catalytic species. As a case study, the 
peptide-nucleic acid hybrid is a prime example of the emergence of new ideas 
to tackle the problems currently faced in origin of life research by combining 
elements of historically opposing fields. 
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2.1 Project overview 
The propagation and translation of molecular information is vital towards 
sustaining life as we know it. Several parallel trends in designing systems 
holding molecular information are found in the literature. Supramolecular 
chemists developed molecular ‘receptors’ to accommodate various substrates 
ranging from simple ions to more complex molecules and polymers. A more 
specialist approach has been developed by chemists working with self-
replicating nucleic acids and even proteins, but not without setbacks such as 
product inhibition. To counter such setbacks we plan to promote the leaving 
group (LG) as an information carrier. So far, in conventional chemistry an 
LG is mostly optimized to obtain high yield and a fast substitution reaction. 
Inspired by the chemical simplification of tRNA as LG and information carrier 
during protein synthesis, developing LGs based on nucleobases or other self-
recognizing structures is a new way to develop ‘molecular genetics’. However, 
this is not only an attempt to create ‘chemical life’, this is a project to grasp 
the complex dynamics behind biochemical systems while developing an 
unconventional approach towards programming molecular information. 
2.2 Goals 
The first objective of this project is designing monomers required for the above 
mentioned concepts. In this research, the following three factors to link 
nucleobases to either amino acids or nucleotides are taken into account: linker 
size and position, the difficult balance between reactivity and stability, and 
necessary protective strategies. 
Figure 2.1: Schematic representation of the leaving group approach 
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A schematic representation of our proposed concept is depicted in Figure 2.1. 
The LG, holding the molecular information for (self) recognition such as base 
pairing and aromatic stacking, will be linked to the monomer of interest by a 
reactive bond. The linker will be chosen according to the reactive bond used, 
in order to manipulate the reactivity and stability of the envisaged building 
block. However, the linker itself could also become a system capable of self-
recognition, for example stacking interactions. Successful polymerization is 
achieved when a monomer drives out the LG of the next monomer in line, by 
breaking the reactive bond and replacing it with a more stable one.  
Secondly and as a proof of concept, the designed monomers will be tested in 
simple reactions. This will provide critical design feedback especially for areas 
such as solvent solubility, reactivity and specificity. The obtained results 
facilitate new models, providing better insight into complex systems. 
2.3 Projects 
Following our inspiration and proposed concept, two main projects were 
devised according to the chemistry involved. When using nucleotides as 
monomers linked to an informational LG, oligomerization will result in the 
formation of a new template; essential in achieving a self-replicating system 
(Chapter 3: Chemical Replication). On the other hand, amino acid monomers 
will result in peptide synthesis that reminds of cellular translation (Chapter 
4: Chemical Translation). 
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3.1 Introduction* 
The search for efficient non-enzymatic replication of nucleotides is of vital 
importance for origin of life research especially regarding to the RNA-world1 
hypothesis. Starting from a series of non-enzymatic, template-directed 
condensation reactions2,3 and after a few simplifications; an autocatalytic 
oligonucleotide4 was developed. Subsequently, more artificial replicators, 
either being nucleotides5-8, peptides9-11 or small molecules12, appeared and 
began participating in more complex systems13 (Figure 1.1). However, the 
analytical evaluation of all these replicators is still based on the same 
principles as discussed by von Kiedrowski in his minimal replicator theory.14 
The minimal replicator is based on the two, experimentally used, 
simplifications: a reaction cycle containing only one condensation step and 
using a self-complementary template. The latter is in contrast to natural 
nucleic acid replication which is cross-catalytic, where one strand catalyses 
the formation of the other and vice versa. The minimal replicator model 
consists of two precursors, A and B, and a template molecule C, 
complementary to A and B and facilitating the unidirectional ligation reaction 
between them by the reversible formation of a ternary complex ABC. The 
reversible dissociation of resulting duplex C2 gives two C molecules as product, 
each capable of beginning a new replication cycle (Figure 3.1a). 
The analytical treatment provides tools to quantify and compare structurally 
different catalyst based on thermodynamic and kinetic data. One derived 
parameter is the autocatalytic reaction order p, describing the autocatalytic 
behaviour of the system. At p = 1, the reaction rate increases linearly with 
increasing amounts of template as expected with exponential growth. On the 
other hand, the square root-law of autocatalysis4 (p = 0.5) describes the rate 
of autocatalysis as being proportional to the square root of initial template 
concentration. The latter case is a frequently witnessed phenomenon4,7,8,10,15 
                                      
* Excerpt previously published (as joint first author) in:  
E. Bigan, H.-P. Mattelaer, P. Herdewijn, Theoretical Analysis of a Self-Replicator With 
Reduced Template Inhibition Based on an Informational Leaving Group. J. Mol. Evol. 82, 
93-109 (2016).  
With adapted layout and phrasing for inclusion in this dissertation 
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attributed to a strongly-bound template duplex and is generally known as 
template inhibition. Much research has gone in overcoming or avoiding such 
inhibition, by destabilizing the C2 complex. Common strategies include 
distorting the template backbone11,16 and reducing template size6,9.* 
Here we propose and analyse theoretically a chemical scheme to counter 
template inhibition by reintroducing an old concept. Inspired by the 
functionality of a few noncoding RNA18 , we propose to promote the leaving 
group (LG) in self-replicating systems from plain activating agent to 
information carrier. This informational leaving group (ILG) approach is best 
illustrated by tRNA, acting as LG and information carrier during protein 
synthesis. Other examples from nature can be found among self-splicing 
introns. Moreover, these oligonucleotide LGs express ribozyme activity 
besides recognition elements needed to excise the intron.19,20 However while 
tRNA acts as conduit for information transfer, introns serve a more selfish 
role consisting of self-recognition, cleavage and product release. 
Implementing an ILG strategy in autocatalysis was first suggested by Song 
and co-workers in a paper reporting the use of pyrophosphate-linked 
dinucleotides as substrates for DNA polymerases.21 Furthermore, these 
compounds seem to be important intermediates in non-enzymatic 
oligonucleotide synthesis.22 Pyrophosphates not only spark the interest of 
prebiotic scientists, they are also known for playing a role in cellular processes 
such as energy metabolism (cofactor NAD+) and DNA repair (poly(ADP-
ribose)).23 Thus, in light of these old problems and new interests, we propose 
to expand the LG-strategy of Song et al. to non-enzymatic replication and we 
analytically compare this proposed Informational Leaving Group model (ILG 
model) with the minimal replicator model. (Chapter 3.2: ILG in autocatalysis) 
  
                                      
* A new approach can be found in the recent primer-extension experiments by Szostak and co-workers, 
where he used oligoarginine peptide to slow down strand reannealing.17 
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Furthermore, an attempt was made to synthesize a monomer designed to 
implement the ILG strategy in the non-enzymatic, template-directed 
condensation reactions (Chapter 1.1.4) from which the minimal replicator 
originated.2,3 Although less pronounced due to a different experimental angle, 
these reactions stall by suffering from similar template inhibition by 
complementary elements24; which we try to counter using the ILG strategy 
(Chapter 3.3: ILG in non-enzymatic oligonucleotide synthesis). 
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3.2 ILG in autocatalysis* 
3.2.1 Model 
Chemical reaction system 
Figure 3.1 illustrates both von Kiedrowski's original minimal replicator 
model14 and the proposed ILG model. In both models, precursors (A, B) and 
template (C) reversibly form a termolecular complex ABC, and a subsequent 
series of kinetic and/or equilibrated steps lead to template self-replication. 
Similar to von Kiedrowski's original work, the approach followed here is that 
of a minimal model where all transient complexes between the template and 
the precursors are neglected. This results in the minimal replicator and ILG 
models given below. 
Minimal replicator model consists of two fast quasi instantaneously 
equilibrated bidirectional reactions (Eq. 1 and 2) and one unidirectional rate-
limiting step (Eq. 3) with kinetic constant k. 
 
 +  +  ⇌   (1) 
 ⇌   (2)  →   (3) 
 
with associated equilibrium constants: 
 
	 =  (4) 
  
 =  (5) 
                                      
* Excerpt previously published (as joint first author) in:  
E. Bigan, H.-P. Mattelaer, P. Herdewijn, Theoretical Analysis of a Self-Replicator With 
Reduced Template Inhibition Based on an Informational Leaving Group. J. Mol. Evol. 82, 
93-109 (2016).  
With adapted layout and phrasing for inclusion in this dissertation 
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ILG model consists of three fast quasi-instantaneously equilibrated 
bidirectional reactions (Eq. 1, 2 and 6) and one unidirectional rate-limiting 
step (Eq. 7) with kinetic constant k.  
 
 +  ⇌   (6)  →   (7) 
 
with associated equilibrium constant for Eq. 6: 
 
 =  (8) 
 
Figure 3.1. The minimal replicator (a) and the ILG model (b): Participating species are: a) 
precursors (A, B), template C, termolecular complex ABC and duplex C2, b) precursors (A, B), 
template C, termolecular complexes ABC and D, duplex C2 and leaving group L. Kn denotes the 
association constants of the respective complexes, k represents the (pseudo)irreversible step where a 
covalent bond is formed (and broken).  
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The reactions that were listed above for the ILG model are necessary for 
template self-replication. However, the formation of unwanted complexes is 
also possible: 
1.  Precursors A and B may bind to one another in two possible ways: looking 
at the schematic in Figure 3.1b, either B binds on top of A with 
equilibrium constant K2, or A binds on top of B with equilibrium constant 
K3.* This may lead to a chain polymerization giving sequences (AB)n, 
where n is an integer. It can be easily shown that if K2[B]K3[A] ≈ 1, then 
A and B freeze into such chain polymers and are no longer available as 
free precursors. On the contrary, if K2[B]K3[A] << 1, then the amount of 
chain polymerized complexes is negligible. In the remainder of this text, 
we shall assume the latter. 
2.  Complexes ABC, D and C2 may also chain polymerize by binding to one 
another in any order, with associated equilibrium constant K2. Precursors 
A and B may also participate in such higher-order complexes. In the 
remainder of this text, we shall assume that the total amount of template† 
c is much smaller than the total amount of precursor, a or b, so that in 
the above assumed regime, K2[B]K3[A] << 1, the contribution of all such 
complexes can be neglected. 
3.  The leaving group L may bind to the template C to give the complex LC 
with equilibrium constant K3. Such a complex may block further self-
replication of C and should therefore be taken into account. Precursor B 
may also bind to this complex to give the complex LBC but in the above 
assumed regime, K2[B]K3[A] << 1, the contribution of this complex can 
be neglected. 
Within the assumed regime of K2[B]K3[A] << 1,the only unwanted reaction 
that should also be taken into account is: 
  
                                      
* The current association constants do not take into account the difference in entropic contribution by 
cooperative binding. This will be clarified by introducing ‘best’ and ‘worst case’ scenarios later on 
for a detailed example (Table 3.1 and relevant discussion text).   
† The following conserved quantities (notation: one uncapitalized character in italics) are defined in 
Equations 11-13.  
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 +  ⇌   (9) 
with associated equilibrium constant 
 =  (10) 
Rapid equilibria 
The model aims at quantifying the rate of template replication at short times 
after mixing a solution containing only the template with a solution 
containing the precursors. It assumes that right after mixing, the chemical 
system reaches thermodynamic equilibrium (as the result of quasi-
instantaneously equilibrated reactions) before the rate-limiting, unidirectional 
step starts to proceed. 
Minimal replicator model: the starting equilibrium state can be determined 
knowing the initial template concentration called c (the total amount of 
template in whichever form; single-strand C or duplex C2 divided by the total 
volume) as well as the initial precursor concentrations a and b (which are the 
total amount of precursors A and B, respectively). This is because the 
quantities a, b and c  are conserved by the equilibrated reactions, which results 
in: 
 =  +   (11) 
 =  +   (12) 
 =  +  +   (13) 
Assuming the initial amount of template is much smaller than the amount of 
precursors, c << a or b, we have [ABC] < c << a or b so that: 
 
 ≈   (14) 
 ≈   (15) 
Defining the dimensionless quantity q as: 
 
 = 1	 (16) 
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and using it in Equations 4 and 5 gives [C] and [C2] as a function of the single 
unknown [ABC]: 
 
 =   (17) 
 = ()  (18) 
 
Feeding the above equations in Equation 13 makes [ABC] the solution of the 
following quadratic equation: 
 
 = (1 + ) + 2()  (19) 
which has a single positive solution: 
 
 = 8 + (1 + ) − (1 + )4  (20) 
ILG model: besides the conserved quantity a, b and c, the system of 
equilibrated reactions has an additional conserved quantity which is the 
amount of leaving group l (which might be initially present as the result of 
residual hydrolysis in the starting precursor solutions). These conserved 
quantities are given by: 
 
 =  +  ≈   (21) 
 =  +  ≈   (22) 
 =  +  +  + 2 + 2  (23)  =  +  +   (24) 
As for the minimal replicator model, the initial amount of template is also 
assumed to be much smaller than the amount of precursors, c << a or b, thus 
the contribution of termolecular complex ABC to the conserved quantities of 
the precursors is again negligible (Eq. 21, 22).  
Using the dimensionless quantity q (Eq.16) in Equations 4, 5 and 8 gives [C], 
[LC],[C2] and [D] as a function of two unknowns [ABC] and [L]: 
 
 =   (25) 
 =   (26)  = ()  (27) 
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 = ()  (28) 
Feeding the above equations in Equations 23 and 24 makes [ABC] and [L] 
solutions of the set of coupled equations (Eq. 29, 30); with a single positive 
solution, but without any analytical expression. 
 
 = (1 +  + ) + 2() 
        + 2() (29) 
   = (1 +  + ()) (30) 
AB complex formation: for both the minimal replicator and ILG models, the 
above analysis neglects the possible formation of complexes by direct 
association between the precursors A and B. If the formation of such an AB 
complex has an equilibrium constant K0  and is no longer neglected, then the 
conserved quantities a and b in the above equations should be replaced by the 
unbound concentrations of A and B, which are given by: 
 
 = ( − !) − 1 + "
( − !)) + 2( + !) + 1
2  
(31) 
   = ! −  +  (32) 
and where cA and cB  are the total known concentrations in bound and unbound 
form of respectively A and B. If there are multiple different such complexes 
(as is the case for the ILG model (Figure 3.8)), then K0  should be replaced in 
the two above equations by the sum of association constants for all such 
complexes. 
Template self-replication 
Starting from the above equilibrium that is reached quasi-instantaneously 
after mixing the template and precursor solutions, the total template 
concentration c (in whichever form - unbound or bound) starts to increase as 
the result of the unidirectional rate-limiting step. The rate of increase in c is 
given by: 
 
d
d$ = % (33) 
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Another quantity of interest is the autocatalytic order p defined as the 
exponent such that: 
 
d
d$ = &' (34) 
Combining and differentiating Equation 33 and 34 gives: 
 
( =  dlog(
--$)dlog() =
d(log())
d(log()) =

 
d
d  (35) 
 
Minimal replicator model: differentiating Equation 20 according to Eq. 35: 
 
( =  48 + (1 + ) − (1 + )8 + (1 + ) (36) 
 
ILG model: the two conserved quantities c and l are both varying as the 
result of the unidirectional rate-limiting step, and at the same rate: 
 
d
d$ =
d
d$ (37) 
which is given by Eq. 33. Differentiating Equations 29 and 30 gives: 
 
d
d$ = (1 +  + )
d
d$   
               +  dd$ + 4
d
d$   
               +2(2 dd$  + 
d
d$ ) (38) 
 
d
d$ = (2 + ) 
d
d$   
               +(1 + () + ) dd$  (39) 
Equating the two above expressions (according to Eq. 37) gives the following 
expression for d[L]/dt: 
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d
d$ =  
d
d$ ×
4 + (1 + ) + 21 −   (40) 
Feeding this back into Equation 38 or 39 and rearranging terms gives: 
 
 dd$ =
d
d$ ×
1 − /  (41) 
from which the autocatalytic order p can be determined using Equation 35: 
 
( =  ×
1 − /  (42) 
where: 
 
/ = (4 + (1 + ))(1 +  + )                 +4 + (1 + ) (43) 
3.2.2 Results 
The following numerical values are used in this section for both the minimal 
replicator and ILG models: a = b = 1.10-3 M and c = 1.10-4 M as in the original 
paper.14 The total, initial amount of leaving group l is an additional conserved 
quantity in the case of the ILG model, for which two extreme values are 
considered: l = 0 and l = 10×c = 1.10-3 M. The former assumes hydrolysis of 
precursors prior to mixing the precursor and template solutions is negligible. 
The latter corresponds to a situation where the purity of the initial precursor 
A solution is only 50% due to significant hydrolysis prior to mixing the 
precursor and template solutions. Further details on the source of l will be 
elucidated when discussing the detailed comparison between the two models. 
General comparison 
For a given k, the ratio [ABC]/c quantifies the relative rate of increase of the 
total template quantity c (Eq. 33). Figure 3.2 shows the autocatalytic order 
(top) and the ratio [ABC]/c (bottom) as a function, of K1 and K2 for the 
minimal replicator model, and of K1 and K = K2 = K3 for the ILG model for 
two different choices of total amount of leaving group l = 0 or l = 10×c. The 
rationale for the choice K2 = K3  for the ILG model is that the bonds involved 
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in the corresponding equilibrated reactions are comparable. This will be made 
clearer with the reference example described in the following section. 
Comparing the bottom plots of Figures 3.2b and 3.2c, the rate of template 
replication decreases on increasing the total amount of leaving group, l. This 
is because the concentration of template bound to a leaving group [LC] and 
that of template duplex bound to a leaving group, [D], both increase on 
increasing l, which in turn contributes to decrease [ABC] because of the 
conservation relation in Equation 23. 
Comparing the top plots of Figures 3.2b and 3.2c, the autocatalytic order p 
increases on increasing the total amount of leaving group, l Although 
surprising at first sight, this may be understood as follows. The lower the 
initial l, the higher the initial rate of template replication. Any template 
replication results in an equal leaving group production rate (Eq. 37). This 
produced leaving group binds to the duplex, thus reducing the rate of increase 
of template replication. And the lower the initial l, the relatively larger this 
inhibition mechanism. In the extreme case where l >> c, then [L] ≈ l and 
from Equation 29, [ABC] is solution of: 
 
 = (1 + (1 + )) + 2()(1 + ) (44) 
which has the same form as Equation 19 for the minimal replicator model, 
replacing q by q(1+ K3l) (or equivalently, replacing K1 by K1/(1+ K3l)) and 
K2  by K2 /(1 + K3l). Increasing l is thus formally equivalent to decreasing 
both K1  and K2 , which asymptotically makes the autocatalytic order close to 
unity as can be seen from Figure 3.2a. This is also the reason why, whereas p 
≥ 0.5 for the minimal replicator model, p may turn negative for the ILG model 
(which would correspond to a sublinear c trajectory). 
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Figure 3.2. Autocatalytic order p (top) and [ABC]/c ratio (bottom) as a function of the decimal logarithm of K: K1  and K2 for the minimal replicator model (a); and, K1 and K = K2 = K3 for 
the ILG model with a total amount of LG of l = 0 (b) and l = 10×c (c). For each plot of p, the vertical axis scale has been adjusted to the range of variation. 
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However, we shall see in the next section below that for a realistic numerical 
example, mirroring that of von Kiedrowski14, the autocatalytic order p for the 
ILG model can actually exceed that for the minimal replicator model. 
It should also be noted that the assumed regime of K2[B]K3[A] << 1 imposes 
K2   < 1/b = 1.103 M-1 and K3  < 1/a = 1.103 M-1. This restricts the applicability 
of Figures 3.2b and 3.2c to the quadrant defined by 2log (K) < 6 and log (K1) 
< 6 (assuming for the latter that K1  is comparable to K2K3, which is itself 
comparable to K2). 
Detailed comparison for a hexanucleotide template reference example 
Figure 3.3 shows the reference hexanucleotide example used for the detailed 
comparison between the minimal replicator and ILG models. Whereas a DNA 
hexamer was used previously4,14, the proposed ILG model relies upon RNA 
(because of the necessary 5'-5' and 3'-2' bonds) instead of DNA. For the sake 
of consistency, we chose to compare the proposed RNA-based ILG model with 
a RNA-based minimal replicator model using the same hexamer template 
(GCGCGC). 
 
Figure 3.3. ILG model: Example template and precursors used for the detailed comparison with 
the minimal replicator model. Other molecules and complexes that are formed in the course of 
template self-replication are also shown. 
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Such a palindromic sequence was taken from previous experimental work4 
where its self-complementary nature was needed in order to create a minimal 
replicator. In contrast, the example template chosen for the proposed ILG 
model should not be self-complementary, so as to avoid the possibility of a 
strongly bound duplex and the resulting template inhibition. Besides, specific 
binding sites for each monomer are necessary in order to obtain the correct 
intermediate for ligation, exactly as in the example used for the minimal 
replicator model. The branched nonanucleotide template shown in Figure 3.3 
was chosen to exclude other template-precursor associations which would 
conflict with the regiochemistry of the ligation step. For example, choosing 
GCGCGC instead of GGCCGG as template sequence (and CGC instead of 
GCC as precursor trimer sequence) could result in the trimer CGC binding in 
two different locations. 
Starting from the chosen template for the ILG model, precursors were chosen 
as follows: 
1.  Precursor A consists of two GCC and CGG trimers connected with a 5'-
5' pyrophosphate GC bond (see Fig. 3.4). Although pyrophosphates can 
be made in situ, the choice of a pre-activated monomer simplifies the 
model. The active bond makes it more prone to hydrolysis. It can be 
considered as the possible source of L and, thus, the previously discussed 
conserved quantity l. 
2.  Precursor B consists of two GGC and CCG trimers connected with a 2'-
3' phosphate CG bond. The resulting ligation of B with the non-LG part 
of A results in the branched template C (see Fig. 3.4). Hydrolysis of 
phosphate bonds will not be considered in both ILG and minimal 
replicator models. 
To the best of our knowledge, the use of branched nucleotides in self-
replication has not been explored yet, but such molecules have been used in 
ligation experiments, be it enzymatically25 or by chemical ligation26. Moreover, 
the reaction occurring in complex ABC, resulting in the branched nucleotide, 
reminds of the lariat structure in RNA splicing.25, 26 The key difference between 
the, previously discussed and inspirational, self-splicing RNAs and our model 
lies in replacing the ribozyme activity by a purely chemical model using 
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activated monomers. Although current synthetic methodology27  allows us to 
translate our model into a hypothetical nucleotide-based replicator example, 
one important caveat should be kept in mind. Thermodynamic data is needed 
to compare the two models, but such experimental data is lacking for 
branched nucleotides. This is the reason why we used data and estimation 
methods of unbranched RNA as an approximation.28 
 
Figure 3.4. ILG model: Schematic of the 5'-5' pyrophosphate GC and of the 2'-3' phosphate CG 
bonds. 
The numerical values used for comparing the two models are given in Table 
3.1. The values for the RNA minimal replicator model are very close to those 
used in von Kiedrowski’s theoretical paper14 for DNA. ∆Gi = ∆Hi -T∆Si, i = 1 
or 2 for the minimal replicator model and i = 1, 2 or 3 for the ILG model, is 
the standard Gibbs energy drop across the corresponding equilibrated reaction 
identified by its index i, so that the corresponding equilibrium constant is 
given by Ki = exp(-(∆Gi/RT)) where R is the ideal gas constant and T is the 
absolute temperature. As in our reference paper14, a best case and a worst case 
were considered for the estimation of the precursors-to-template association 
parameters (∆Hi and ∆Si). The best case assumes a cooperative binding 
between precursors upon addition to the template whereas the worst case 
assumes non-cooperative binding. 
It should be noted that the assumed regime defined by K2[B]K3[A] << 1 
restricts the applicability of the analysis to temperatures above 284 K (11 °C) 
for the ILG model.  
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 Best case Worst case   Best case Worst case 
∆H1 -56.45 2 × ∆H0  ∆H1 -58.36 ∆H2 + ∆H3 
∆S1 -160.72 2 × ∆S0  ∆S1 -163.94 ∆S2 + ∆S3 
∆H2 -56.45  ∆H2 -22.23 
∆S2 -148.17  ∆S2 -66.37 
∆H0 -22.23  ∆H3 -24.06 
∆S0 -66.37  ∆S3 -69.05 
(a) Minimal replicator  (b) ILG 
Table 3.1: Numerical parameters used for the comparison between the two models. Enthalpy 
changes (∆H) are given in kcal.mol-1 and entropy changes (∆S) in cal.mol-1.K-1. 
Without taking AB complex formation into account: Figure 3.5 shows how 
the equilibrium distribution of the different species varies with temperature, 
for the minimal replicator model (left) and for the ILG model (right). For 
both minimal replicator and ILG models, a main difference between the best 
case and the worst case is the temperature below which the ABC complex can 
exist. Unlike for the minimal replicator model, in the ILG model the template 
duplex C2 is never present in any significant amount compared to the ABC 
complex or to the unbound template C. Increasing the amount of leaving 
group impacts only marginally this distribution. 
As in von Kiedrowski 199314, both k and [C] contribute to the temperature 
dependence of the rate r of template formation given by Equation 33. The 
rate constant k is expected to vary with temperature as: 
 
% = 0 × exp (− 4567) (45) 
where A is a constant. Figure 3.6 shows how the rate r of template formation 
varies with temperature, for the minimal replicator model (left) and for the 
ILG model (right), for various activation energies Ea. 
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Figure 3.5. Best case (top) and worst case (bottom) equilibrium distributions of the various species as a function of temperature: for the minimal replicator model (a), and 
for the ILG model with a total amount of LG of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside the applicable temperature range (T < 11 °C). The 
vertical scale is the concentration of each species divided by the corresponding conserved quantity: [ABC]/c, [C]/c and [C2]/c for the minimal replicator model; [ABC]/c, [C]/c, [C2]/c, 
[L]/l, [D]/l and [LC]/l for the ILG model. 
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Figure 3.6. Best case (top) and worst case (bottom) decimal logarithm of the rate r of template formation as a function of temperature: for the minimal replicator model (a), 
and for the ILG model with a total amount of LG of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside the applicable temperature range (T < 11 °C). 
The different curves correspond to different activation energies Ea ranging from 10 to 30 kcal.mol-1 in 4 kcal.mol-1 increments. The multiplicative coefficient (Eq.45) was arbitrarily 
taken as A = 1.1011 s-1 as in von Kiedrowski 199314. 
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Figure 3.7 shows how the autocatalytic order p varies with temperature, for 
the minimal replicator model (left) and for the ILG model (right). 
In his exposé on the minimal replicator theory14 von Kiedrowski distinguished 
three regimes: 
1.  strong exponential: most of the template resides in the ABC complex 
form, the autocatalytic order p is close to unity, and the rate of template 
formation r increases on increasing temperature. 
2.  weak exponential: most of the template resides either in the ABC complex 
or in the unbound C forms, but not in the duplex C2 form, the 
autocatalytic order p is intermediate between 0.5 and 1, and the rate of 
template formation typically decreases on increasing temperature. 
3.  parabolic: most of the template resides either in the ABC complex or in 
the duplex C2 forms, but not in the unbound C form, the autocatalytic 
order p is close to 0.5, and the rate of template formation either increases 
or decreases on increasing temperature. 
Whereas the minimal replicator model behaves as strong exponential at low 
temperature, weak exponential at high temperature, and parabolic at 
intermediate temperature, the ILG model behaves as strong exponential at 
low temperature and as weak exponential at high temperature. The 
autocatalytic order p stays close to unity throughout the investigated 
temperature range, and the rate of template formation r reaches its maximum 
at a temperature that is nearly independent of the activation energy. Besides, 
this behaviour is only marginally impacted by the initial amount of leaving 
group. 
It thus appears that the ILG model is more favourable than the minimal 
replicator model because (i) its autocatalytic order remains close to unity over 
the entire temperature range, and (ii) the rate of template formation r is 
always higher for the ILG model than for the minimal replicator model. 
Besides, these properties hold for both best and worst cases (regarding the 
estimation of ∆G1) as well as for a low or high initial amount of leaving group.
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Figure 3.7. Best case (top) and worst case (bottom) autocatalytic order p as a function of temperature: for the minimal replicator model (a), and for the ILG model with a 
total amount of leaving group of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside the applicable temperature range (T < 11 °C).
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This advantage holds even when only considering temperatures above 284 K 
(11 °C) for the ILG model (solid lines in Figures 3.5-7, so as to ensure 
K2[B]K3[A] << 1, as discussed previously). However, within this restricted 
temperature range, the maximum self-replication rate strongly depends on the 
estimated ∆G1: it is significantly higher in the best case than in the worst 
case, because the maximum self-replication rate occurs very close to the lowest 
applicable temperature. Similarly, Figure 3.5 shows that for the ILG model, 
strong exponential self-replication might only be observed close to this lowest 
temperature (freezing point of precursors into long chain-polymerized 
assemblies) and for the best case. For the worst case, the template resides 
mostly in the unbound C form in the applicable temperature range, which 
results in weak exponential self-replication. 
This result is not a general property of the ILG model as seen in Figure 3.2. 
Depending on the values of K1 and K = K2 = K3, the autocatalytic order p 
may even turn negative, whereas it is always higher than 0.5 in the case of 
the minimal replicator model. 
The reason why the ILG model is advantageous for the considered 
hexanucleotide example may be understood as follows. From Equations 28 
and 30, we have: 
 
 = ()1 +  + ()  
        < ()1 + () (46) 
From Equation 29, we have q[ABC] < c which fed into the above equation 
gives: 
 < 1 +  (47) 
The contribution of [D] to Equation 27 would thus be negligible if the 
following condition were verified: 
 
1 +  ≪  (48) 
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This is indeed the case for the considered hexanucleotide example. At room 
temperature (T = 298 K) we have K2 ≈ 60 M-1 and K3 ≈ 360 M-1. This gives 
K2K3c2 ≈ 2×10-4 << 1 so that the above condition is equivalent to K2K3cl << 
1. We have K2K3cl ≈2×10-3 even in the extreme case where l = 10×c. The 
contribution of [D] to Equation 29 being thus negligible; the rate of template 
replication, given by Eq. 33, approximately takes the same expression for the 
minimal replicator and ILG models. The key advantage of the ILG model 
arises from the significantly lower duplex stability (and associated lower K2 
equilibrium constant) because it only involves one A - B bond instead of two 
for the minimal replicator model. 
 
Figure 3.8. AB complex formation: The two complexes that can be formed by direct association 
between the precursors A and B for the ILG model. 
 
Taking AB complex formation into account: For the minimal replicator 
model, there is only one such possible complex and the corresponding 
association constant K0  is given in Table 1. In this case, a and b should be 
replaced by the expressions given by Eq. 31 and 32. 
For the ILG model, Figure 3.8 reveals that there are two possible such 
complexes, with association constants K2 and K3 as given in Table 1. In this 
case, a and b should be replaced by the expressions given by Eq. 31 and 32, 
replacing K0 by K2 + K3. 
Figures 3.9-11 show how the equilibrium distribution of the different species, 
the rate r of template formation, and the autocatalytic order p, respectively, 
vary with temperature, for the minimal replicator model (left) and for the 
ILG model (right). As stressed out in the minimal replicator theory14, 
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formation of complex AB makes it difficult to observe strong exponential 
growth which otherwise might be found at low temperatures. For the ILG 
model, AB complex formation does not result in any significant difference in 
the applicable temperature range. 
3.2.3 Conclusion 
We have proposed a self-replicating scheme based on an Informational 
Leaving Group (ILG), inspired by the role of tRNA as leaving group and 
information carrier during protein synthesis. The potential advantage of such 
scheme is the weaker bonding of the template duplex and thus reduced 
template inhibition. We have carried out a theoretical analysis of this ILG 
scheme following the same approach as that of von Kiedrowski for the minimal 
replicator model, and have compared theoretical predictions for this scheme 
with those for the minimal replicator model. Although the autocatalytic order 
p may even turn theoretically negative for certain values of dissociation 
constants, when comparing this ILG scheme with the minimal replicator 
model for a hexanucleotide template sequence mirroring that used by von 
Kiedrowski in his original theoretical work14, we have found that the ILG 
scheme was expected to outperform the minimal replicator model, with a 
higher replication rate and a higher autocatalytic order. Although this ILG 
scheme is expected to be sensitive to initial hydrolysis, this advantage is 
expected to hold even with significant hydrolysis in the initial mix. For the 
minimal replicator model, direct precursor-to-precursor complex formation 
should prevent strong exponential growth which otherwise might be found at 
low temperatures.14 For the proposed ILG model, the applicable temperature 
range is further restricted to temperatures above the freezing point of 
precursors into chain-oligomerized self-assemblies. Whether strong 
exponential growth might be observed in this applicable temperature range 
strongly depends on the estimated thermodynamic data for the template-
precursors complex, for which experimental data is lacking. This stresses the 
need to confirm these theoretical predictions by future experimental work. 
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Figure 3.9. Taking AB complex formation into account. Best case (top) and worst case (bottom) equilibrium distributions of the various species as a function of temperature: 
for the minimal replicator model (a), and for the ILG model with a total amount of LG of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside the applicable 
temperature range (T < 11 °C). The vertical scale is the concentration of each species divided by the corresponding conserved quantity: [ABC]/c, [C]/c and [C2]/c for the minimal 
replicator model; [ABC]/c, [C]/c, [C2]/c, [L]/l, [D]/l and [LC]/l for the ILG model.
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Figure 3.10. Taking AB complex formation into account. Best case (top) and worst case (bottom) decimal logarithm of the rate r of template formation as a function of 
temperature: for the minimal replicator model (a), and for the ILG model with a total amount of LG of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside 
the applicable temperature range (T < 11 °C). The different curves correspond to different activation energies Ea ranging from 10 to 30 kcal.mol-1 in 4 kcal.mol-1 increments. The 
multiplicative coefficient (Eq.45) was arbitrarily taken as A = 1.1011 s-1 as in von Kiedrowski 199314.
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Figure 3.11. Taking AB complex formation into account. Best case (top) and worst case (bottom) autocatalytic order p as a function of temperature: for the minimal 
replicator model (a), and for the ILG model with a total amount of leaving group of l = 0 (b) and l = 10×c (c). For the ILG scheme, dotted lines are used outside the applicable 
temperature range (T < 11 °C).
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3.3 ILG in non-enzymatic oligonucleotide synthesis* 
3.3.1 Experimental design 
As previously discussed (Chapter 1.1.4), a multitude of LG’s have been used 
to replace the natural substrate for oligonucleotide synthesis (nucleoside 
triphosphates) by a chemically more reactive species in non-enzymatic 
reactions. To introduce the ILG strategy in this field, a monomer was 
envisaged based on the well-known imidazole phosphoramidates. (Figure 3.12) 
In fact, by introducing an uracil moiety on imidazole as a biaryl system, the 
resulting LG resembles a purine (xanthine) with the five and six membered 
rings unfused.   
 
 
Figure 3.12. Envisaged monomer for introducing the ILG strategy in non-enzymatic 
oligonucleotide synthesis: 1-(5'-adenylyl) 4-(uracil-5-yl)-1H-imidazole (3.1a), 1-(5'-adenylyl) 2-(uracil-
5-yl)-1H-imidazole (3.1b) with 1-(5'-adenylyl)-1H-imidazole (3.1c) as our reference.  
This LG (2/4-(uracil-5-yl)-1H-imidazole) will be coupled to adenosine 
monophosphate by known methods, although the presence of additional 
nucleophilic entities (N1 and N3 of uracil) may result in the formation of side-
products. Purification and separation techniques have been described on these 
unstable compounds that could be used if such side-reactions occur.29 
Foreseeing these issues; the first, real challenge would be obtaining sufficient 
amounts of LG for experimental optimisation by cost-efficient,  safe and easy 
                                      
* This chapter was the topic of the Master’s thesis of Anne-Sophie Van Hool titled:  
 “Expanding the scope of phosphorimidazolides as models for the origin of life” (KULeuven 2013-14). 
Excerpts of this mentored work are summarized, commented and amended while incorporated in 
this dissertation.  
CHEMICAL REPLICATION 
| 77 
means. There exist ample literature regarding modified nucleobases, due to 
medicinal properties30,31 and their use as probes in nucleic acids32. However the 
reported synthesis of biheteroaryl systems using nucleobases either concerns 
(semi-) protected systems such as nucleotides33,34 or utilises expensive and 
hazardous chemicals. All of the above claims are well illustrated by the bulk 
of the literature regarding the introduction of an imidazole ring onto an uracil 
scaffold, namely the Stille coupling of (1-protected) 4-(tributylstannyl)-
imidazole with a 5-iodouridine analogue.34,35 Besides mentioned drawbacks, 
the necessary protection strategies utilised introduce extra steps and diminish 
overall yield. 
Thus, the stage was set to uncover a facile synthesis, without any metal 
catalysts or reagents and minimal protection strategies, of 2/4-(uracil-5-yl)-
1H-imidazole. 
3.3.2 Synthetic approach and Results 
Scouring the literature resulted in only one article meeting our objectives. 
This medicinal chemistry paper36 describes the synthesis of both 2- and 4-
(uracil-5-yl)-1H-imidazole. However due to the low yield and harsh conditions 
(liquid ammonia) for obtaining the 2-substituded compound via Debus-
Radziszewski imidazole synthesis, our focus shifted to obtaining compound 
3.6 according to Scheme 3.1. This synthetic pathway starts with the 
Bergmann-Johnson two-step modification of the Biginelli reaction37, resulting 
in 5-acetyluracil (3.4) through base-mediated ring closure and 
rearrangement38 of the isolated intermediate ethyl 
ureidomethyleneacetoacetate (3.2). The ring closed intermediate 3.3 can be 
isolated prior to rearrangement by reducing the reaction time and 
temperature. 
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Scheme 3.1: First attempt at synthesizing 4-(uracil-5-yl)-1H-imidazole. Reagents and conditions: 
(a) Ethyl acetoacetate (1.1 eq), CH(OEt)3 (1.1 eq), urea (1 eq), overnight 110 °C, 46%; (b) 1) 7.5% 
KOH, 1 min RT; 2) conc. HCl, 51%; (c) 11.11% KOH, 1h reflux; 2) conc. HCl, 45% (c’) cfr c, quant.; 
(d) various methods (e) Formamide (excess), N2, 1 h, 140 °C (untested) 
The next step was to brominate the α-position of 5-acetyluracil to obtain 3.5. 
However various reaction attempts (Br2/(+HBr) acetic acid, Br2/methanol), 
for prolonged periods of time (several days) gave no trace of the desired 
compound. Failure to reproduce published results36 and time constraints 
forced us to follow a different synthetic route. 
Scientific research needs discussion as it results in fresh perspectives and new 
ideas mostly gathered from experience and/or ancient literature,. The possible 
usage of tosylmethylisocyanide (TosMIC) in the Van Leusen imidazole 
synthesis was conceived due to the previously synthesized, necessary starting 
material (5-formyluracil (3.8)), whose synthesis will be discussed in Chapter 
4. The resulting synthetic pathway is depicted in Scheme 3.2. To the best of 
our knowledge, there are no examples of Van Leusen imidazole synthesis 
performed on a nucleobase and mostly N-substituted derivatives are obtained 
by using primary amines. NH-analogues are either obtained by deprotection 
or using ammonium hydroxide as a base.39 In our system, using commercially 
available 7M NH3 in methanol as the base in a pressurized reaction vessel 
results in 3.6 precipitating out of the reaction mixture, which is isolated in 
good yield (66%) without further purification. Using ammonium hydroxide 
solution as amine source gives a similar precipitate although less easily 
filtrated, and much is lost during work-up. 
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Scheme 3.2: Successful synthesis of 4-(uracil-5-yl)-1H-imidazole. Reagents and conditions: (a) 
(CHO)n 90% (3 eq), Et3N (1.5 eq), H2O, 12 h 65 °C, 88%; (b) K2S2O8 (1.81 eq), AgNO3 (3 mol%), H2O, 
45 °C 20 min, 93%; (c) 1) 7M NH3/MeOH 1 h reflux, 2) TosMIC (1.6 eq) 1 h reflux, 66%. 
After obtaining our LG 3.6, a first attempt was undertaken to obtain the 
desired monomer 3.1a by Mukaiyama reaction40, the most conventional 
reaction to obtain compound such as 3.1c (Scheme 3.3).41 That reference was 
also synthesized in order to evaluate the synthetic viability and most 
importantly to obtain analytical reference data as little NMR data is reported 
regarding these unstable compounds.29 * Copying this method to our LG, 
however, gave no result on the first try probably due to the poor solubility of 
the 5 equivalents excess in the small volume of DMF used. A second attempt 
led to the observation of phosphoramidates as minor entity at -7.26 ppm in 
the 31P NMR as shown in Figure 3.13. Additionally the formation of 
pyrophosphate (at -10.39 ppm) can also be accounted to activation of the 
phosphate group. But unfortunately, the identification was rendered difficult 
by their instability and optimisation of this coupling was postponed in favour 
of the main project of this dissertation. 
 
Scheme 3.3: Synthesis of imidazole phosphoramidates. Reagents and conditions: (a) 1) Ph3P (2 eq), 
2,2’-dipyridyldisulfide (2 eq), imidazole (5 eq), Et3N/DMF, 1.5 h RT, 2) Et3N/ 
NaClO4/acetone/anhydrous Et2O, 1 h RT, 74%; (a’) cfr a, 4-(uracil-5-yl)-1H-imidazole (5 eq) 
                                      
* This reference confirmed in hindsight that we obtained 3.1c, previous analyses in literature were done 
by TLC using retention times obtained by radiolabelled references.  
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Figure 3.13. 31P NMR detecting phosphoramidates in the attempted synthesis of 3.1a: without 
internal reference, signal to the left 4.16 ppm is starting (hydrolysis) material AMP. The two signals 
on the right are suspected to be respectively the phosphorimidazolide (-7.26 ppm) and the 
pyrophosphate (-10.39 ppm) of AMP. 
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4.1 Introduction 
4.1.1 Prebiotic peptides* 
The RNA-protein world 
The genetic first-approach to the origin of life has been sufficiently discussed 
in the introductory part of this dissertation; but only the difficulties to sustain 
the RNA-world with a steady flow of monomers in itself, are a concern to be 
recognized. On the other hand, since Millers experiment in 19532, the prebiotic 
advent of proteins and availability of amino acids can be considered as 
established.1,3,4 So although the quest for a prebiotic polymer capable of storing 
and transferring genetic information continues, the possible simultaneous (or 
even prior) role of amino acids, peptides, proteinoids† and proteins cannot be 
ignored. Further arguments for the RNA-protein world are found in key 
elements of the RNA-world. The pathways for prebiotic RNA synthesis 
provide ample precursors to support the wide variety of amino acids.4,5 
Catalytic properties of peptide and amino acids in those pathways has been 
established.6-8 The simultaneous origin of both biopolymers is believed to 
contribute to the universality of the genetic code.9 
And as a last remark, the hydrolysis of peptides results in the generation of 
more feedstock material (Scheme 4.2, dashed bond). In contrast, the less 
stable oligonucleotides are prone to further degradation; making monomer 
recycling more difficult. This advantage of proteins has founded the argument 
of establishing proto-metabolic networks where selection would occur due to 
sequential condensation and hydrolysis of peptide bonds until a more stable 
species was obtained.1 Stability might be linked to three-dimensional structure 
and the association to other biomolecules.10 
  
                                      
* Inspiration was found in the excellent review by Pascal and co-workers1 in order to supplement the 
introduction in Chapter 1, to give a concise chemical background in prebiotic peptide formation. 
† With an amide bonded backbone, either via the α-carbon or side chain functional groups, thus amino 
acids such as lysine and glutamic acid could result in branched structures. 
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Amino acid and peptide bond formation 
The chemistry behind Miller-type experiments is proposed to be the Strecker 
synthesis of α-amino acids (Scheme 4.1).11 The reaction of cyanide, ammonia 
and aldehydes is made irreversible by subsequent nitrile hydrolysis. The latter 
can be accelerated by aldehyde organocatalysis.12* The α-aminonitriles might 
also convert to hydantoins in the presence of bicarbonate (Bücherer-Bergs 
reaction). Further hydrolysis results in N-carbamoylamino acids, known 
precursors of peptide synthesis.12 Other less popular theories behind the 
electron discharge chemistry include the direct reaction of methane and 
ammonia, and the involvement of cyanide building blocks such as 
cyanoacetylene and AIM.14 
 
 
Scheme 4.1. The proposed chemistry behind Miller-type experiments: The earlier discovered 
Strecker synthesis of amino acids via the hydrolysis of α-aminonitriles. The formation of α-
hydroxynitriles competes for building blocks, the respective acids are also found in electron discharge 
experiments. In presence of bicarbonate (thus also CO2) the Bücherer-Bergs reaction and subsequent 
hydrolysis leads to N-carbamoylamino acids, known precursors for peptide synthesis. Figure adapted 
from reference15 
Peptide bond formation is a condensation reaction thermodynamically more 
favoured for oligopeptides over single amino acids. Besides entropic 
considerations, the increased ionisation of free amino acids reduces the 
reactive forms in amide bond formation.16 The elimination of water can be 
accelerated and yields increased by hydrothermal or drying conditions. After 
rehydration of the reaction, the obtained peptide can be considered a product 
                                      
* Resulting in amino acid amides, also used in heating-drying (microwave) experiments to obtain 
oligopeptides13  
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out-of-equilibrium as its formation was more favoured at higher temperature 
while degradation is slowed by the relative kinetic stability of the amide bond. 
Early experiments with heat-dry cycling yielded short oligomers, although 
their analysis might have been incomplete due to technical restraints.17,18 A 
recent communication mentions the formation of oligomers of glycine up to 
14-mers with high conversion, but the prebiotic viability might be 
questionable due to the high pH used.19 Furthermore, in heat-dry cycling the 
formation of diketopiperazines (DKP), the cyclic product from a dipeptide, 
does not hamper oligomerisation, moreover, it can be used as feedstock 
material. 
The use of activation agents for prebiotic peptide synthesis finds its roots in 
the current cellular translation mechanism. Biological protein synthesis 
proceeds via 2’(3’)-amino acyl esters of tRNA, obtained by the nucleophilic 
displacement of the mixed anhydride of adenosine and amino acid. The 
necessary aminoacyl adenylate is the resulting activated species from the 
reaction of ATP and the amino acid. In both cases, nature activates the 
carboxylic acid through bound intermediates. Elongation proceeds from N- to 
C-terminal end of peptide, with the free amine of the next amino acid 
displacing the growing peptide chain bound as ester on tRNA (Figure 4.1A).20 
Carboxylic activation agents are key products for peptide synthesis21 and have 
also been used in a prebiotic context.*22-28 André Brack saw a key role for N-
carboxyanhydrides† (NCA) of free amino acids (Scheme 4.2, left).10 In the 
presence of CO2, free amino acids are equilibrated with their NCA analogue. 
Additionally activated amino acid species convert readily to NCA, which 
reacts even faster and amino acyl adenylate is no exception.1 Recently, Pascal 
and coworkers have expanded the scope to peptides and the respective 5(4H)-
oxazolone reacts in a similar fashion (Scheme 4.2, right).30  
                                      
* The activating agents are similar to those discussed for phosphodiester formation (Chapter 1.1.4) with 
again EDC as most popular. 
† Orgel and Ghadiri proposed COS as prebiotic activating agent29  
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Scheme 4.2. Possible central role for N-carboxyanhydrides  in prebiotic peptide formation: NCA 
can be obtained by in situ activation or the reaction of activated esters with CO2. NCAs can oligomerize 
to peptides or result in the formation of mixed anhydrides with phosphates (including mononucleotides). 
The latter plays an important role in translation. C-activation results in racemisation of amino acids 
via oxazolone intermediate. Important hydrolysis pathways to complete the reaction scheme are in 
hashed bonds. Figure inspired on reference.1 
4.1.2 Prebiotic translation 
In 1979, Klotz and co-workers anticipated later developments in nucleic acid 
templated reactions by proposing a system mimicking natural tRNA function 
(Figure 4.1B).31 In order for the system to work, a 5’-amino acyl 
oligonucleotide needed to be reactive enough, unfortunately the kinetic studies 
proved the lack of reactivity of the primary alkyl ester. Almost 
simultaneously, Orgel investigated the properties of 2’(3’)-amino acyl esters 
of nucleotides. Several papers followed, where a templating effect could be 
found resulting mostly in increased DKP formation * .31-35 Later, he 
unsuccessfully tried a different approach by using amino acids with a 
nucleobase side chain.36 Meanwhile advances in oligonucleotide, peptide and 
organic chemistry, generated the means of creating various templated 
reactions37-39 and even artificial enzyme mimicking models.40,41 Of the latter, 
one example is worth mentioning, namely the artificial ribosome by Leigh and 
co-workers.42 This small molecular machine is based on a rotaxane, where a 
cysteine charged macrocycle would form sequential amide bonds through 
native chemical ligation43 of esterified amino acids on the thread (Figure 
4.1C). Although interesting proof of concepts, they lack the simplicity 
expected in a prebiotic context.  
                                      
* Unreactive at low temperatures, thus a thermodynamic trap for oligomerization. 
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Figure 4.1. Comparing ribosomal peptide with synthetic models  (A) ribosomal peptide synthesis; 
(B) system proposed by Klotz et al.31; (C) small artificial ribosome by Leigh et al.42. Figure B illustrates 
the attempt to mimic ribosomal N→C peptide synthesis by oligonucleotide templated ligation, however 
the 5’ amino acyl ester of nucleoside was found to be unreactive. The molecular machine (rotaxane part 
simplified) in Figure C, does not have a first association step. It is deprotected to start the sequence of 
native chemical ligations resulting in C→N peptide synthesis. R = amino acid side-chain; Colour 
scheme: red arrows indicate reactions, green bold arrows association/dissociation, blue indicates the 
amino acid added to the growing chain. 
To summarize, early attempts at researching the interface of the RNA and 
protein world prior to the research done on tRNA’s evolution, give us an 
interesting starting point for further investigating the interaction between 
nucleic acids and amino acids. 
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4.2 Synthesis of small molecule tRNA mimics 
4.2.1 Design of the monomer 
True to our proposed concept in Figure 2.1, this research package evaluates 
the potential of an ILG to mimic tRNA’s role in protein translation (Figure 
4.2). Therefore a library of small molecule tRNA mimics was envisaged, where 
uracil analogues would act as carboxylic activators for amino acids. 
 
Figure 4.2. The chemical simplification of tRNA. 
What follows is a brief walkthrough in the rationale that led to choosing uracil 
as the recognition element, the amino acid phenylalanine and UV-irradiation 
as deprotection strategy. 
Uracil as recognition element 
When considering the recognition element both monomer and complementary 
template should be kept in mind. The obvious first choice would be the G-C 
base pair, due to stronger interactions; however there are some known issues 
that would complicate analysing the system, expected to be already quite 
complex. Guanine and its oligomers tend to aggregate on their own, forming 
a supramolecular structure known as quadruplexes.44 Furthermore, although 
pyrimidine templates are favoured45; choosing a purine (guanine, adenine and 
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even xanthine) as monomer to build on, will certainly raise synthetic issues 
necessitating the use of protection/deprotection strategies (as discussed in 
Chapter 4.2.3). Thus consuming more precious time before the envisaged 
system can be tested and optimized. Cytosine, by the same logic, is also more 
difficult to modify and is believed to be less important prebiotically due to 
instability.46 
This leaves us uracil as our prime candidate for monomer synthesis. A 
prebiotically available compound47,48 with interesting handles for unprotected 
modifications49, some of them known in nature50 and prebiotically feasible.51 
Of the latter even a phenolic derivative (compound 4.8, Scheme 4.1) is known, 
perfect for achieving the necessary carboxylic activation of amino acids*31 
without utilising the prebiotic theorized thioesters.52 Their inherent reactivity 
would hamper the synthesis and storage of the obtained monomers. 
The amino acid phenylalanine 
The choice of amino acid was primarily based upon synthetic simplicity 
avoiding side chains with functional groups. The presence of an aromatic 
moiety would increase UV sensitivity, and is useful during synthesis (TLC 
monitoring of reactions) and analysis (LC-UV detection of purity). Obviously, 
the analysis of the resulting oligomers after deprotection will also benefit from 
UV-detection. Phenylalanine was chosen over tryptophan for structural 
simplicity. 
UV-irradiation as deprotective strategy 
The N-terminus of the amino acid needs to be protected during all synthetic 
steps, using the final deprotection to start the actual complex system. The 
protection strategies for amino acid are well known due to their 
implementation in chemical peptide and protein synthesis.53 Using efficiently 
cleavable amino protecting groups is the core of solid-phase peptide synthesis 
and has been widely explored to accommodate compatibility with orthogonal 
protection strategies.21,53 However, most of these systems are based on 
                                      
* The artificial ribosome by Leigh et al. in Figure 4.1C is a good example of amino acids carboxylic 
activated by phenolic moieties (although subsequently aided by a nearby thiol, thus native chemical 
ligation)  
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simultaneous usage of base- and acid-labile protecting groups. The conditions 
are optimized for organic solvents and quite harsh, implying that the 
envisaged system would have to be started with even more manipulation. This 
could mean neutralizing the deprotecting conditions or even isolating the 
obtained product either by precipitation as a salt or extraction. All these 
added steps consume more time and might even pose problems concerning the 
stability of the activated ester currently occupying the monomer. While 
reviewing this literature on peptide synthesis, a group of photocleavable 
protecting strategies based on well-known carboxybenzyl- or Cbz-group, was 
found.54-56 Various literature57-60 describing photocleavable strategies aside, the 
choice fell upon simple structures (compound 4.50-52, Scheme 4.9) as none of 
these precursor materials were commercially available. 
4.2.2 Synthesis of uracil derivatives* 
The first goal was to obtain the prebiotically relevant51 5-(4-
hydroxybenzyl)uracil, compound 4.8 and analogues with the methylene 
replaced by other geometrically interesting linkers such as a double bond, 
triple bond or by directly coupling. However obtaining a stilbene analogue of 
uracil and phenol was later omitted due to foreseen difficulties regarding 
photocyclisation and isomerisation.61 Compound 4.8 was obtained in two 
reaction steps by literature procedures (Scheme 4.3, reaction g and h).62,63 
Intermediate 4.7, 5-hydroxymethyluracil, was also used for the synthesis of 
monomers but to no avail as discussed in Chapter 4.2.4. Despite this set-back, 
4.7 was still very useful to obtain oxime 4.10 and imidazole 3.6 (Chapter 3.3) 
via the aldehyde 4.9. Although the preparation of that aldehyde was 
reported62, the selective oxidation of alcohol 4.7 deserves extra clarification. 
Key factors here were the timing of reagent addition and temperature control, 
to precipitate the aldehyde out before allowing further oxidation to the acid. 
                                      
* Compounds in Scheme 4.2B and 4.3 are have been made together with the MSc student Nikolaos 
Papastavrou and were part of his Master’s thesis entitled: “Synthesis of modified nucleobases for a 
tRNA-inspired chemical translation system” (KULeuven 2013-14). Excerpts of this mentored work 
are summarized, commented and amended while incorporated in this dissertation. Besides 
mentoring, 2D NMR identification of various regioisomers were my own contribution to this work. 
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If done correctly, extra purification (by aqueous alkaline washing) was not 
necessary. 
To obtain analogues of 4.8, the use of palladium catalysed reactions was 
envisaged; Suzuki-reaction for direct aromatic coupling and Sonogashira 
coupling to obtain a triple bonded analogue. A central intermediate for this 
was 5-iodouracil 4.11, although commercially available, easily synthesized in 
large scale. One Sonogashira coupling with trimethylsilylacetylene (TMSA) 
later, followed by alkaline silyl deprotection, the stage was set for the next 
Sonogashira reaction with 4-iodophenol (Scheme 4.3, reaction m); obtaining 
the desired product 4.13 after the serendipitous discovery of an unorthodox 
isolation method. Diluting the reaction mixture with ethyl acetate (EtOAc), 
followed by washing with 1M HCl, resulted in the formation of a yellow 
precipitate in the separating funnel. Direct isolation by filtration during 
extraction, gave the desired compound. Attempts at neutralizing the reaction 
mixture with an organic acid (acetic acid) and precipitating the compound by 
addition of EtOAc were unsuccessful. Plain aqueous HCl addition did not 
work either. Further pursuit on the workings of this biphasic precipitation 
method was abandoned. 
The direct Suzuki-reaction between 5-iodouracil 4.11 and 4-hydroxyphenyl 
boronic acid, however, did not result in any clear product formation. The 
complicated mixture indicated the presence of a disubstituted uracil, probably 
due to (additional) Chan Lam-type coupling of the boronic acid to one of the 
acidic nitrogens of uracil.64 Compound 4.5 was eventually obtained via a 5 
step synthetic pathway incorporating a protection strategy around O-
methylation of uracil (Scheme 4.3, reaction a-e). Although low yielding (30%), 
the patent derived Suzuki protocol65 managed to afford enough 4.4 for the 
deprotection. The multistep procedure was inefficient and the decision was 
made to abandon compound 4.5 as possible LG in favour of the other products 
obtained. 
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Scheme 4.3. Synthesis of 5-(4-hydroxybenzyl)uracil and analogues: Reagents and conditions: (a) 
POCl3, 5 h reflux, 60%; (b) Na (2.55 eq), MeOH, overnight reflux, 81%; (c) NIS (1.2 eq), AcOH, 
overnight reflux, 67%; (d) 4-hydroxyphenyl boronic acid (1 eq), Pd(OAc)2 (3 mol%), PPh3 (11 mol%) 
Na2CO3 (2.5 eq), nPrOH, overnight reflux, 30%; (e) conc. HCl, AcOH, 2 h reflux, 53%; (f) 1) K2S2O8 (2 
eq), 1 M KOH, 24 h RT, 2) 6M HCl, 1 h RT, 10%; (g) (CHO)n 90% (3 eq), Et3N (1.5 eq), H2O, 12 h 
65 °C, 88%; (h) phenol (1.2 eq), 0.1M HCl, 3 h 90 °C, 74%; (i) K2S2O8 (1.81 eq), AgNO3 (3 mol%), H2O, 
20 min 40°C, 93%; (j) NH2OH.HCl (1 eq), KOAc (1 eq), MeOH/H2O (1:1), 1 min reflux, 80%; (k) I2 
(0.6 eq), CAN (0.5 eq), ACN, 80%; (l) 1) TMSA (1.4 eq), Pd(PPh3)4 (0.5 mol%), CuI (3 mol%), 
Et3N/EtOAc (1:3), overnight RT, 2) 1 M NaOH, 2 h RT, 86%; (m) 4-iodophenol (1.2 eq), Pd(PPh3)4 
(1 mol%), CuI (3 mol%), (iPr)2NH/DMF (2:5), overnight RT, 58% 
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Reviewing intermediates obtained and techniques used, we have considered 
preparing triazole linked analogues of 4.8 (Scheme 4.4). Having the uracil 
alkyne 4.12 available, 4-azidophenol 4.18 was synthesized for copper catalysed 
azide-alkyne crosscoupling (CuAAC). However, the red oily azide obtained is 
not stable66 and did not give any of the desired product (Scheme 4.2B, reaction 
e). There were also no results when using the more stable 4-hydroxybenzyl 
azide 4.21 under various conditions (not shown). On the other hand, synthesis 
of the reversely connected triazole 4.17 was accomplished but it needed some 
ingenuity (Scheme 4.4A). 4-Ethynylphenol 4.15, made from TMSA and 4-
iodophenol, turned blue during rotary evaporation after deprotection of the 
silyl group on 4.14 (not shown). This was believed to be a phenolic conjugated 
polymer as it did not elute on a TLC plate and changed colour (green) while 
adding aqueous base. The problem was addressed by adding 
dimethylformamide (DMF) to the organic layer after extracting the 
compound from the deprotection; followed by evaporating only the low boiling 
solvent at low temperature and high vacuum. The resulting DMF solution 
was used as such to couple to 5-azidouracil 4.16. An analogue of the originally 
investigated product 4.19 was eventually made via O-methylation protection 
of uracil (Scheme 4.4B, reaction f-h). This was done in order to use a different 
copper catalyst, soluble in organic solvents. The CuAAC reaction was 
optimized using 4-hydroxybenzyl azide 4.21 over 4-hydroxyphenyl azide 4.18. 
Sadly, there was no time left to try the latter. 
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Scheme 4.4. Synthesis of triazole coupled uracil and phenol products:  Reagents and conditions: A) 
(a) 1) TMSA (1.2 eq), Pd(PPh3)4 (0.5 mol%), CuI (3 mol%), Et3N/THF (3:7), overnight RT, 87% 
(4.14), 2) 1M NaOH, 2 h RT, 3) DMF; (b) 1) NaNO2 (1.1 eq), 10% HCl, 30 min RT, 2) NaN3 (1.2 eq), 
1 h RT, 87 %; (c) CuI (0.5 eq), DMF/dioxane (1:4), overnight RT, 60%; B) (d) 1) NaNO2 (1.1 eq), 
10% HCl, 30 min RT, 2) NaN3 (1.2 eq), 1 h RT, 88%; (e) various methods; (f) 1) TMSA (1.4 eq), CuI 
(0.3 eq), Pd(PPh3)4 (5 mol%), Et3N/EtOAc, (3:10), overnight RT, 2) TBAF (1.0 eq), dry THF, 20 min 
RT, 61%; (g) NaN3 (1.2 eq.), PPh3 (1.0 eq.), 1:4 CCl4/DMF, 5h 90 °C, 80%; (h) 4.21 (1.0 eq), 
[Cu(CH3CN)4]PF6 (0.2 eq), DCM, 2 h RT, 89%; (i) conc. HCl, AcOH, 2 h reflux, 22%; 
Also an N-substituted isomer of our lead 4.8 was produced by either 
nucleophilic substitution or silyl-Hilbert-Johnson-Vorbrüggen67,68 reaction 
using bromide 4.25 (Scheme 4.5, reaction c and d). Various synthetic 
pathways were investigated to obtain the multifunctional bromide 4.25; 
starting from either 4-hydroxybenzyl alcohol or p-cresol (results not shown), 
but the best method is shown here in Scheme 4.5. From the nucleophilic 
substitution of uracil, a disubstituted side-product was isolated and identified 
as 4.27 (Appendix C), whereas the silyl-Hilbert-Johnson reaction obtained 
the desired product 4.26 in higher yield. Both products where successfully 
converted to the free phenol by alkaline hydrolysis. 
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Scheme 4.5. Synthesis of N1-substituted uracil with the desired phenolic moiety: Reagents and 
conditions: (a) Ac2O/Pyridine (1:1), 48h RT, 98%; (b) NBS (1.05 eq), BPO (0.01 eq), CCl4, overnight 
reflux, 95%; (c) 4.25 (1.2 eq), NaH (1.0 eq), DMF, 2 h RT, 46% (4.26), 17% (4.27); (d) 1) 2:2:1 
HDMS/BSA/TMS-Cl, overnight 80 °C, 2) 4.25 (1.2 eq), overnight 80 °C, 69% (4.26); (e) LiOH (2.0 
eq), H2O/MeOH/THF (1:1:1), 2 h RT, 76%; (f) LiOH (4.0 eq), H2O/MeOH/THF (1:1:1), 2 h RT, 50%. 
4.2.3 Synthesis of xanthine derivatives* 
A logical expansion of the LG library was using xanthine instead of uracil.69 
Both bear the same recognition element, and form base pairs with adenine. 
However, being a member of the purine family of heterocycles, the double ring 
structure results in improved stacking interactions, thus, hopefully increasing 
the efficiency of the designed and envisaged system (Chapter 2 and 4.2.1).  
To counteract expected synthetic difficulties (regioselectivity and solubility), 
the choice was made to make a 4-hydroxybenzyl variant of xanthine (just like 
model compound 4.8) via N7 or N9-substition of 4.35 using the now available 
bromide 4.25. However obtaining 2,6-dimethoxypurine (4.35) was not as easy 
as obtaining the 2,4-dimethoxyuracil 4.2 due to the decreased reactivity of C2 
after monosubstitution of C6 resulting in 4.31.† It was necessary to block the 
NH of the imidazole ring by means of the well-known acid-labile 
tetrahydropyranyl protection group70 in order to get 4.35 (Scheme 4.6). 
Despite the protection strategy, a monomethoxylated purine 4.33 was still 
isolated albeit unintentionally by an attempted alkaline hydrolysis of the 
dichloropurine 4.32. The C6 methoxylation by LiOH in H2O/THF/MeOH is 
attributed to changes in the basicity of CH3O-/HO- due to better solvation of 
the latter in THF. 
                                      
* This chapter was the main topic of the Master’s thesis of Nikolaos Papastavrou (see also the footnote 
on Chapter 4.2.2.) Excerpts of this mentored work are summarized, commented and amended while 
incorporated in this dissertation. 
† For further discussion regarding mechanism and prior literature, the reader is kindly referred to 
Appendix C. 
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Scheme 4.6. The protection strategy used with xanthine: Reagents and conditions: (a) POCl3 (10 
eq), DBU (6.0 eq), 6 h reflux, 33%; (b) Na (2.55 eq), MeOH, 48 h reflux, 86%; (c) THP (2.5 eq), pTsOH 
(0.1 eq), EtOAc, 3 h  45 °C, 98%; (d) LiOH (1.0 eq), H2O/MeOH/THF (1:2:2), 2 h RT, 96%; (e) Na 
(3.0 eq), MeOH, 2 h reflux, 91%; (f) HCl 1N, EtOH, 1 h reflux, 74%; 
After obtaining 4.35, reaction with bromide 4.25 resulted in a mixture of N7 
and N9 substituted products. (Scheme 4.7) Also intermediates 4.30 and 4.31 
were used as part as two-pronged strategy. Earlier results and literature 
revealed the necessity of N-protection for easily substituting 2,6-
dichloropurine (see Scheme 4.6 and discussion in Appendix C). This provided 
the opportunity to use the desired N-substitution as protection group and 
thus reduce the number of steps needed to obtain the desired compound. 
Simultaneously, by using 4.31, information regarding N7 and N9 
regioselectivity could be derived. 2D NMR was used for compound 
identification. Table 4.1 shows the results of reacting purine 4.30, 4.31 and 
4.35 with bromide 4.25. The reaction clearly favours the formation of the N9 
regioisomer. It is our belief that the N7 regioisomer is the first to form, being 
the kinetic product of the reaction. However, in excess of bromide and over 
the course of time, the bisalkylated product serves as an intermediate for the 
formation of the thermodynamically favoured N9 isomer.71 Furthermore, the 
negative effect of the methoxy substitution at the positions 2 and 6 of the 
purine ring to the N-alkylation is evident by the lower yields observed in 
compounds 4.38-41. The increased electron density probably destabilizes the 
intermediate anion, hindering reaction progress. 
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Scheme 4.7. Synthesis of N-substituted xanthine: Reagents and conditions: (a) 4.25 (1.5 eq.), K2CO3 
(3.0 eq), DMF, overnight RT, for yields see Table 4.1; (b) 1) HDMS/BSA/TMS-Cl (2:2:1), overnight 
80 °C, 2) 4.25 (1.2 eq), overnight 80 °C, 3%.  
 
 
 
 
 
 
 
Curiosity led to attempting a reaction using silyl-Hilbert-Johnson67 or 
Vorbrüggen68 conditions on xanthine. (Scheme 4.7, reaction b) As expected a 
complex mixture of different substitution grades and regioisomers thereof was 
obtained; but by multiple, demanding purification steps one compound was 
isolated in low yield (3%) followed by structure elucidation and identification 
as 4.42. 
Yet again, the alkaline hydrolysis of dichloropurine analogues (4.36, 4.37) was 
to no avail resulting in monomethoxylation (Scheme 4.8, method a), which 
was a similar result as the synthesis of 4.33 and a mild methoxylation strategy 
(Scheme 4.8, method b). There are 2 important notes on the alkaline 
hydrolysis. First and foremost, the LiOH in H2O/THF/MeOH systems gave 
side products, one of which was isolated and identified as 4.48. Furthermore, 
Table 4.1. Optimization and regioselectivity of N9/N7-substition  
Starting  
material  
Bromide 
4.25 (eq) 
N9- 
yield (%) 
N7- 
yield (%) 
Total  
yield (%)  
4.30 1.2 48 22 70 
4.30 1.5 69 29 98 
4.30 2.0 65 24 89 
4.31 1.5 60 30 90 
4.35 1.5 47 trace 47 
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omitting MeOH did not result in any significant improvement as monitored 
by TLC. This led us to move on to full methoxylation and aim for an acid-
based deprotection instead of an alkaline-based one. Increasing methoxide 
equivalents and temperature gave the disubstituted compound (4.45) and 
subsequent treatment with concentrated acid only resulted in the 6-oxo 
analogue 4.47. Unfortunately, lack of time made it impossible to optimize the 
final deprotection. 
 
Scheme 4.8. Moving towards the targeted N-(benzyl)-substituted xanthine: Reagents and 
conditions: (a) LiOH (2.0 eq), H2O/MeOH/THF (1:1:1), 2 h RT, 66% (4.43); (b) Na (2.0 eq), MeOH, 
3 h RT, 74% (4.43), 85% (4.44); (c) Na (5.0 eq), MeOH, 8 h reflux, 87% (4.45), trace (4.46); (d) HCl 
6N, 3 h 60°C, 45% 
4.2.4 Amino acid protection and esterification 
The objective stated the need of using a photocleavable group and our design 
included the rather simple structures of 4.52a-c, although the synthesis was 
less straightforward than originally thought (Scheme 4.9). Contrary to Cbz 
and FMOC, the unstable chloroformate is not commercially available. Known 
procedures54,55,72,73 were explored and combined, resulting in the complete 
conversion of alcohol 4.49a to 4.50a by triphosgene (bis(trichloromethyl) 
carbonate (BTC)) as monitored by crude NMR. This complete conversion 
was necessary due to the oily state of 4.50a, and the lack of purification 
methods for a compound which is sensitive to both light and moisture. 
Attempts to speed up the reaction (1 week) by adding base (Et3N, DBU), 
were unsuccessful due to incomplete filtration of the HCl salt formed in 
dioxane. The same was expected for chloroformate 4.50b; prepared from 
alcohol 4.49b, previously obtained from reducing the respective ketone by 
NaBH4 (synthesis not shown). Chloroformate 4.50c, however, is a yellow solid 
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according to a patent by Chu74; allowing for possible recrystallization. Further 
purification was eventually not necessary as the NMR spectrum of the crude 
product was found to be pure after removal of Et3N.HCl salt by filtration and 
evaporation of the solvent.* 
 
 
Scheme 4.9. Synthesis of photocleavable N-protected phenylalanine and esterification with a 
desired LG: Reagents and conditions: (a) 4.49a (1 eq), BTC (1 eq), dioxane, 1 week 40 °C, quant.; (b) 
4.49c (1 eq), BTC (1 eq), Et3N (1 eq), THF, overnight RT, 71%; (c) 4.49a-b (1 eq), CDI (1.1 eq), 
DCM, 30 min RT, quant. (4.51a), 80% (4.51b); (d) Phe (1.2 eq), NaHCO3 (2.5 eq), H2O/dioxane, 1 h 
0°C, 3 h RT, 81% (4.52a), 64% (4.52c); (e) 4.51a-b (1.1 eq), Phe (1 eq), tetrazole (0.5 eq), ACN, 35% 
(4.52a), 30% (4.52b); (f) LG (1.1 eq), EDC.HCl (1.5 eq), DMAP (1.5 eq), DMF, yields see Table 4.2.  
An alternative way to obtain 4.52a-b was via 1,1'-carbonyldiimidazole (CDI) 
activation of the alcohol. This was a quantitative reaction resulting in a solid 
intermediate, which was sensitive to moisture. However, the subsequent 
reaction (Scheme 4.9, e) with phenylalanine was less efficient as the one 
utilising the chloroformate 4.51a-b. So while CDI is safer and easily activates 
the alcohol, BTC is less expensive and chloroformates react better to obtain 
N-protected amino acids.† Therefore CDI was chosen for fast, small scale 
reactions (1g); and BTC was chosen for planned, large batch reactions up to 
± 40g as the safety hazard only applies during reaction setup (phosgene 
formation by air exposure).72,75  
Combining the library of LG and N-protected amino acids resulted in the 
formation of the activated carboxylic acids necessary for oligomerization 
                                      
* Comparing the synthesis of 4.50a (an oil in dioxane, containing Et3N.HCl when the base was added 
even after filtration) to that of 4.50c (a solid dissolved in THF, where Et3N.HCl would precipitate 
out quantitatively) one can conclude that Et3N.HCl is more soluble in dioxane than in THF. 
†  Under Schotten-Baumann conditions: dropwise addition of the chloroformate in dioxane, to a 
saturated solution of NaHCO3 in H2O/dioxane containing the amino acid in suspension.  
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reactions. The first method of esterification investigated utilised N-
ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), known for amino 
acids and the lack of racemization thereof during reaction.76 But due to the 
advent of impurities (as discussed further on) and the excess of alcohol needed, 
the method was abandoned in favour of a modified Steglich esterification.77 
Originally using dicyclohexylcarbodiimide (DCC) and 4-
dimethylaminopyridine (DMAP), DCC was replaced by 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC). Carbodiimide activating agents 
result in the formation of the respective urea side-product which is filtered off 
when conducting the reaction in organic solvents such as dichloromethane 
(DCM) and EtOAc. However the poor solubility of uracil and analogues in 
such solvents forced the use of a better solvating medium such as DMF and 
thus eliminated the possibility of filtering off the formed urea. The water 
soluble EDC (and derived urea) would then be more suited for washing the 
reaction mixture before purification by column chromatography. An aqueous 
wash was also necessary to remove DMF; but the low yields across the board 
of Table 4.2 are believed to be caused by loss of the desired compound during 
work-up, either by too high aqueous solubility (saturated NaHCO3) or too low 
solubility in EtOAc. A small optimization (not shown) of the extraction 
parameters for compound 4.54a resulted in a yield increase of 20% (from 30 
to 50%). This method was then used to obtain all other compounds, without 
further optimization. Further purification on normal phase column 
chromatography was still necessary to obtain a pure compound. At first, a 
system with a gradient of methanol (2 to 10%) in DCM was used; but the 
sequential evaporation of solvents often led to impurity formation, suspected 
to be methanolysis of the active phenolic ester. This was addressed by 
switching the polar solvent to acetone (10 to 50%).* 
  
                                      
* This is also probably the main reason for the difference in yield of 4.56a (34% using MeOH/DCM) 
and 4.56c (59% using acetone/DCM), 4.55a-c were all chromatographed using MeOH. 
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Table 4.2. Unoptimized yields (%) from esterification reaction for obtained final products 4.53–57 
 N- Protected amino acid  Structures of envisaged final products 
 
LGa 4.52a 4.52b 4.52c Final 
product 
4.7 3b,c - 12c 4.53 
4.8 50 58 64 4.54 
4.13 17 17 24 4.55 
4.6 38 - 59 4.56 
4.10 trace - - 4.57 
a
 Scheme 4.3, b 8% with EEDQ, c not the envisaged product, identified as impurity see Figure 4.3 
A few issues regarding the synthesis of 4.53-57 remain, namely the formation 
of side-products and the related identification of the target compounds. The 
N1 and N3 of uracil are also nucleophilic and were expected to react alongside 
the available hydroxy group (alkyl alcohol, phenol, carboxime) during 
esterification; contributing to the observed low yields by presence and 
hampering of purification. Sometimes side-products were isolated, but 
amounts were too low for extensive structure elucidation. * Purification 
difficulties aside, the final product was isolated and confirmed by NMR. 2D 
experiments (HSQC, HMBC) were used to prove the coupling of LG and 
amino acid took place between the free carboxylic acid and the available 
alcohol group; and not the nucleophilic nitrogens of the uracil moiety. 
Examples are discussed in Appendix C. One of the obtained compounds 
(4.53a) was originally believed to be a side product of using EEDQ. This 
feeling was reinforced by the fact that EEDQ gave a complex mixture when 
using 4.8 as alcohol (synthesis of 4.54a). But after obtaining similar NMR 
results from the EDC-coupled reaction and when using another carboxylic 
acid (4.54c), the cause of the difficulties involved must have been the LG 4.7.  
                                      
* High resolution mass spectrometry indicated higher molecular masses, but no hypothesis regarding 
possible compound formation and predicted molecular formulas could be made in the limited time 
spent on these side products. 
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Figure 4.3. Identified side-products of reactions between 4.7 and 4.52 
As a matter of fact, after reviewing notes and data obtained, one batch of 4.7 
was found to be contaminated by side-products; insufficiently removed by the 
prescribed precipitation protocol. This batch was used without NMR 
confirmation due to prior successful synthesis of this product and (simple) 
TLC comparison with the prior obtained reference showed no difference. 
Although the impurities in the one batch of 4.7 were not identified, the main 
products isolated during esterification were identified to be those shown in 
Figure 4.3. 
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4.3 Kinetic and thermodynamic background parameters* 
Before studying oligomerisation reactions of the model compound 4.54c; any 
influence of the LG on amide formation was studied. This was done by 
comparing the LG properties by pKa determination and reviewing pseudo-
first order kinetics of model compounds 4.58 and 4.59 (Figure 4.4). 
 
Figure 4.4. Reference products for analysing ester bond properties 
4.3.1 The influence of uracil on a phenolic moiety 
As LG qualities are influenced by acid dissociation constants, the pKa of 4.8 
and p-cresol were determined by NMR, to resolve different pKas of the uracil 
LG. When the chemical shift of selected nearby protons and carbons was 
plotted in function of pH, the pKa was given by the inflection point. The 
results are shown in Table 4.3, and illustrate an increase of 0.5 for the phenolic 
value of 4.8 in comparison to the reference. This would designates 4.8 as a 
poorer LG than p-cresol. 
 
Table 4.3. pKa values determined in D2Oa 
Compound  pKa1a pKaNb 
p-cresol 10.4 - 
4.8 10.9 10.5 
a phenolic group; b acidic nitrogens of uracil ring 
 
  
                                      
* Further details are given in Chapter 6.3.2, 6.3.3 and in the Appendix D, including Figures D.1-3 
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4.3.2 Catalytic effect of uracil derivatives on amide synthesis 
Kinetic experiments were designed to compare 4.8 and p-cresol as LG; in 
order to determine any influence of the uracil moiety on the amide bond 
formation, as pyrimidinones share an amide group similar to pyrimidones 
which are known for their catalytic effect.78,79  
Pseudo-first order analyses of esters 4.58 and 4.59 were conducted in excess 
of benzylamine, followed by plotting the decrease in starting material versus 
time. The first analysis already indicated the uracil LG was more reactive in 
ACN (Table 4.4, 1th entry; Figure 4.5), contrary to what could be concluded 
from the previous pKa determination. 
 
Figure 4.5. Plot of k1 pseudo versus [amine] for aminolyis reactions of ester 4.58 and 4.59: insert = 
zoom of lower concentrations of amine. Reagents and conditions: 1.6x10-4 M of ester; 10, 12.5, 20, 25, 
30, 40, 50, 100, 150, 200 or 250 eq of benzylamine; solvent: ACN; each measurement is the average of 
at least 3 experiments. Dashed bonds = Confidence Interval 95% 
Further investigation showed that this trend held in a range of 12.5-250 eq of 
amine in a plot of k1 pseudo/[amine] versus [amine] for 4.58 and 4.59 (Appendix 
D). The linear fit obtained agrees with previous literature regarding amide 
bond formation.80 However, for ester 4.58, with the LG of interest 4.8, a 
quadratic fit is better indicating the possible presence of an additional term 
in the rate equation and thus an influence of the uracil moiety on the reaction 
rate (Equations 1-3 in Appendix D). Addition of one equivalent of 4.8, 
however, did not increase the rate more than the residual amount of DMSO 
from the stock solution of 4.8. (Table 1, 2nd and 3rd entry). 
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Table 4.4. Pseudo-first order constants (k (min-1)) and respective standard 
deviation (SD) for ester aminolysis reaction of ester 4.58 and 4.59 a 
  Ester 4.58 Ester 4.59 
Solvent additive k1 SD k1 SD 
ACN None 1.14x10-4 2.70x10-5 4.63x10-5 1.04x10-5 
 None b - - 6.37x10-5 8.60x10-6 
 4.8b,c - - 6.63x10-5 4.88x10-6 
DMSO None 1.65x10-4 1.93x10-5 1.04x10-4 1.67x10-5 
 4.8c - - 1.47x10-4 2.92x10-5 
DMSO:H2O (1:1)d None >10-3 - >10-3 - 
a 50 eq benzylamine; b 4.2% DMSO; c 1eq; d reaction rate near limit of measurable range, 
values given for general idea of magnitude 
A more polar solvent such as DMSO increased the aminolysis rate. Looking 
at the values of Table 4.4 (4th entry),  ester 4.58 still remains more reactive 
than 4.59, but the ratio is smaller (1.6x versus 2.5x). This time, spiking ester 
4.59 with 4.8 does give a rate increase (Table 4.4, 5th entry), resulting in a 
value similar to the one derived from the aminolysis of 4.58. Adding water 
results in more than twenty-fold rate increase, reaching the limits of the 
experimental set-up (Table 4.4, 6th entry), which is reason to believe that the 
potential influence of LG is minimal in comparison to solvent effects on 
peptide bond formation. 
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4.4 Photolysis and oligomerization reactions 
4.4.1 General scheme 
Scheme 4.10 below, shows the expected formation of compounds during and 
after deprotection of monomers (Figure 4.6) by UV irradiation. Freeing the 
amine moiety creates the opportunity for polymerisation when attacking a 
nearby carboxylic acid, activated by the LG (bold-green). Consistent with the 
ILG strategy proposed, investigating the influence of a template 
complementary to the recognition element in the LG will be the primary 
objective (red). The system will be complicated by side-reactions either by 
the nitroso aldehyde resulting from the photocleaved protection group or 
hydrolysis (blue). 
 
Scheme 4.10. Envisaged complex system from the deprotection of monomers: Colour scheme: 
deprotection and polymerisation of monomer (green), side-reactions (blue) including hydrolysis (hashed 
lines), possible influence of template (red). LG = Leaving Group, PG = Protection Group, only one 
shown here for simplicity. 
4.4.2 Early results 
Early results were conducted in organic solvents to avoid hydrolysis and thus, 
simplify reaction mixtures. Using 4.54a in ACN was encouraging, albeit slow 
in progress. The preceding kinetic experiments suggested the use of more polar 
solvents such as DMSO and DMF. However, these solvents adsorb the UV 
irradiation currently used (254 nm) and thus, ester 4.54c was needed to 
proceed. The change in deprotection condition (366 nm) also simplified 
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experimental protocol as quartz glassware was no longer necessary and ozone 
generation was less of a safety hazard (Appendix F). 
Figure 4.6. Esters used in photolytic experiments 
4.4.3 Oligonucleotide catalysis of peptide formation* 
Spontaneous formation of peptides from esters 4.54c and 4.60 was studied by 
deprotecting a solution of monomer in DMSO by UV irradiation, followed by 
the addition of an equal volume of either water, buffer and/or a solution of 
the investigated product. After a set time of incubation, the reaction mixture 
was analysed. 
Figure 4.7 depicts the result analysed by RP-HPLC. Oligomers of 
phenylalanine up to tetramers were obtained. Furthermore, from the noisy 
baseline, a few hydrolysis products could be seen. All products were identified 
using simultaneous MS spectra (Figure 4.9) or with retention times derived 
from commercial or synthesized references (Figure D.4). The mass spectrum 
in Figure 4.9 additionally revealed minor secondary peaks with equal mass for 
oligomerized species, indicating the possible formation of diastereoisomers 
during reaction. This observation agrees with previously obtained results of 
prebiotic peptide formation of activated species.81 Another interesting finding 
is the relatively low amounts of diketopiperazine (DKP) in all of the 
conducted analyses. Whether it is a blank reaction or with an additive, the 
                                      
* Extra figures can be found in Appendix D and are numbered Figure D.4-10 
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cyclized product is only a minor side product of this system, contrary to other 
known systems.33,81* 
 
 
Figure 4.7. Photolytic reaction of 4.54c, result without addition of oligonucleotide: full spectrum 
UV detection at 215 nm with identification of species. Reaction conditions: compound 4.54c in DMSO 
2 h 368 nm, followed by addition of an equal volume of water. Incubation time 1 h RT before analysis. 
LG = 4.8, DKP = diketopiperazine, SM = starting material. 
 
Figure 4.8. Photolytic reaction of 4.54c, result with a posteriori addition of oligonucleotide: full 
spectrum UV detection at 215 nm with identification of species. Reaction conditions: compound 4.54c 
                                      
* Interestingly the paper of Pascal and co-workers81, describes phenyl esters as weakly activated species 
who result in the formation of DKP over oligomerisation.  
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in DMSO 2 h 368 nm, followed by addition of an equal volume of oligonucleotide solution (dA)12, final 
concentration = 5 mol%. Incubation time 1 h RT before analysis. LG = 4.8, DKP = diketopiperazine, 
SM = starting material. 
Figure 4.8 shows the result of adding oligonucleotide (dA)12 to a deprotected 
solution of 4.54c. After two hours of photolysis, little difference is to be found 
in the amounts of deprotected product (LGPhe) and the dimer (LGPhe2). The 
main difference is the remarkable increase of trimer (LGPhe3) and moderate 
increase of tetramer (LGPhe4). The experiment was repeated in Figure 4.10 
using a different oligonucleotide (dA)10 for background measurements against 
the subsequent investigation of pH influence (Figure 4.11-12, Figure D.6-7) 
and different substrates (Figure D.8).  
 
 
Figure 4.9. Normalized ion extract chromatograms (IEC) for investigated species. The IEC were 
derived from the experiment listed in Figure 4.8. Phe3 was omitted due to a low signal to noise ratio. 
Mass signals were double checked against retention times derived from commercial or synthesized 
references. cPhe2 = DKP. Arrows indicate diastereoisomers. 
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Figure 4.10. Photolytic reaction of 4.54c, result with (red) or without (blue) a posteriori addition 
of oligonucleotide: zoomed (10-25 min) spectra UV detection at 215 nm. Reaction conditions: 
compound 4.54c in DMSO 2 h 368 nm, followed by addition of an equal volume of water (blue) or 
oligonucleotide solution (dA)10, final concentration = 5 mol%. Incubation time 1h RT before analysis. 
LG = 4.8, DKP = diketopiperazine; NVOC2 = 6,6'-(Diazene-1,2-diyl)bis(3,4-dimethoxybenzoic acid), 
dimer sideproduct of deprotection; SM = starting material. 
The same conclusion can be drawn from the overlay of Figure 4.10 as from 
Figure 4.7 and 4.8. The side product from the cleaved protecting group poses 
a problem, as its formation comprises of the reaction of a nitroso aldehyde 
intermediate with primary amines.55 No effect was noticed when using ester 
4.60 without 4.8 as LG (Figure D.8). 
Adding the oligonucleotide before photolysis (Figure D.5), gave no significant 
changes in reaction mixture versus control experiment (Figure 4.10); probably 
due to degradation of the template.82 Investigating the effect of buffering can 
be seen in Figure 4.11-12 and Figure D.6-7. Slightly acidic pH (6.0) results 
only in the decrease of unprotected monomer (UPhe) in favour of the dimer 
(Figure 4.11).  
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Figure 4.11. Photolytic reaction of 4.54c, effect of acidic pH versus blank: zoomed (10-25 min) 
spectra UV detection at 215 nm. General reaction and analysis conditions see Figure 4.10 and Chapter 
6 (blue) no oligonucleotide, no buffering (red) no oligonucleotide, pH 6.0 (red). 
An alkaline environment (pH 8.4) results in a distinctively different pattern 
(Figure D.6), the identity of new peaks was unresolved in MS nor were any 
of the mass values recognized. The effect seen by adding oligonucleotide in 
Figure 4.7 and 4.10 is repeated in acidic (Figure 4.12), but not in alkaline 
environment (Figure D.7). 
The formation of side-products during photolysis and hydrolysis contributes 
to the result obtained by keeping the samples at room temperature for 2 days 
(Figure D.9-10). All amino acid derived peaks diminished in favour of a more 
chaotic and unresolved baseline. Furthermore the sample with (dA)10 in acidic 
environment knows the same degradation as seen in unbuffered samples 
(Figure D.10). 
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Figure 4.12. Photolytic reaction of 4.54c, effect of oligonucleotide at pH 6.0: general reaction and 
analysis conditions see Figure 4.10 and Chapter 6 (blue) no oligonucleotide, pH 6.0; (red) (dA)10, pH 
6.0. 
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5.1 General conclusions and overview 
We have introduced the Informational Leaving Group concept to counter the 
setbacks of designed complex systems aimed at uncovering the interplay 
between biomolecules in prebiotic context. The ILG approach was 
implemented in two lines of information transfer: nucleic acid-nucleic acid and 
nucleic acid-peptides. Non-enzymatic template-directed nucleotide 
condensation and ligation are historically important examples burdened by 
template inhibition of complementary elements. On the other hand, 
identifying the chemical interaction between nucleic and amino acids is  still 
a work in progress as illustrated by the ongoing search for the origin of the 
genetic code. The evolution of tRNA might have played an important role 
and has also been the inspiration for our experimental and theoretical models 
of template directed formation of nucleic acids and peptides. 
To summarize: 
• The ILG approach was introduced in the minimal replicator theory. This 
thermodynamic and kinetic model supports the experimental evidence of 
existing chemical replicators, where the dissociation of the duplex is the 
rate limiting step. Our ILG adaptation introduced new elements and 
equilibria to counter this. Despite a slight reservation towards the 
thermodynamic data used to translate this model into a working example, 
the ILG model lives up to its expectations and outperforms the minimal 
replicator theory. (Chapter 3.2) 
 
• An attempt to obtain a monomer that could introduce the ILG strategy 
in non-enzymatic, templated oligonucleotide synthesis is reported. A new 
synthetic route towards imidazole substituted uracil avoiding metal 
catalyzed reactions and hazardous reagents was optimized. The 
subsequent coupling, however, was proven to be more difficult but not 
without promise. (Chapter 3.3) 
 
• A library of compounds based on the chemical simplification of tRNA was 
synthesized in order to function in experiments for templated peptide 
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synthesis initiated by photochemistry. Synthetic difficulties and 
unexpected finds are discussed in Chapter 4.2. 
 
• The model experiments for template directed peptide synthesis were 
preceded by measuring thermodynamic and kinetic properties of the 
elements involved. The conclusion was drawn that the uracil-based leaving 
group will have minimal to no influence on the formation of peptide bonds 
in the framework of subsequent research. (Chapter 4.3) 
 
• The oligomerisation experiments with amino acids, activated by a 
prebiotically plausible uracil derived LG, showed the influence of adding a 
complementary oligonucleotide in obtaining more of higher oligomerized 
products. (Chapter 4.4) 
 
5.2 Future outlook 
This dissertation provides a proof of concept for the implementation of the 
Informational Leaving Group strategy in experiments aimed at template-
directed synthesis of oligonucleotides and peptides. The continuation of this 
work will provide further insights in such reactions, while simultaneously 
addressing the synthetic challenges that are left in functionalising nucleobases. 
The latter deserves to be explored as these compounds are medicinally 
interesting. First of all, the introduction of isocyanides as reagents for 
heterocyclic biaryl systems containing a nucleobase, deserves more exploring 
as small modifications to reaction conditions could potentially open the route 
to libraries of molecules previously difficult to reach. The current route avoids 
materials such as metal catalysts which are a concern in pharmaceutical 
synthesis. Secondly, failure to obtain a directly coupled uracil-phenol analogue 
via Suzuki reaction led to a longer alternative synthetic route. Preliminary 
results have shown a possible compatibility of halouracils for C-H activation 
of phenolic moieties. 
Looking at the experimental and theoretical models conceived, an interesting 
new project would be to obtain and test a nucleic acid replicator. The 
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comparison of the minimal replicator theory and the Informational Leaving 
Group approach provides a theoretical starting point to design these 
experiments to confirm the model and expand this to similar replicating 
systems with other molecular scaffolds. 
The phosporamidate building block for non-enzymatic oligonucleotide 
synthesis with a nucleobase in its leaving group was obtained, although 
inefficiently. The presence of pyrophosphate confirms the activation of the 
nucleotide, however the large amount of hydrolysis or starting material calls 
for further investigation and optimisation in order to obtain viable amounts 
for oligomerisation experiments. The alternative would be to use the 
informational leaving group as co-factor for in situ activation of 
mononucleotides as reported in Scheme 1.4.  
The model for templated peptide synthesis using a small molecule as tRNA 
mimic has proven its worth in the exploratory phase of the evaluation. 
However, additional experiments will further prove the observed catalytic 
effect of oligonucleotides as templating such as observing the reaction by NMR 
or titrating the amount of oligonucleotide. Using different leaving groups and 
amino acids would be the next step to prove the generality of the concept, 
followed by mixing different monomers in order to research selectivity and 
thus efficiency of information transfer.  
“At best, this can be regarded as a primitive sign of life; at the very least, the 
system offers a bridge between the information of nucleic acids and the 
synthesis of amide bonds. It should be possible to design systems capable of 
peptide synthesis on a nucleic acid backbone and thereby provide models for 
events that occurred some time ago.” J. Rebek Jr and coworkers* 
 
                                      
* In 1990, Rebek Jr. and co-workers reported a self-replicating system based on a nucleotide scaffold. 
(T. Tjivikua, P. Ballester, J. Rebek, A Self-Replicating System. J. Am. Chem. Soc. 112, 1249-1250 
(1990)) Hydrogen bonding acted as recognition element and the bond formed was an amide. Defining 
life solely by self-replication might be too optimistic, but the rest of the quote fits nicely to our research 
on the tRNA-like model.  
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6.1 General experimental conditions 
For all reactions, chemicals of analytical or synthetic grade were obtained 
from commercial sources and were used without further purification unless 
otherwise stated. Water was ultrapure (18 MΩcm) and prepared by a 
Millipore purification system. The stationary phase in column 
chromatography was 70-230 mesh silica 60 (E.M. Merck). Analytical Thin 
Layer Chromatography (TLC) was performed on Alugram® silica gel UV254 
mesh 60, 0.20mm (Macherey-Nagel). Centrifugation was carried out on a 
Heraeus® Megafuge 1.0 at 3700 rpm (3000g). 1H NMR spectra and 13C NMR 
spectra were recorded on a Bruker Avance 300 (5mm BBO Probe). 2D NMR 
spectra on a Bruker Avance 500 a TXI Z gradient probe or Bruker Avance II 
600 MHz with a 5 mm TCI HCN Z gradient cryoprobe. Chemical shifts are 
expressed as δ units (part per million) down field from TMS (tetramethyl 
silane) for 1H and 13C-spectra. Low resolution mass spectra were recorded on 
a Thermo electron LCQ advantage ion trap mass spectrometer connected to 
Agilent 1100 HPLC system. High Resolution Mass Spectrometry (HRMS) 
spectra were acquired on a quadrupole orthogonal acceleration time-of-flight 
mass spectrometer (Synapt G2 HDMS, Waters, Milford, MA). Samples were 
infused at 3 µL/min and spectra were obtained in positive or negative 
ionization mode with a resolution of 15000 FWHM using leucine encephalin 
as lock mass. The IR spectra were recorded on a Bruker Alpha-T FT-IR 
spectrometer with universal sampling module coupled to OPUS software. All 
samples were applied neat. Melting points were collected by DSC (Mettler 
Toledo Star System) with Indium as calibration agent. LC-MS analysis was 
conducted on an Agilent 1100 HPLC with quaternary pump, auto sampler, 
UV-DAD detector and a thermostatic column (25 °C) module coupled to 
Agilent 6110 single-quadrupole electrospray ionization mass spectrometry 
(capillary voltage = +3500V or -3000V). The column was a Grace Prevail 
RP-C18 3μm 150mm x 2.1mm. Data collection and analysis was done with 
Agilent LC/MSD Chemstation software. Chromatograms were processed 
using Microsoft Excel. Photolytic cleavage of protection groups was conducted 
in a homemade cylindrical reactor (Appendix E), closed from ambient light. 
Venting holes and fan cooling were present and a cylindrical, polished stainless 
steel casing provided reflection of UV lamps installed towards the reaction 
center. The setup could accommodate 4 circuits of each 4 Sylvania 
F8W/T5/BL368 UV lamps. 
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6.2 Chemical Replication 
6.2.1 ILG in autocatalysis 
Graphical analysis of the minimal replicator and ILG model was performed 
by Python 2.7.10 coding of the Spyder2 application by Anaconda 2.3.0 (64-
bit, Continuum Analytics). An example of the input file used (.py) is given 
in the Appendix B. 
6.2.2 ILG in non-enzymatic oligonucleotide synthesis 
 
1-(5'-Adenylyl)-1H-imidazole* (3.1c) procedure according to literature1: A solution 
of 5’-AMP monohydrate (181.6 mg, 0.5 mmol, 1 eq) in DMF (15 ml) was added dropwise to 
a solution of PPh3 (262.2 mg, 1 mmol, 2 eq), 2,2’-dipyridyldisulfide (220.3 mg, 1 mmol, 2 eq) 
and imidazole (170.2 mg, 2.5 mmol, 5 eq) in a mixture of 15ml DMF and 0.9 ml Et3N. The 
result was stirred for 1.5 h at room temperature followed by dropwise addition of the reaction 
mixture to a third solution containing saturated NaClO4 in acetone, diluted with anhydrous 
Et2O (1:1) and 5% Et3N. After 1 h, the supernatans was decanted from the precipitated 
ImpA. The precipitate was resuspended in acetone and transferred to 30 ml Corex tubes, 
followed by centrifugation for 10 min at 3000g. The resulting pellet was decanted and washed 
twice with acetone and once with Et2O, each time followed by centrifugation. 156 mg (74% 
yield) of a white residue was obtained.  
1H NMR (300 MHz, DMSO-d6, δ): 8.40 (s, 1H, A-H2), 8.14 (s, 1H, A-H8), 7.64 (s, 1H, Im-H2), 
7.27 (s, 2H, NH2), 7.10 (s, 1H, Im-H4/5), 6.85 (s, 1H, Im-H4/5), 5.89 (d, 3JHH = 6.0 Hz, 1H, H1’), 
5.47 (bs, 1H, OH), 5.29 (bs, 1H, OH), 4.59 (bs, 1H, H2’/3’/4’), 4.04 (s, 1H, H2’/3’/4’), 3.95 (s, 1H, 
H2’/3’/4’), 3.79-3.62 (m, 2H, H5’,5’’); 31P NMR (121 MHz, DMSO-d6, δ): -9.61.† 
 
                                      
* Adenosine 5-phosphorimidazolide 
† Qualitatively measured without internal reference (phosphoric acid) 
MATERIALS AND METHODS 
| 133 
 
Ethyl ureidomethyleneacetoacetate (3.2) procedure according to literature2: Ethyl 
acetoacetate (27.5 g, 0.14 mol, 1.1 eq), triethyl orthoformate (20.3 g, 0.14 mol, 1.1 eq) and 
urea (7.5 g, 0.12 mol, 1 eq) were combined and stirred overnight at 110 °C. The precipitate 
was then cooled, filtered and washed with Et2O yielding 25 g (46 % yield) of a pale orange 
powder. The crude product was used without further purification and characterization. 
 
Ethyl 4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (3.3) procedure 
according to literature2: A KOH solution (7.5%, 125 ml) was added to ethyl 
ureidomethyleneacetoacetate (10 g, 50 mmol). After swirling for 1 min, the solution was 
neutralized with concentrated HCl and evaporated to dryness, yielding 4.6 g (51%) of a 
greenish yellow powder. 
1H NMR (500 MHz, DMSO-d6, δ): 8.73 (s, 1H, H6), 4.23 (q, 3JHH = 7.1 Hz, 2H, H9), 2.54 (s, 
3H, H8), 1.28 (t, 3JHH = 7.1 Hz, 3H, H10). 13C NMR (126 MHz, DMSO-d6, δ): 163.57 (C4/7), 
162.39 (C4/7), 151.07 (C2), 149.10 (C6), 111.07 (C5), 60.50 (C9), 20.78 (C8), 14.16 (C10). HRMS 
= 183.0762 [M+H]+; Tm = 227-35 (lit = 248-250 °C) 
 
5-Acetyluracil (3.4) procedure according to literature2: A KOH solution (11%, 125 
ml) was added to ethyl ureidomethyleneacetoacetate (10 g, 50 mmol). After boiling for 1 
hour, the solution was neutralized with concentrated HCl and evaporated to dryness. The 
residue was then recrystallized in water, yielding 3.7 g (48%) of a greenish yellow powder.  
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1H NMR (300 MHz, DMSO-d6, δ): 11.71 (bs, 1H, NH), 11.39 (s, 1H, NH), 8.05 (s, 1H, H6), 
2.43 (s, 3H, H8); 13C NMR (75 MHz, DMSO-d6, δ): 193.69 (C7), 162.34 (C4), 150.78 (C2), 
148.60 (C6), 111.26 (C5), 30.26 (C8); HRMS = 153.0322 [M-H]-; Tm > 300 °C (lit =294 °C) 
5-(2-Bromoacetyl)uracil (3.5) not obtained 
 
5-(Imidazole-4-yl)uracil (3.6) 7N NH3 in MeOH (1.4 mL, 9.9 mmol, 3 eq) was added 
to 5-formyluracil (0.46 g, 3.3 mmol, 1 eq) in MeOH (7 mL). The mixture was stirred and 
refluxed in a pressure tube for 1 hour before adding TosMIC (1.03 g, 5.28 mmol, 1.6 eq). 
After refluxing for another hour, the result was filtered, washed with Et2O and 0.35 g (66% 
yield) of 5-(imidazole-4-yl)uracil as a light grey precipitate was obtained.  
1H NMR (300 MHz, DMSO-d6, δ): 7.81 (s, 1H, U-H6), 7.63 (s, 1H, Im-H2), 7.50 (s, 1H, H5); 
3C NMR (75 MHz, DMSO-d6, δ): 162.59 (U-C4), 150.75 (U-C2), 135.52 (U-C6), 135.10 (Im-
C2), 132.57 (Im-C4), 113.77 (Im-C5), 107.93 (U-C5); HRMS = 177.0425 [M-H]-; Tm > 300 °C 
(dec.) (lit = 312-20 °C) 
 
5-Hydroxymethyluracil (3.7) procedure according to literature3: To a solution of 
uracil (8.8 g, 78.5 mmol, 1 eq) and paraformaldehyde (90%, 7.85 g, 0.236 mol, 3 eq) in water 
(200 mL), triethylamine (16.4 mL, 0.118 mol, 1.5 eq) was added. Heating to 65 °C turned the 
solution clear, continued by further stirring at 65 °C for 12 h. The water was removed by 
rotary evaporation until approximately 1/10 of volume remained. The residue was diluted 
with an equal amount of 95% ethanol, which was allowed to stand for 30 min at RT and 
further cooled at 4 °C. The white precipitate was filtered off and washed with 95% ethanol. 
The filtrate was used to repeat the process of concentration and precipitation three times, 
resulting in a combined 88% (9.82 g) yield. 
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 1H NMR (300 MHz, DMSO-d6, δ): 11.05 (s, 1H, NH3), 10.72 (s, 1H, NH1), 7.23 (s, 1H, H6), 
4.85 (s, 1H, OH), 4.10 (s, 2H, H7); 13C NMR (75 MHz, DMSO-d6, δ): 163.80 (C4), 151.35 (C2), 
138.20 (C6), 112.72 (C5), 55.81 (C7); m/z = 141.0 [M-H]-; Tm = 192-6 °C (lit = 195-200 °C) 
 
5-Formyluracil (3.8) procedure according to literature3: 3.7 (10.75 g, 75.6 mmol, 1 
eq) was dissolved in H2O (400 mL) by heating to 90 °C. The solution was then cooled to 45 
°C followed by administration of AgNO3 (0.4 g, 2.3 mmol, 3 mol%) and slow, partial addition 
of K2S2O8 (37.5 g, 0.14 mol, 1.81 eq) which led to the gradual formation of a white precipitate. 
The reaction was left stirring for 20 min at 40 °C and 15 min at RT. The suspension was 
then placed at 4 °C, filtered and washed with cold water to yield 9.8 g (93%) as an off-white 
solid. 
1H NMR (300 MHz, DMSO-d6, δ): 11.93 (bs, 1H, NH3), 11.52 (s, 1H, NH1), 9.73 (s, 1H, H7), 
8.14 (s, 1H, H6); 13C NMR (75 MHz, DMSO-d6, δ): 191.64 (C7), 167.68 (C4), 155.69 (C2), 
154.54 (C6), 115.30 (C5); m/z = 139.1 [M-H]-; Tm > 300 °C (lit = 302-3 °C) 
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6.3 Chemical Translation 
6.3.1 Synthesis 
NOTE: For most uracil derivatives, the nomenclature pyrimidine-
2,4(1H,3H)-dione or 2,4-dioxo-1,2,3,4-tetrahydropyrimidine is replaced by 
a substituent notation with uracil as core for ease of interpretation. 
 
2,4-Dichloropyrimidine (4.1) reference adapted4: A mixture of uracil (1 g, 8.9 mmol, 
1 eq) in POCl3 (15 mL, 0.2 mol, 20 eq) was refluxed for 5 h, followed by pouring the resulting 
clear solution in ice. The cooled aqueous solution was extracted with CHCl3 (3x). The 
combined organic layers were washed with brine until a neutral pH was obtained, followed 
by drying over MgSO4 and evaporated in vacuo. The crude product was immediately* used, 
without further purification (60% yield). 
1H NMR (300 MHz, CDCl3, δ): 8.54 (d, 3JHH = 5.2 Hz, 1H, H5), 7.34 (d, 3JHH = 5.2 Hz, 1H, 
H5); 13C NMR (75 MHz, DMSO-d6, δ): 162.75 (C2), 161.12 (C4), 160.06 (C6), 120.34 (C5). 
 
2,4-Dimethoxypyrimidine (4.2) reference adapted5: A freshly prepared solution of 
CH3ONa, by sequential dissolving of sodium metal (0.84 g, 36.4 mmol, 2.55 eq) in MeOH (13 
mL), was added to 4.1 (2 g, 14.3 mmol, 1 eq) under stirring at 0 °C. The reaction mixture 
was refluxed overnight, followed by quenching with water and extraction with DCM. 
Evaporation in vacuo obtained a yellow oil, identified by NMR as the desired product which 
was used without further purification (81% yield). 
                                      
* Acidic fumes came from samples stored at RT 
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1H NMR (300 MHz, CDCl3, δ): 8.19 (d, 3JHH = 5.7 Hz, 1H, H6), 6.38 (d, 3JHH = 5.7 Hz, 1H, 
H5), 4.00 (s, 3H, OCH3), 3.97 (s, 3H, OCH3); 13C NMR (75 MHz, CDCl3, δ): 171.50 (C2), 
165.53 (C4), 158.31 (C6), 102.08 (C5), 54.74 (OCH3), 53.73 (OCH3). 
 
5-Iodo-2,4-dimethoxypyrimidine (4.3) reference adapted4: To a stirred solution of 
4.2 (0.8 g, 5.7 mmol, 1 eq) in acetic acid was added NIS (1.5 g, 6.9 mmol, 1.2 eq). The 
reaction mixture was left stirring at 80 °C overnight. The reaction mixture was poured into 
EtOAc/water. The organic layer was washed with 1M NaOH until a neutral to slightly 
alkaline pH was obtained*, followed by drying over MgSO4 and rotary evaporation. The 
identified light orange compound was used without further purification (67% yield).  
1H NMR (300 MHz, CDCl3, δ): 8.45 (s, 1H, H6), 4.04 (s, 3H, OCH3), 3.99 (s, 3H, OCH3); 13C 
NMR (75 MHz, CDCl3, δ): 168.81 (C6), 165.46 (C4), 164.79 (C2), 68.96 (C5), 55.20 (OCH3), 
55.11 (OCH3). Tm = 71-74 °C (lit: 72 °C) 
 
5-(4-Hydroxyphenyl)-2,4-dimethoxypyrimidine (4.4) reference adapted6: A 
suspension of 4.3 (0.5 g, 3.8 mmol, 1 eq), Na2CO3 (0.43 g, 9.4 mmol, 2.5 eq) and PPh3 (0.1 
g, 0.4 mmol, 11 mol%) in n-propanol (12 mL) was degassed and stirred under atmosphere, 
followed by the addition of 4-hydroxyphenyl boronic acid (0.52 g, 3.75 mmol, 1 eq) and 
Pd(OAc)2 (25 mg, 0.1 mmol, 3 mol%). The reaction mixture was left refluxing overnight 
under atmosphere, followed by pouring it in EtOAc and washing with 1M HCl. The organic 
layer was dried over MgSO4 and evaporated in vacuo. Purification by column chromatography 
(EtOAc/heptane, 3:7) resulted in 0.26 g (30% yield) a slightly orange compound as the title 
product. 
                                      
* The color of the organic layer changed upon reaching this point from purple-brown to yellow. 
MATERIALS AND METHODS 
138 |  
1H NMR (300 MHz, DMSO-d6, δ): 9.57 (s, 1H, H6), 7.33 (d, 3JHH = 8.7 Hz, 2H, H9,11), 6.81 
(d, 3JHH = 8.7 Hz, 2H, H8,12), 6.55 (s, 1H, OH), 3.94 – 3.90 (m, 6H, OCH3); 13C NMR (75 
MHz, DMSO-d6, δ): 172.68 (C2), 168.76 (C4), 162.26 (C10), 162.20 (C6), 154.94, 135.10, 128.52, 
120.86, 120.75, 120.44 (C8,12,7,9,11), 59.69 (OCH3), 59.11 (OCH3); HRMS = 233.0925 [M+H]+; 
Tm = 132-8 °C 
 
5-(4-Hydroxyphenyl)uracil (4.5) procedure according to literature7: The 
dimethoxypyrimidine 4.4 (0.1 g, 0.4 mmol) was refluxed for 2 h in a mixture of concentrated 
HCl and acetic acid (2 mL, 1:1). The cooled mixture was diluted with water and refluxed for 
an additional 2 min, followed by cooling and filtration of the precipitate. The obtained white, 
silky product (53%) was identified as the title product. 
1H NMR (300 MHz, DMSO-d6, δ): 11.15 (s, 1H, NH), 11.00 (bs, 1H, NH), 9.42 (s, 1H, OH), 
7.45 (s, 1H), 7.36 – 7.28 (m, 2H, H9,11), 6.77 – 6.70 (m, 2H, H8,12); 13C NMR (126 MHz, DMSO-
d6, δ): 163.42 (C4), 156.62 (C10), 151.02 (C2), 138.19 (C6), 129.18 (C8,12), 123.95 (C7), 114.88 
(C9,11), 112.36 (C5); HRMS = 203.0458 [M-H]-; Tm > 300 °C 
 
5-Hydroxyuracil (4.6) reference adapted8: To a solution of uracil (2 g, 18 mmol, 1 
eq) in 1M KOH (100 mL) was added K2S2O8 (9.6 g, 36 mmol, 2 eq) and the solution was 
stirred at 4 °C for 24 h. The resulting colorless solution was neutralized with concentrated 
sulfuric acid and diluted with MeOH (100 mL). The precipitate was filtered off, followed by 
concentrating the filtrate and resuspending the residue in water (100 mL). An aqueous 
solution of 0.15M BaCl2 (20 mL) was added under stirring, the resulting precipitate discarded 
by filtration. The residue was recrystallized from water/acetone, followed by addition of 
concentrated HCl (5 mL) and refluxing for 5 min. The resulting, white precipitate was filtered 
and washed with water (10% yield).  
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1H NMR (500 MHz, DMSO-d6, δ): 11.14 (s, 1H, NH), 10.16 (s, 1H, NH), 8.38 (s, 1H, OH), 
6.83 (d, 3JHH = 5.4 Hz, 1H, H6); 13C NMR (126 MHz, DMSO-d6, δ):) 161.50 (C4), 150.06 (C2), 
131.87 (C5), 120.68 (C6); HRMS = 129.0296 [M+H]+; Tm = 180-5 °C (lit > 300 °C (dec.)) 
Compound 4.7 is already described under 5-hydroxymethyluracil (3.7) 
 
5-(4-Hydroxybenzyl)uracil (4.8) procedure according to literature9: A mixture of 
4.7 (4.8 g, 33.8 mmol, 1 eq) and phenol (3.19 g, 33.8 mmol, 1 eq) suspended in 0.1M HCl 
(100 mL) turned clear on heating at 90 °C. After 2 h, a precipitate was formed and additional 
phenol (0.64 g, 6.76 mmol, 0.2 eq) was added. The suspension was left stirring for 1h at 90 
°C, followed by cooling, filtration of the white solid and washing with water to obtain the 
desired compound (5.46 g, 74%). 
1H NMR (300 MHz, DMSO-d6, δ): 11.05 (s, 1H, NH3), 10.66 (s, 1H, NH1), 9.18 (s, 1H, OH), 
7.12 (s, 1H, H6), 7.01 (d, 3JHH = 8.1 Hz, 2H, H10,12), 6.66 (d, 3JHH = 8.2 Hz, 2H, H9,13), 3.40 (s, 
overlap with HOD-peak, H7); 13C NMR (75 MHz, DMSO-d6, δ): 164.26 (C4), 155.53 (C11), 
151.31 (C2), 138.30 (C6), 129.76 (C8), 129.43 (C9,13), 114.97 (C10,12), 112.47 (C5), 30.81 (C7). 
HRMS: 219.0765 [M+H]+; Tm > 300 °C (lit = 330°C) 
Compound 4.9 is already described under 5-formyluracil (3.8) 
 
5-Formyluracil oxime* (4.10) reference adapted10: 4.9 (1 g, 7.1 mmol, 1 eq) was 
added to a mixture of water and MeOH (40 mL, 1:1) and then heated at reflux, followed by 
addition of an aqueous solution of NH2OH.HCl (0.5 g, 7.1 mmol, 1 eq) and KOAc (0.72 g, 
7.1 mmol, 1 eq). A precipitate formed immediately, was isolated by filtration and washed 
with cold water and acetone to yield 0.88 g (80%) as a white solid identified as the title 
product.   
                                      
* 2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde oxime 
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1H NMR (300 MHz, DMSO-d6, δ): 11.35 (s, 1H, NH3), 11.21 (bs, 1H, OH), 11.03 (s, 1H, NH1), 
7.81 (s, 1H, H6), 7.69 (s, 1H, H8); 13C NMR (75 MHz, DMSO-d6, δ): 162.97 (C4), 151.20 (C8), 
141.76 (C2), 139.02 (C6), 106.01 (C5); HRMS = 156.0411 [M+H]+; 178.0229 [M+Na]+; Tm not 
determined* 
 
5-Iodouracil (4.11) procedure according to literature11: A mixture of uracil (20 g, 0.2 
mol, 2 eq), iodine (27.2 g, 0.11 mol, 1.2 eq) and CAN (48.9 g, 0.09 mol, 1 eq) in ACN (400 
mL) was stirred at reflux for 5 h. The white precipitate formed during the reaction was 
isolated by cooling the suspension, filtration and washing with a small amount of cold CAN. 
This material was recrystallized with 50% EtOH to give 34 g (80% yield) as colorless needles. 
1H NMR (300 MHz, DMSO-d6, δ): 11.31 (bs, 2H, NH), 7.89 (s, 1H, H6); 13C NMR (75 MHz, 
DMSO-d6, δ): 161.93 (C4), 151.70 (C2), 147.45 (C6), 68.00 (C5); HRMS = 238.9317 [M+H]+; 
Tm > 280 °C (dec.) (lit > 250 °C (dec.)) 
 
5-Ethynyluracil (4.12) procedure according to literature11: A suspension of 4.11 (5.0 
g, 21 mmol, 1.0 eq) in 42 mL of EtOAc was deoxygenated for 1 h with N2 at RT, followed 
by the addition of CuI (120 mg, 0.63 mmol, 0.03 eq), Pd(PPh3)4 (121 mg, 0.105 mmol, 5 
mol%), TMSA (4.2 mL, 29.4 mmol, 1.4 eq) and 12.6 mL of Et3N. The resulting mixture was 
stirred overnight under N2 atmosphere, after which it was brought to 0 °C and filtered. The 
precipitate was collected, suspended in 1M NaOH (100 mL) and stirred for 2 h at RT; followed 
by dilution with H2O and filtration. The filtrate was acidified with acetic acid and upon 
reaching pH±5, a precipitate formed. The precipitate was filtered off, washed with cold water 
and dried to afford 2.5 g (86% yield) of the title compound as an off-white powder. 
1H NMR (300 MHz, DMSO-d6, δ): 11.37 (s, 1H, NH), 11.30 (s, 1H, NH), 7.82 (s, 1H, H6), 
4.04 (s, 1H, H8); 13C NMR (75 MHz, DMSO-d6, δ): 162.71 (C4), 150.41 (C2), 146.44 (C6), 
                                      
* DSC indicated a reaction occurred at 287-297 °C 
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96.22 (C5), 83.23 (C7), 76.53 (C8); HRMS = 137.0363 [M+H]+, 159.0182 [M+Na]+; Tm not 
observed*  
 
5-((4-Hydroxyphenyl)ethynyl)uracil (4.13) A solution of 4.12 (0.54 g, 4 mmol, 1 
eq) and 4-iodophenol (1 g, 4.8 mmol, 1.2 eq) in DMF (5 mL) was deoxygenated for 1 h with 
argon, followed by addition of Pd(PPh3)4 (46 mg, 0.04 mmol, 1 mol%) and CuI (23 mg, 0.12 
mmol, 3 mol%) while stirring vigorously. (iPr)2NH (2 mL) was added dropwise under constant 
flushing of the reaction mixture, before keeping the mixture overnight at RT under 
atmosphere and stirring. EtOAc was added followed by filtration and washing with 1M HCl. 
Any precipitate formed during the extraction was collected. The organic layer was dried over 
MgSO4 and evaporated in vacuo. Addition of EtOAc to the residue resulted in precipitation 
of a yellow solid. All collected solids were identified separately as the desired, pure compound. 
(58% yield)  
1H NMR (300 MHz, DMSO-d6, δ): 11.38 (bs, 2H, NH3,1), 9.90 (s, 1H, OH), 7.80 (s, 1H, H6), 
7.27 (d, 3JHH = 8.1 Hz, 2H, H11,13), 6.77 (d, 3JHH = 8.1 Hz, 2H, H10,14); 13C NMR (75 MHz, 
DMSO-d6, δ): 162.61 (C4), 157.80 (C12), 150.43 (C2), 144.97 (C6), 132.73 (C10,14), 115.66 (C11,13), 
112.74 (C9), 97.36 (C5), 92.00 (C8), 80.25 (C7); HRMS = 227.0464 [M-H]-; Tm = 158-161 °C 
 
4-((Trimethylsilyl)ethynyl)phenol (4.14) A solution of 4-iodophenol (2 g, 9.1 mmol, 
1 eq) in THF (14 mL) was stirred and continuously flushed with argon, followed by addition 
of CuI (51.8 mg, 0.3 mmol, 3 mol%) and Pd(PPh3)4 (52.5 mg, 0.05 mmol, 0.5 mol%). 
Afterwards, TMSA (1.1 g, 10.9 mmol, 1.2 eq) and Et3N (6 mL) were added dropwise under 
                                      
* DSC indicated a reaction had occurred at 238-248 °C, ESI-MS indicated the formation of an ion of 
549 in positive mode which would account to slightly more than 4 units of 4.12 in a possible 
polymerisation reaction. This is of course not conclusive and further investigation is needed. 
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continued atmospheric renewal. The reaction mixture was left stirring until the starting 
material was no longer detectable via TLC analysis (EtOAc/heptane, 2:8). The reaction 
mixture was poured into EtOAc and washed 1M HCl. The organic layer was dried over 
MgSO4 and evaporated in vacuo. The crude product, a viscous amorphous solid, was used 
without further purification. (87% yield) 
1H NMR (300 MHz, CDCl3, δ): 7.37 (dd, 3JHH = 8.7, 2.1 Hz, 2H, H3,5), 6.76 (dd, 3JHH = 8.8, 
2.1 Hz, 2H, H2,6), 0.28 – 0.15 (m, 9H, H10,11,12). 13C NMR (75 MHz, DMSO-d6, δ): 155.82 (C1), 
133.64 (C3,5), 115.42 (C4), 115.26 (C2,6), 104.98 (C7), 60.43 (C8), 0.00 (C10,11,12). 
 
4-(Ethynyl)phenol (4.15) To a solution of 4.14 (1.5 g, 7.9 mmol) in Et2O (10 mL) 
was added 1M NaOH* (10 mL) while stirring at RT. The reaction was monitored until 
completion by TLC (EtOAc/heptane, 3:7). DMF (10 mL) was added and Et2O was removed 
by rotary evaporation. The resulting solution was used without further purification and 
treated as a quantitative conversion.  
 
5-Azidouracil (4.16) reference adapted12: To a solution of 5-aminouracil (2 g, 15.7 
mmol, 1 eq) in 10% HCl (72 mL), was added a solution of NaNO2 (1.20 g, 17.3 mmol, 1.1 eq) 
in H2O (24 mL) dropwise while stirring at 0 °C. After 30 min, a solution of NaN3 (1.23 g, 
18.9 mmol, 1.2 eq, 36 mL H2O) was added dropwise and the subsequent formation of a gas 
can be observed. After 1 h of stirring at RT the resulting precipitate was filtered off and 
washed with small amounts of cold water and Et2O. The isolated yellow solid† (2.1 g, 87% 
yield) was identified to be the desired product by MS and IR spectroscopy.  
HRMS = 152.0210 [M-H+]; IR (neat, cm-1): 2110 (N=N=N). 
                                      
* Using 5M NaOH and MeOH followed by acidic washing, resulted in the suspected formation of 
significant quantities of 4-acetylphenol as monitored by TLC using a commercial reference. 
† Turned black upon storage at RT, orange while stored in the freezer 
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5-(4-(4-Hydroxyphenyl)-1H-1,2,3-triazol-1-yl)uracil (4.17) A solution of 4.15 (7.9 
mmol, 1 eq) in DMF (10 mL) was added to a mixture of 4.16 (1.2 g, 7.9 mmol, 1eq) and CuI 
(0.75 g, 3.9 mmol, 0.5 eq) in dioxane (40 mL) under atmosphere, followed by overnight 
stirring at RT. The reaction mixture was filtered before pouring into EtOAc and 1M HCl 
which resulted in the formation of a precipitate in the extraction funnel (see 4.13). The 
organic layer and precipitate was washed with 1M HCl (3x) to remove DMF, followed by 
collection of the precipitate and evaporation of the organic layer after drying over MgSO4. 
The combined solids were identified as the title product (60% yield). 
1H NMR (300 MHz, DMSO-d6, δ): 11.75 (bs, 1H, NH3/1), 11.58 (bs, 1H, NH3/1), 9.62 (s, 1H, 
OH), 8.56 (s, 1H, H11), 8.18 (s, 1H, H6), 7.75 – 7.62 (m, 2H, H13,17), 6.90 – 6.78 (m, 2H, H14,16); 
13C NMR (101 MHz, DMSO-d6, δ): 160.03, 157.88, 150.92, 147.00, 139.82, 127.15, 122.37, 
121.81, 116.16, 112.87; HRMS = 270.0631 [M-H]-; Tm = 264-9 °C 
 
4-Azidophenol (4.18) procedure according to literature12: To a vigorously stirred 
solution of 4-aminophenol (2.5 g, 22.5 mmol, 1.0 eq) in 10% HCl (50 mL) at 0 °C under 
argon, was added dropwise a solution of NaNO2 (1.7 g, 24.8 mmol, 1.1 eq) in 10 mL of water 
over 5 min and was left stirring for an addition 30 min. A solution of NaN3 (1.76 g, 27 mmol, 
1.2 eq) in 15 mL of water was then added dropwise over a period of 10 min. The resulting 
mixture was left stirring overnight at RT, followed by dilution with water (100 mL) and 
extraction with Et2O (3 x 100 mL). The combined organic layers were concentrated in vacuo 
to afford 2.68 g (88% yield) of the title compound as a purple oil, which was kept in the 
freezer. 
1H NMR (300 MHz, CDCl3, δ): 6.91 (d, 3JHH = 8.9 Hz, 2H, H3,5), 6.83 (d, 3JHH = 8.9 Hz, 2H, 
H2,6); 13C NMR (75 MHz, CDCl3, δ): 152.96 (C1), 132.45 (C4), 120.17 (C3,5), 116.60 (C2,6); IR 
(neat, cm-1):= 2110.72 
5-(1-(4-Hydroxyphenyl)-1H-1,2,3-triazol-1-yl)uracil (4.19) not obtained 
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5-Ethynyl-2,4-dimethoxypyrimidine (4.20) procedure according to literature13: A 
solution of 4.3 (532 mg, 2.0 mmol, 1.0 eq) in 4 mL of EtOAc was deoxygenated for 1 h with 
N2 at RT. CuI (12 mg, 0.06 mmol, 0.03 eq), Pd(PPh3)4 (12 mg, 0.01 mmol, 5 mol%), TMSA 
(0.4 mL, 2.8 mmol, 1.4 eq) and 1.2 mL of Et3N were then added. The resulting mixture was 
left stirring overnight under N2 atmosphere, followed by dilution with DCM and run through 
a plug of silica. The filtrate was washed with 1M HCl, dried over MgSO4 and concentrated 
in vacuo. The residue was dissolved in dry THF (3 mL) and TBAF (630 mg, 2 mmol, 1.0 eq) 
was added dropwise at 0 °C over 10 min. The reaction was left stirring for 30 min under RT, 
quenched with MeOH and filtered over a plug of silica. The filtrate was evaporated under 
reduced pressure and the residue purified by column chromatography using EtOAc in PE 
(1:10) as eluent, yielding 200 mg (61%) of the desired compound as a colorless oil. 
1H NMR (300 MHz, CDCl3, δ): 8.38 (s, 1H, H6), 4.07 (s, 3H, OCH3), 4.02 (s, 3H, OCH3), 3.36 
(s, 1H, H8)*  
 
 
4-(Azidomethyl)phenol (4.21) procedure according to literature14: To a stirred 
solution of 4-(hydroxymethyl)phenol (2.48 g, 20 mmol, 1.0 eq) in 40 mL of CCl4/DMF (1:4) 
at RT under argon atmosphere were added PPh3 (5.24 g, 20 mmol, 1.0 eq) and NaN3 (1.56 g, 
24 mmol, 1.2 eq). The resulting mixture was heated for 5 h at 90 °C, after which it was 
allowed to cool at room temperature. The mixture was diluted with 100 mL of Et2O and 
washed with water (3 x 50 mL), brine and dried over anhydrous MgSO4. The organic solvents 
were removed under reduced pressure and the residue purified by column chromatography 
using a mixture of PE and EtOAc (10:1) as eluent to afford 1.05 g (80% yield) of the title 
compound as a yellowish oil. 
                                      
* The complete product was consumed in further reactions. 
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1H NMR (300 MHz, CDCl3, δ): 7.20 (d, 3JHH = 8.6 Hz, 2H, H3,5), 6.84 (d, 3JHH = 8.6, 2H, H2,6), 
4.26 (s, 2H, H7); 13C NMR (75 MHz, CDCl3, δ): 155.69 (C1), 130.00 (C3,5), 127.29 (C4), 115.73 
(C2,6), 54.30 (C7); IR (neat, cm-1): 2094 (N=N=N), 3373 (O-H). 
 
4-((4-(2,4-Dimethoxypyrimidin-5-yl)-1H-1,2,3-triazol-1-yl)methyl)phenol (4.22) 
To a stirred solution of 4.20 (200 mg, 1.22 mmol, 1.0 eq) in DCM at RT under N2 atmosphere, 
4.21 (181 mg, 1.22 mmol, 1.0 eq) and [Cu(CH3CN)4]PF6 (91 mg, 0.24 mmol, 0.2 eq) were 
added. The reaction was monitored by TLC. After 2 h, the solvent was evaporated in vacuo. 
The residue was suspended in 1M HCl (100 mL) and extracted with EtOAc (3 x 50 mL). The 
combined organic layers were washed with brine and dried over MgSO4. The solvent was then 
removed under reduced pressure to afford 344 mg (89% yield) of the title compound as a 
brown solid. 
1H NMR (300 MHz, DMSO-d6, δ): 8.94 (s, 1H, H6), 8.36 (s, 1H, H11), 7.21 (d, 3JHH = 8.6 Hz, 
2H, H14,18), 6.75 (d, 3JHH = 6.8 Hz, 2H, H15,17), 5.52 (s, 2H, H12), 4.03 (s, 3H, OCH3), 3.94 (s, 
3H, OCH3); 13C NMR (126 MHz, DMSO-d6, δ): 166.42 (C2), 164.11 (C4), 157.47 (C16), 155.27 
(C6), 138.58 (C7), 129.64 (C11), 126.34 (C14,18), 123.22 (C13), 115.53 (C5), 106.32 (C15,17), 54.77 
(C19/20), 54.35 (C19/20), 52.67 (C12). HRMS = 314.1248 [M+H]+; Tm = 187-204 °C 
 
5-(1-(4-Hydroxybenzyl)-1H-1,2,3-triazol-4-yl)uracil (4.23) procedure according to 
literature7: 4.22 (100 mg, 0.32 mmol, 1.0 eq) was suspended in a mixture of concentrated HCl 
(2 mL) and acetic acid (2 mL) and the mixture was heated until reflux, turning it into a 
yellowish solution. After 2 h, the reaction mixture was diluted with water and upon cooling; 
a precipitate formed. The solid was filtered, washed with water and cold MeOH and dried 
under vacuum to afford 20 mg (22% yield) of the light yellow title compound.  
1H NMR (300 MHz, DMSO-d6, δ): 11.40 (s, 1H, NH3), 11.18 (d, 3JHH = 5.0 Hz, 1H, NH1), 
9.53 (s, 1H, H6), 8.28 (s, 1H, H11), 8.01 (d, 3JHH = 6.1 Hz, 1H, H14,18), 7.19 (d, 3JHH = 8.5 Hz, 
2H, H15,17), 6.74 (d, 3JHH = 8.5 Hz, 2H), 5.47 (s, 2H, H12). 13C NMR (151 MHz, DMSO-d6, δ): 
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162.23 (C4), 157.42 (C16), 150.64 (C2), 139.27 (C6), 137.58 (C7), 129.72 (C14,18), 126.36 (C13), 
121.67 (C11), 115.48 (C15,17), 103.92 (C5), 52.51 (C12); HRMS = 284.0781 [M-H]-; Tm > 300 °C 
 
p-Tolyl acetate (4.24) procedure according to literature15: p-Cresol (3.0 g, 27.7 
mmol, 1.0 eq) were dissolved in pyridine (4 mL) and the solution cooled to 0 °C under 
atmosphere. Ac2O (4 mL) was added dropwise over a period of 5 min and the reaction mixture 
was stirred for 48 h at RT. The reaction was quenched with 100 mL of ice/water (1:1) and 
subsequently extracted with Et2O (3 x 80 mL). The combined organic layers were washed 
with 1M HCl, brine and dried over anhydrous MgSO4. Concentration under reduced pressure 
afforded 4.08 g (98% yield) of the title compound as a colorless oil. 
1H NMR (300 MHz, CDCl3, δ): 7.16 (d, 3JHH = 8.7, 2H, H3,5), 6.95 (d, 3JHH = 8.5 Hz, 2H, H2,6), 
2.33 (s, 3H, H8), 2.27 (s, 3H, H9); 13C NMR (101 MHz, DMSO-d6, δ): 169.63 (C7), 148.56 (C1), 
135.36 (C4), 129.91 (C3,5), 121.28 (C2,6), 20.95 (C9), 20.77 (C8); m/z = 151.1 [M+H]+ 
 
4-(Bromomethyl)phenyl acetate (4.25) procedure according to literature15: 4.24 (2 g, 13.3 
mmol, 1.0 eq) was dissolved in 130 mL of CCl4 under atmosphere, followed by the subsequent 
addition of NBS (2.47 g, 13.9 mmol, 1.05 eq) and BPO (32 mg, 0.13 mmol, 0.01 eq). The 
resulting mixture was refluxed overnight, followed by cooling to RT and filtering of the 
reaction mixture. The solvent was evaporated in vacuo and the residue purified by column 
chromatography using a mixture of PE and EtOAc (10:1) as eluent to afford 2.9 g (95% 
yield) of the title compound as a white solid. This was used immediately or briefly stored in 
the freezer due to instability issues.* 
1H NMR (300 MHz, CDCl3, δ): 7.46 – 7.37 (m, 2H, H3,5), 7.13 – 7.01 (m, 2H, H2,6), 4.50 (s, 
2H, H9), 2.31 (s, 3H, H8); 13C NMR (300 MHz, CDCl3, δ): acquired but showed degradation, 
as did the subsequent 1H NMR. 
                                      
* Benchtop storing over the weekend resulted in an expansive reaction with a purple-brown spill; 
suspected to be a ‘run-away’ polymerization triggered by the acid catalysed, ester hydrolysis of the 
acetyl group followed with the nucleophilic substitution of the bromide. The resulting compound 
dissolved slowly in acetone, not in MeOH and previous attempts to make the bromide from 4-
(hydroxymethyl)phenol in THF (Appel reaction) always resulted in a similar precipitate that did 
not elute on a TLC plate. 
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4-((Uracil-1-yl)methyl)phenyl acetate (4.26)  
Method A. Uracil (0.5 g, 4.46 mmol, 1.0 eq) was dissolved in 50 mL of DMF at RT, followed 
by the addition of NaH (107 mg, 4.46 mmol, 1.0 eq) After 30 min of continuous stirring, 
bromide 4.25 (1226 mg, 5.35 mmol, 1.2 eq) was added with continued stirring for an 
additional 2 h. The solvent was then evaporated under reduced pressure and the residue was 
purified by column chromatography. Elution with 20% EtOAc in PE afforded 0.53 g (46% 
yield) of the title compound as a white solid. 
Method B. An oven-dried 50 mL flask was charged with uracil (0.5 g, 4.46 mmol, 1.0 eq) 
and a mixture of HDMS, BSA and TMS-Cl (2:2:1, 25 mL) under argon atmosphere. The 
resulting mixture was heated at 80 °C overnight, after which it became a transparent solution. 
Bromide 4.25 (1.1 g, 5.35 mmol, 1.2 eq) was then added and the reaction mixture was left 
stirring for an additional 24 h at 80 °C. The reaction was quenched with the slow addition of 
ice/acetic acid (100 mL, 1:1) and extracted with EtOAc (3 x 80 mL). The combined organic 
layers were washed with brine dried over anhydrous Na2SO4 and concentrated in vacuo. The 
resulting residue was purified by column chromatography using a mixture of EtOAc and PE 
(10:2) as eluent to afford 800 mg (69% yield) of the title compound as a white solid. 
1H NMR (300 MHz, CDCl3, δ): 8.88 (s, 1H, NH3), 7.32 (d, 3JHH = 8.6 Hz, 2H, H9,13), 7.17 (d, 
3JHH = 7.9 Hz, 1H, H6), 7.14 – 7.08 (m, 2H, H10,12), 5.71 (d, 3JHH = 7.9 Hz, 1H, H5), 4.90 (s, 
2H, H7), 2.31 (s, 3H, H15); 1H NMR (300 MHz, MeOD-d4, δ): 7.66 (d, 3JHH = 7.9 Hz, 1H, H6), 
7.39 (d, 3JHH = 8.7 Hz, 2H, H9,13), 7.12 (d, 3JHH = 8.6 Hz, 2H, H10,12), 5.68 (d, 3JHH = 7.9 Hz, 
1H, H5), 4.95 (s, 2H, H7), 2.27 (s, 3H, H15).* 
 
                                      
* The complete product was consumed in further reactions. 
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 ((2,4-Dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))bis(4,1-phenylene) 
diacetate (4.27) Synthesized according to Method A used for the synthesis of compound 
4.26. Column chromatography afforded 200 mg (17% yield) of the title compound as a white 
solid. 
1H NMR (300 MHz, CDCl3, δ): 7.53 (d, 3JHH = 8.6 Hz, 2H, H18,22/19,21), 7.30 (d, 3JHH = 8.6 Hz, 
2H, H9,13), 7.14 – 7.07 (m, 3H, H6,10,12), 7.01 (d, 3JHH = 8.6 Hz, 2H, H18,22/19,21), 5.76 (d, 3JHH = 
7.9 Hz, 1H, H5), 5.11 (s, 2H, H16), 4.89 (s, 2H, H7), 2.30 (s, 3H, H15/24), 2.28 (s, 3H, H15/24). * 
 
1-(4-Hydroxybenzyl)uracil (4.28) 4.27 (550 mg, 2.11 mmol, 1.0 eq) was dissolved 
in 17 mL of a MeOH/THF mixture (1:1) at RT and 8.5 mL of a freshly prepared 0.5N LiOH 
(4.23 mmol, 2.0 eq) solution was added under vigorous stirring. The reaction was followed on 
TLC. Upon the disappearance of starting material, the reaction mixture was diluted with 100 
mL of water, acidified to pH±1 and extracted with EtOAc (3 x 80 mL). Recrystallization by 
MeOH afforded 350 mg (76% yield) of the title compound as a white solid. 
1H NMR (300 MHz, MeOD-d4, δ): 7.60 (d, 3JHH = 7.9 Hz, 1H, H6), 7.20 (d, 3JHH = 8.6 Hz, 
2H, H9,13), 6.78 (d, 3JHH = 8.6 Hz, 2H, H10,12), 5.65 (d, 3JHH = 7.9 Hz, 1H, H5), 4.83 (s, 2H, H7); 
13C NMR (151 MHz, DMSO-d6, δ): 164.14 (C4), 157.53 (C11), 151.47 (C2), 145.91 (C6), 129.70 
(C9,13), 127.45 (C8), 115.84 (C10,12), 101.66 (C5), 50.27 (C7); HRMS = 217.0639 [M-H]-; Tm = 
223-6 °C 
 
1,3-Bis(4-hydroxybenzyl)uracil (4.29) Same conditions as 4.28, with 4.0 eq of LiOH 
resulting in a white solid (50% yield).  
1H NMR (300 MHz, MeOD-d4, δ): 7.58 (d, 3JHH = 7.9 Hz, 1H, H6), 7.23 (d, 3JHH = 8.6 Hz, 
2H, H9,13), 7.18 (d, 3JHH = 8.6 Hz, 2H, H16,20), 6.77 (d, 3JHH = 8.6 Hz, 2H, H10,12), 6.70 (d, 3JHH  
                                      
* The complete product was consumed in further reactions. 
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= 8.6 Hz, 2H, H17,19), 5.74 (d, 3JHH  = 7.9 Hz, 1H, H5), 5.01 (s, 2H, H14), 4.86 (s, 2H, H7); 13C 
NMR (75 MHz, DMSO-d6, δ): 162.25 (C4), 157.11 (C11/18), 156.56 (C11/18), 151.13 (C2), 144.00 
(C6), 129.36 (C9,13/16,20), 129.26 (C9,13/16,20), 127.38 (C8/15), 126.68 (C8/15), 115.33 (C10,12/17,19), 
114.92 (C10,12/17,19), 100.42 (C5), 51.01 (C7), 42.90 (C14); HRMS = 323.1028 [M-H]-; Tm = 174-
7 °C 
 
2,6-Dichloropurine (4.30) procedure according to literature16,17: To a mixture of 
xanthine (3.0 g, 19.72 mmol, 1.0 eq) in 36 mL (0.2 mol, 10.0 eq) of POCl3 at 50 °C under 
atmosphere, DBU (18 mL, 118.32 mmol, 6.0 eq) was added slowly and the temperature 
increased to 105 °C. After 6 h, the reaction mixture was cooled to room temperature and 
quenched with ice (300 mL). The resulting mixture was filtered through a pad of celite and 
extracted with EtOAc (4 x 150 mL). The combined organic layers were concentrated in vacuo 
and the residue was suspended in water (100 mL). The mixture was neutralized with 3M 
NaOH, extracted with EtOAc (3 x 80 mL), washed with brine and dried over anhydrous 
MgSO4. The organic solvent was then removed under reduced pressure to afford 1.24 g (33% 
yield) of the desired yellow solid. 
1H NMR (300 MHz, MeOD-d4, δ): 8.58 (s, 1H, H8); 13C NMR (75 MHz, DMSO-d6, δ): 116.76, 
143.89, 150.93, 156.77, 159.44; HRMS = 188.9728 [M+H]+ (100%), 190.9699 [M+H]+ (64%); 
Tm = 169-177 °C (dec.) (lit = 177 (dec.)  
 
2-Chloro-6-methoxypurine (4.31) 4.30 (200 mg, 1.06 mmol, 1.0 eq) was suspended 
in 2 mL of MeOH and heated at 50 °C. A freshly prepared solution of CH3ONa (2.70 mmol, 
2.55 eq) in MeOH was added and the reaction mixture was refluxed. After 48 h, the reaction 
was quenched with water (150 mL) and extracted with EtOAc (3 x 100 mL). The combined 
organic layers were washed with brine, dried over anhydrous MgSO4 and evaporated under 
reduced pressure. The residue was purified by column chromatography using PE and EtOAc 
(1:1) as eluent to afford 168 mg (86% yield) of the title compound as an off-white solid. 
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1H NMR (300 MHz, MeOD-d4, δ): 8.28 (s, 1H, H8), 4.18 (s, 3H, CH3O); 13C NMR (75 MHz, 
DMSO-d6, δ): 159.44 (C6), 156.77 (C2), 150.93 (C4), 143.89 (C8), 116.76 (C5), 54.67 (C10) * 
 
2,6-Dichloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (4.32) procedure according 
to literature18 4.30 (1.0 g, 5.29 mmol, 1.0 eq) was suspended in 30 mL of EtOAc under 
atmosphere at RT. p-Toluenesulphonic acid (100 mg, 0.53 mmol, 0.1 eq) was then added, 
followed by dropwise addition of 3,4-dihydro-2H-pyran (1.2 mL, 13.23 mmol, 2.5 eq). The 
reaction mixture was subsequently heated at 45 °C for 3 h; after which it was cooled to RT, 
diluted with EtOAc (120 mL) and washed with saturated NaHCO3 solution, water, brine and 
dried over anhydrous MgSO4. Removal of the organic solvent under reduced pressure afforded 
1.41 g (98% yield) of the desired, yellow solid. 
1H NMR (300 MHz, CDCl3, δ): 8.33 (s, 1H, H8), 5.77 (dd, 3JHH = 10.4, 2.4 Hz, 1H, H10), 4.19 
(dd, 3JHH = 10.8, 3.0 Hz, 1H, H14), 3.88 – 3.67 (m, 1H, H14), 2.24 – 1.90 (m, 4H, H11,12,13), 1.89 
– 1.62 (m, 2H, H11,12,13). 13C NMR (300 MHz, CDCl3, δ): 152.97 (C2), 152.15 (C4), 151.75 (C6), 
143.73 (C8), 130.74 (C5), 82.48 (C10), 68.96 (C14), 32.04 (C11), 24.70 (C13), 22.51 (C12); m/z = 
273.0 (100%), 275.0 (64%) [M+H]+; Tm = 116-22 °C (lit = 122-4 °C) 
 
2-Chloro-6-methoxy-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (4.33) 4.32 (150 
mg, 0.55 mmol, 1.0 eq) was dissolved in 2 mL of a MeOH/THF mixture (1:1) at RT and 1.1 
mL of a freshly prepared 0.5N LiOH (0.55 mmol, 1.0 eq) solution were added under vigorous 
stirring. The reaction was followed on TLC. Upon disappearance of starting material, the 
reaction mixture was diluted with 50 mL water, neutralized and extracted with EtOAc (3 x 
30 mL). Removal of the organic solvent under reduced pressure afforded 148 mg (96% yield) 
of the title compound as a colorless oil. 
                                      
* The complete product was consumed in further reactions. 
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1H NMR (300 MHz, CDCl3, δ): 8.15 (s, 1H, H8), 5.75 (dd, 3JHH = 10.5, 2.3 Hz, 1H, H10), 4.21 
(s, 3H; H15), 4.18 – 4.14 (m, 1H, H14), 3.79 (td, 3JHH = 11.4, 3.1 Hz, 1H, , H14), 2.08 – 1.93 (m, 
2H, , H11,12,13), 1.88 – 1.64 (m, 4H, H11,12,13). 13C NMR (75 MHz, CDCl3, δ): 161.34 (C6), 153.13 
(C4), 152.24 (C2), 140.47 (C8), 120.26 (C5), 81.95 (C10), 68.85 (C14), 55.08 (C15), 32.09 (C11), 
24.81 (C13), 22.68 (C12);  m/z = 269.1 (100%) 271.1 (33%) [M+H]+ 
 
2,6-Dimethoxy-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (4.34) 4.32 (1.0 g, 3.66 
mmol, 1.0 eq) was dissolved in 15 mL of MeOH at RT. A freshly prepared solution of CH3ONa 
(10.99 mmol, 3.0 eq) in MeOH was added and the resulting mixture was refluxed. After 2 h, 
the reaction was cooled to RT, quenched with water (150 mL) and extracted with EtOAc (3 
x 100 mL). The combined organic phases were washed with brine, dried over anhydrous 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography using 
PE and EtOAc (2:1) as eluent to afford 0.88 g (91% yield) of the title compound as a white 
solid. 
1H NMR (300 MHz, CDCl3, δ): 7.97 (s, 1H, H8), 5.66 (dd, 3JHH = 9.6, 3.1 Hz, 1H, H10), 4.22 
– 4.10 (m, 4H, H14,15/16), 4.04 (s, 3H, H15/16), 3.76 (d, 3JHH = 3.1 Hz, 1H), 2.14 – 1.98 (m, 2H, 
H11,12,13), 1.82 – 1.58 (m, 4H, H11,12,13); 13C NMR (75 MHz, CDCl3, δ): 171.09 (C2/6), 161.92 
(C2/6), 161.72 (C4), 152.81 (C8), 138.56 (C5), 117.08 (C10), 68.65 (C14), 55.02 (C15/16), 54.21 
(C15/16), 31.59 (C11), 24.86 (C13), 22.80 (C12); HRMS = 265.1299 [M+H]+; Tm = 95-102 °C 
 
2,6-Dimethoxypurine (4.35) procedure according to literature18 4.34 (790 mg, 2.99 
mmol, 1.0 eq) was dissolved in 8 mL of EtOH and 0.5 mL of 1M HCl was added. The mixture 
was refluxed for 1 h, resulting in a white suspension. Solvent was evaporated and the residue 
was resuspended in water, followed by filtration to yield 400 mg (74% yield) of the title 
compound as a white solid. 
1H NMR (300 MHz, DMSO-d6, δ): 8.15 (s, 1H, H8), 4.03 (s, 3H, H10,11), 3.90 (s, 3H, H10,11); 
13C NMR (75 MHz, DMSO-d6, δ): 161.08 (C2/6), 160.99 (C2/6), 154.13 (C5), 140.12 (C8), 116.14 
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(C4), 54.46 (C11), 53.71 (C10); HRMS = 181.0718 [M+H]+; Tm = 253-8 °C, dec. at 260 °C (lit 
= 233 °C, dec. at 300 °C) 
 
4-((2,6-Dichloro-9H-purin-9-yl)methyl)phenyl acetate (4.36) A suspension of 4.30 
(1.0 g, 5.29 mmol, 1.0 eq) and K2CO3 (2.19 g, 15.87 mmol, 3.0 eq) in 22 mL of DMF was 
stirred for 30 min at RT under atmosphere followed by the addition of 4.25 (1.82 g, 7.94 
mmol, 1.5 eq). The reaction mixture was then stirred overnight, after which it was diluted 
with water (150 mL) and extracted with EtOAc (3 x 100 mL). The combined organic layers 
were washed with brine, dried over anhydrous MgSO4 and evaporated under reduced pressure. 
The residue was purified by column chromatography using a PE and EtOAc (1:1) as eluent 
to afford 1.2 g (69% yield) of a white solid identified by 2D NMR as the title compound. 
1H NMR (300 MHz, MeOD-d4, δ): 8.63 (s, 1H, H8), 7.47 (d, 3JHH = 8.4 Hz, 2H, H12,16), 7.13 
(d, 3JHH = 8.4 Hz, 2H, H13,15), 5.51 (s, 2H, H10), 2.27 (s, 3H, H18); 13C NMR (75 MHz, DMSO-
d6, δ): 169.10 (C17), 153.34 (C2), 151.12 (C4), 150.19 (C6), 149.79 (C14), 148.33 (C8), 133.10 
(C11), 130.49 (C5), 128.87 (C12,16), 122.19 (C13,15), 46.48 (C10), 20.77 (C18); HRMS = 337.0255 
[M+H]+(100%), 339.0228 [M+H]+(64%); Tm = 141-153 °C 
 
4-((2,6-Dichloro-7H-purin-7-yl)methyl)phenyl acetate (4.37) Isolated 
simultaneously as 4.36 during column chromatography as the second fraction: 0.5 g (29% 
yield) of a white solid, identified to be the title compound by 2D NMR. 
1H NMR (300 MHz, MeOD-d4, δ): 9.06 (s, 1H, H8), 7.27 (d, 3JHH = 8.6 Hz, 2H, H12,16), 7.11 
(d, 3JHH = 8.6 Hz, 2H, H13,15), 5.74 (s, 2H, H10), 2.23 (s, 3H, H18); 13C NMR (75 MHz, DMSO-
d6, δ): 169.08 (C17), 163.37 (C2), 152.81 (C4), 151.10 (C6), 150.05 (C14), 143.13 (C8), 133.82 
(C11), 127.85 (C5), 122.19 (C12,16), 121.85 (C13,15), 48.99 (C10), 20.78 (C18); HRMS = 358.0065 
[M+Na]+(100%), 361.0039 [M+Na]+(64%); 337.0265 [M+H]+; Tm = 199-207 °C, dec. at 275 
°C 
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4-((2-Chloro-6-methoxy-9H-purin-9-yl)methyl)phenyl acetate (4.38) Prepared 
from 4.31 (100 mg, 0.54 mmol) according to the procedure followed for the synthesis of 4.36. 
Column chromatography afforded 108 mg (60% yield) of the title compound as a white solid. 
1H NMR (500 MHz, DMSO-d6, δ): 8.54 (s, 1H, H8), 7.34 (d, 3JHH = 8.6 Hz, 2H, H12,16), 7.11 
(d, 3JHH = 8.6 Hz, 2H, H13,15), 5.45 (s, 2H, H10), 4.10 (s, 3H, H19), 2.24 (s, 3H, H18); 13C NMR 
(126 MHz, DMSO-d6, δ): 169.23, 160.97, 153.18, 151.63, 150.19, 144.60, 133.82, 128.77, 122.29, 
119.96, 55.03, 46.20, 20.87; HRMS = 355.0563 [M+Na]+ (100%), 357.0545 [M+Na]+ (32%), 
333.0750 [M+H]+; Tm = 156-64 °C, dec. at 240 °C 
 
 
4-((2-Chloro-6-methoxy-7H-purin-7-yl)methyl)phenyl acetate (4.39) Isolated 
simultaneously as 4.38 during column chromatography as the second fraction: 54 mg (30% 
yield) of a white solid, identified to be the title compound. 
1H NMR (500 MHz, DMSO-d6, δ): 8.74 (s, 1H, H8), 7.34 (d, 3JHH = 8.7 Hz, 2H, H12,16), 7.10 
(d, 3JHH = 8.6 Hz, 2H, H13,15), 5.54 (s, 2H, H10), 4.06 (s, 3H, H19), 2.24 (s, 3H, H18).13C NMR 
(126 MHz, DMSO-d6, δ): 169.24, 162.72, 157.41, 151.25, 150.24, 148.36, 134.26, 128.75, 122.26, 
111.72, 55.09, 49.55, 20.90. HRMS = 333.0749 (100%) 335.0719 (33%) [M+H]+; Tm = 163-72 
°C, dec. at 210 °C 
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4-((2,6-Dimethoxy-9H-purin-9-yl)methyl)phenyl acetate (4.40) Prepared from 
4.35 (100 mg, 0.55 mmol) according to the procedure followed for the synthesis of 4.36. 
Column chromatography afforded 86 mg (47% yield) of the title compound as a white solid. 
1H NMR (500 MHz, DMSO-d6, δ): 8.29 (s, 1H, H8), 7.39 (d, 3JHH = 8.4 Hz, 2H, H12,16), 7.10 
(d, 3JHH = 8.5 Hz, 2H, H13,15), 5.36 (s, 2H, H10), 4.04 (s, 3H, H19), 3.92 (s, 3H, H20), 2.24 (s, 
3H, H18). 13C NMR (126 MHz, DMSO-d6, δ): 169.24, 161.43, 161.20, 153.47, 150.12, 142.16, 
134.28, 129.06, 122.19, 116.52, 54.72, 54.05, 45.92, 20.88; HRMS = 329.1219 [M+H]+, 351.1038 
[M+Na]+; Tm = 245-6 °C 
4-((2,6-Dimethoxy-7H-purin-7-yl)methyl)phenyl acetate (4.41) was not isolated 
in sufficient quantity to ensure identification, only trace amounts on TLC were observed. 
 
((2,6-Dioxo-1,6-dihydro-3H-purine-3,7(2H)-diyl)bis(methylene))bis(4,1-
phenylene) diacetate (4.42) To an oven-dried 50 mL flask was added xanthine (0.5 g, 3.29 
mmol, 1.0 eq) and a mixture of HDMS, BSA and TMS-Cl (2:2:1, 25 mL) under argon 
atmosphere. The resulting mixture was heated at 80 °C overnight, after which it became a 
transparent solution. Bromide 4.25 (1.1 g, 4.93 mmol, 1.5 eq) was then added, followed by 
stirring of the reaction mixture for an additional 5 h at 80 °C. The reaction was quenched 
with the slow addition of ice/acetic acid (100 mL, 1:1), forming a fine precipitate which was 
filtered off and washed with water and Et2O. Two subsequent recrystallizations by MeOH 
afforded 50 mg a white solid, identified to be the title compound by 1D and 2D NMR (3% 
yield). 
1H NMR (500 MHz, DMSO-d6, δ): 11.28 (s, 1H, NH1), 8.24 (s, 1H, H8), 7.42 (d, 3JHH = 8.5 
Hz, 2H, H21,25), 7.37 (d, 3JHH = 8.4 Hz, 2H, H12,16), 7.10 (d, 3JHH = 8.5 Hz, 2H, H22,24), 7.06 (d, 
3JHH = 8.5 Hz, 2H, H13,15), 5.44 (s, 2H, H19), 5.08 (s, 2H, H10), 2.29 – 2.17 (m, 6H, H18,27). 13C 
NMR (126 MHz, DMSO-d6, δ) 169.67, 169.62, 155.23, 151.23, 150.61, 150.14, 150.10, 142.97, 
134.91, 134.82, 129.45, 129.23, 122.56, 122.28, 106.89, 48.93, 44.83, 21.27; HRMS = 449.1453 
[M+H]+, 471.1271 [M+Na]+; Tm = 192-196 °C 
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4-((2-Chloro-6-methoxy-9H-purin-9-yl)methyl)phenol (4.43)  
Method A. 4.36 (530 mg, 1.572 mmol, 1.0 eq) was dissolved in 12 mL MeOH/THF (1:1) at 
RT and 6 mL of a freshly prepared 0.5N LiOH (3.14 mmol, 2.0 eq) solution was added under 
vigorous stirring. The reaction was followed on TLC: upon the disappearance of starting 
material, the reaction mixture was diluted with 100 mL of water, acidified to pH≈1 with 
concentrated HCl and extracted with EtOAc (3 x 80 mL). Purification by column 
chromatography using EtOAc and PE (7:3) afforded 300 mg (66% yield) of the title 
compound as a white solid. 
Method B. 4.36 (200 mg, 0.59 mmol, 1.0 eq) was suspended in 5 mL of MeOH at RT. A 
freshly prepared solution of CH3ONa (1.18 mmol, 2.0 eq) in MeOH was subsequently added 
and the reaction mixture was stirred for 2 h. The reaction was quenched with water (50 mL), 
neutralized with 1M HCl and extracted with EtOAc (3 x 40 mL). The combined organic 
layers were washed with brine, dried over anhydrous MgSO4 and evaporated under reduced 
pressure. The residue was purified by column chromatography using EtOAc and PE (7:3) to 
afford 128 mg (74% yield) of the title compound as a white solid. 
1H NMR (500 MHz, DMSO-d6, δ): 9.49 (s, 1H, OH), 8.46 (s, 1H, H8), 7.16 (d, 3JHH = 8.6 Hz, 
2H), 6.72 (d, 3JHH = 8.6 Hz, 2H), 5.29 (s, 2H, H10), 4.09 (s, 3H, H17); 13C NMR (126 MHz, 
DMSO-d6, δ): 160.89 (C6), 157.30 (C14), 153.10 (C2), 151.50 (C4), 144.46 (C8), 129.24 (C12,16), 
126.46 (C11), 119.89 (C5), 115.53 (C13,15), 54.98 (C17), 46.47 (C10). HRMS = 291.0634 (100%) 
[M+H]+ 293.0612 (32%) [M+H]+; Tm = 212-7 °C 
 
4-((2-Chloro-6-methoxy-7H-purin-7-yl)methyl)phenol (4.44) Prepared from 4.37 
(445 mg, 1.32 mmol) according to the method B for the synthesis of 4.43. Column 
chromatography afforded 283 mg (74% yield) of the title compound as a white solid.  
1H NMR (500 MHz, DMSO-d6, δ): 9.49 (s, 1H, OH), 8.67 (s, 1H, H8), 7.16 (d, 3JHH = 8.6 Hz, 
2H, H12,16), 6.72 (d, 3JHH = 8.6 Hz, 2H, H13,15), 5.39 (s, 2H, H10), 4.09 (s, 3H, H17); 13C NMR 
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(126 MHz, DMSO-d6, δ): 162.69 (C6), 157.41 (C4/14), 157.35 (C4/14), 151.11 (C2), 148.08 (C8), 
129.22 (C12,16), 126.84 (C11), 115.51 (C13,15), 111.59 (C5), 55.04 (C17), 49.83 (C10). HRMS = 
313.0447 [M+Na]+ (100%), 315.0420 [M+Na]+ (32%), 291.0634 [M+H]+; Tm = 201-5 °C, dec. 
at 210 °C 
 
4-((2,6-Dimethoxy-9H-purin-9-yl)methyl)phenol (4.45) 4.36 (650 mg, 1.93 mmol, 
1.0 eq) was suspended in 10 mL of MeOH and heated at 65 °C under atmosphere. A freshly 
prepared solution of CH3ONa (13.5 mmol, 7.0 eq) in MeOH was added and the reaction 
mixture was refluxed for 4 h. The reaction was cooled to RT, quenched with water (100 mL) 
and neutralized with 1M HCl. Upon reaching pH≈7, a precipitate formed which was filtered 
off, washed with water and Et2O and dried under vacuum to afford 480 mg (87% yield) of 
the title compound as an off-white solid. 
1H NMR (300 MHz, DMSO-d6, δ): 9.49 (s, 1H, OH), 8.23 (s, 1H, H8), 7.22 (d, 3JHH = 8.4 Hz, 
2H, H12,16), 6.72 (d, 3JHH = 8.4 Hz, 2H, H13,15), 5.21 (s, 2H, H10), 4.03 (s, 3H, H17/18), 3.94 (s, 
3H, H17/18); 13C NMR (75 MHz, DMSO-d6, δ): 161.70 (C2), 161.47 (C6), 157.56 (C14), 153.74 
(C4), 142.40 (C8), 129.86 (C12,16), 127.35 (C11), 116.84 (C5), 115.80 (C13,15), 55.06 (C17/18), 54.38 
(C17/18), 46.52 (C10); HRMS = 287.1139 [M+H]+; Tm = 253-6 °C, dec. at 260 °C 
4-((2,6-Dimethoxy-7H-purin-7-yl)methyl)phenol (4.46) was not isolated in 
sufficient quantity to ensure identification, only trace amounts on TLC were observed. 
 
9-(4-Hydroxybenzyl)-2-methoxy-9H-purin-6-ol (4.47) 4.45 (50 mg, 0.18 mmol) in 
6N HCl (4 mL) was heated at 60 °C. After 2 h, the reaction mixture was cooled to room 
temperature, diluted with water and brought to pH≈5, when a white precipitate formed. The 
solid was filtered off, washed with water and Et2O and dried under vacuum to afford 22 mg 
(45% yield) of the title compound as a white solid. 
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1H NMR (300 MHz, DMSO-d6, δ): 12.10 (bs, 1H, NH1), 9.50 (s, 1H, OH), 7.95 (s, 1H, H8), 
7.22 (d, 3JHH = 8.5 Hz, 2H, H12,16), 6.72 (d, 3JHH = 8.5 Hz, 2H, H13,15), 5.12 (s, 2H, H10), 3.95 
(s, 3H, H17); 13C NMR (75 MHz, DMSO-d6, δ): 157.05 (C2), 148.32 (C6), 147.43 (C14), 140.73 
(C4), 138.60 (C8), 129.49 (C12,16), 126.99 (C11), 119.20 (C5), 115.30 (C13,15), 54.89 (C17), 45.97 
(C10); HRMS = 271.0849 [M-H]-; Tm = 238-43 °C 
 
4-((2-Chloro-6-(4-((2-chloro-6-methoxy-9H-purin-9-yl)methyl)phenoxy)-9H-
purin-9-yl)methyl)phenol (4.48) Isolated simultaneously as 4.43 using method A during 
column chromatography as the second fraction, trace amounts of a white solid, identified to 
be the title compound by 2D NMR. 
1H NMR (500 MHz, DMSO-d6, δ): 9.51 (s, 1H, OH), 8.60 (s, 1H, H8), 8.59 (s, 1H, H32), 7.42 
(d, 3JHH = 8.7 Hz, 2H, H19,21), 7.32 (d, 3JHH = 8.7 Hz, 2H, H18,22), 7.20 (d, 3JHH = 8.6 Hz, 2H, 
H12,16), 6.74 (d, 3JHH = 8.6 Hz, 2H, H13,15), 5.51 (s, 2H, H23), 5.33 (s, 2H, H10), 4.12 (s, 3H, H33). 
13C NMR (126 MHz, DMSO-d6, δ): 161.00, 159.49, 157.34, 154.27, 153.23, 151.65, 151.58, 
151.14, 145.57, 144.65, 134.04, 129.33, 129.06, 126.33, 122.03, 120.16, 119.98, 115.53, 55.03, 
46.61, 46.21.* 
2-Nitrobenzylalcohol (4.49a) was commercially available 
 
                                      
* Not enough material remained for further identification 
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1-(R,S)-1-(2-Nitrophenyl)ethan-1-ol (4.49b) reference adapted19: A solution of 2-
nitroacetophenone (10 g, 61 mmol, 1 eq) in 1,4-dioxane and MeOH was stirred for 10 min at 
0 °C, followed by slow addition of NaBH4 (5.7 g, 0.15 mol, 2.5 eq). The mixture was left to 
warm to RT and the reaction was followed by TLC (DCM/Et2O, (5:2)). After achieving 
complete conversion, acetone was added to quench the reaction. Solvents were evaporated in 
vacuo. The residue was taken up in EtOAc and washed with H2O (3x), followed by drying 
over MgSO4 resulting in a clear yellow oil, identified as the pure product. 
1H NMR (300 MHz, CDCl3, δ): 7.98 – 7.80 (m, 2H, H3-6), 7.66 (t, 3JHH = 7.6 Hz, 1H, H3-6), 
7.43 (t, 3JHH = 7.6 Hz, 1H, H3-6), 5.42 (d, 3JHH = 5.9 Hz, 1H, H7), 1.58 (d, 3JHH = 6.3 Hz, 3H, 
H8). 13C NMR (75 MHz, CDCl3, δ): 147.13 (C1,2), 140.40 (C1,2), 132.93 (C3-6), 127.34 (C3-6), 
126.84 (C3-6), 123.49 (C3-6), 65.89 (C7), 64.35 (C7), 22.89 (C8); m/z = 168.0655 [M+H]+ 
4,5-Dimethoxy-2-nitrobenzylalcohol (4.49c) was commercially available 
 
2-Nitrobenzyl chloroformate (NBOC-Cl) (4.50a) reference adapted20,21: 4.49a (20 
g, 0.13 mol, 1 eq) and triphosgene (37.6 g, 0.13 mol, 1 eq) were dissolved in 1,4-dioxane and 
kept stirring at 40 °C under atmosphere. The reaction was monitored by crude NMR until 
full conversion was obtained. The solvent was evaporated at 40 °C in vacuo and the residual 
oil was immediately used further without any additional purification.  
Crude 1H NMR (300 MHz, CDCl3, δ): 8.21 (d, 3JHH = 5.2 Hz, 1H, H7), 7.89 – 7.47 (m, 3H, 
H4-6), 5.76 (s, 2H, H2)*, 3.71 (dioxane). 
1-(R,S)-(2-nitrophenyl)ethyl chloroformate (4.50b) was not obtained 
 
 
4,5-Dimethoxy-2-nitrobenzyl chloroformate (NVOC-Cl) (4.50c) procedure 
according to patent22: A solution of Et3N (3.25 mL, 23.5 mmol, 1 eq) in THF (75 mL) was 
added dropwise to a stirred solution of BTC (7 g, 23.5 mmol, 1 eq) and 4.49c (5 g, 23.5 
                                      
* 4.99 (s, H2) for 4.49a 
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mmol, 1 eq) in THF (100 mL) at 0 °C. Afterwards the mixture was left stirring overnight at 
room temperature. Any solids were filtered away and the filtered concentrated in vacuo. The 
residue was recrystallized in toluene to yield 6.48g (71%) as a yellow-orange solid, used 
without further purification. 
1H NMR (300 MHz, CDCl3, δ): 7.77 (s, 1H, H3), 7.01 (s, 1H, H6), 5.75 – 5.72 (m, 2H, H7), 
4.02 (s, 3H, H9/10), 3.98 (s, 3H, H9/10); 13C NMR (75 MHz, CDCl3, δ): 153.75 (C5), 150.40 (C8), 
148.94 (C4), 139.88 (C2), 124.23 (C3), 110.43 (C1), 108.40 (C6), 69.85 (C7), 56.56 (C9/10), 56.51 
(C9/10). 
 
2-Nitrobenzyl 1H-imidazole-1-carboxylate (4.51a) procedure according to 
literature23: A mixture of 4.49a (2 g, 13 mmol, 1 eq) and CDI (2.33 g, 14 mmol, 1.1 eq) in 
DCM (12 mL) was stirred for 30 min at RT. The solution was diluted with additional DCM, 
followed by washing the solution with saturated NaHCO3 (1x). The organic layer was dried 
over MgSO4 and evaporated in vacuo resulting in a pure, light yellow powder in quantitative 
yield.  
1H NMR (300 MHz, CDCl3, δ): 8.19 (s, 1H, Im-H2), 7.77 – 7.54 (m, 4H, Bn-H3-6), 7.47 (s, 1H, 
Im-H5), 7.11 (s, 1H, Im-H4), 5.86 (s, 2H, Bn-H7); 13C NMR (75 MHz, CDCl3, δ): 148.24 (Im-
C8), 147.61 (Bn-C2), 137.13 (Im-C2), 134.12 (Im-C4/Bn-C3-6), 131.01 (Im-C4/Bn-C3-6), 130.13 
(Bn-C1), 129.80 (Im-C4/Bn-C3-6), 129.31 (Im-C4/Bn-C3-6), 125.49 (Im-C4/Bn-C3-6), 117.15 (Im-
C5), 66.28 (Bn-C7). 
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1-(R,S)-(2-Nitrophenyl)ethyl 1H-imidazole-1-carboxylate (4.51b) Prepared from 
4.49b (5 g, 30 mmol, 1 eq) according to the procedure for the synthesis of 4.41a. The residue 
after evaporation was washed with toluene followed by filtration and drying in vacuo, 
resulting in an off-white solid (80% yield). 
1H NMR (300 MHz, CDCl3, δ): 8.16 (s, 1H, Im-H2), 8.03 (d, 3JHH = 7.6 Hz, 1H, Bn-H3), 7.68 
(s, 2H, Bn-H4-6), 7.52 (bs, 1H, Bn-H4-6), 7.43 (s, 1H, Im-H5), 7.09 (s, 1H, Im-H4), 6.59 (d, 3JHH 
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= 6.1 Hz, 1H), 1.85 (d, 3JHH = 5.1 Hz, 3H); 13C NMR (75 MHz, CDCl3, δ): 147.64 (Bn-C9), 
137.02, 136.09, 134.02, 130.90, 129.26, 126.88, 124.85, 117.09, 112.92 (Im-C2,4,5/Bn-C1-6), 72.66 
(Bn-C7), 21.94 (Bn-C8). 
 
N-(2-Nitrobenzyloxycarbonyl)-L-phenylalanine (4.52a)  
Method A: reference adapted20,24 A solution of 4.50a (21.3 g, 99 mmol, 1.2 eq) in 
dioxane (40 mL) was added dropwise to a stirred suspension of phenylalanine (13.63 g, 82.5 
mmol, 1 eq) and NaHCO3 (20.8 g, 0.25 mol, 2.5 eq) in water/dioxane (200 mL, 1:1) at 0 °C. 
After completion of the addition, the mixture was stirred for 1 h at 0 °C and 3 h at room 
temperature. The mixture was washed with Et2O (3x), acidified with concentrated HCl and 
extracted with EtOAc (5x). The combined organic layers were washed with distilled water 
(2x) and brine (1x), followed by drying over anhydrous MgSO4. After rotary evaporation of 
the solvent, the desired product was obtained as an yellow-orange oil (23.1 g, 81% yield). 
Method B: reference adapted23 Phenylalanine (0.5 g, 3 mmol, 1 eq) was suspended 
in a solution of tetrazole in ACN (0.45M, 1.5 mmol, 0.5 eq), 4.51a (0.8 g, 3.3 mmol, 1.1 eq) 
and DMF (1 mL), followed by overnight refluxing. The clear solution was evaporated in 
vacuo and resuspended in Et2O. The residue was extracted with 0.5M phosphate buffer pH 
12.5 (3x). The collected aqueous layers were acidified with concentrated HCl until pH 2 was 
reached, followed by extraction with DCM (3x). The combined organic layers were dried over 
MgSO4 and evaporated in vacuo to yield a yellow-orange oil. (0.36 g, 35%) 
1H NMR (300 MHz, CDCl3, δ): 8.18 – 8.01 (m, 1H, H15), 7.69 – 7.56 (m, 1H, H17), 7.56 – 7.41 
(m, 2H, H16,18), 7.37 – 7.28 (m, 3H, H5-9), 7.22 – 7.16 (m, 2H, H5-9), 5.52 (s, 2H, H12), 5.37 – 
5.21 (m, 1H, NH10), 4.79 – 4.64 (m, 1H, H2), 3.29 – 3.21 (m, 1H, H3), 3.19 – 3.08 (m, 1H, H3); 
13C NMR (75 MHz, DMSO-d6, δ): 173.36, 155.66, 147.04, 138.07, 134.18, 133.13, 129.27, 
128.94, 128.49, 128.30, 126.50, 124.89, 62.16, 55.76, 36.70; HRMS = 345.1081 [M+H]+ 
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N-(1-(R,S)-1-(2-Nitrophenyl)ethyloxycarbonyl)-L-phenylalanine (4.52b) 
Prepared from 4.51b (0.5 g, 3 mmol, 1.1 eq) according to the Method B for the synthesis of 
4.52a. After rotary evaporation of the solvent, the desired product was obtained as an orange 
oil (0.56 g, 73% yield)  
1H NMR (300 MHz, CDCl3, δ): 8.02 – 7.86 (m, 1H, H15), 7.74 – 7.53 (m, 3H, H16-18), 7.48 – 
7.29 (m, 3H, H5-9), 7.19 – 7.05 (m, 2H, H5-9), 6.30 – 6.18 (m, 1H, H12), 5.25 – 5.11 (m, 1H, 
NH10), 4.70 – 4.50 (m, 1H, H2), 3.15 (m, 2H, H3), 1.67 – 1.49 (m, 3H, H19); HRMS = 357.1097 
[M-H]- 
 
N-(4,5-Dimethoxy-2-nitrobenzyloxycarbonyl)-L-phenylalanine (4.52c) Prepared 
from 4.50c (3 g, 10.9 mmol, 1 eq) and phenylalanine (2.16 g, 13.1 mmol, 1.2 eq) according to 
the Method A for the synthesis of 4.52a. After rotary evaporation of the solvent, the desired 
product was obtained as an orange-brown solid (2.82 g, 64% yield). 
1H NMR (300 MHz, DMSO-d6, δ): 7.94 (d, 3JHH = 8.4 Hz, 1H, NH10), 7.70 (s, 1H, H15), 7.29 
– 7.25 (m, 3H, H5-9), 7.24 – 7.16 (m, 2H, H5-9), 7.10 (s, 1H, H16), 5.42 – 5.18 (m, 2H, H12), 4.25 
– 4.12 (m, 1H, H2), 3.86 (s, 3H, H19/20), 3.85 (s, 3H, H19/20), 3.14 – 3.05 (m, 1H, H3), 2.92 – 
2.78 (m, 1H, H3); 13C NMR (75 MHz, DMSO-d6, δ): 206.50 (C1), 173.25 (C11), 161.90 (C17), 
155.59 (C16), 153.42 (C14), 147.55 (C4), 138.89 (C15), 137.84 (C5-9), 129.00 (C5-9), 128.14 (C5-9), 
126.37 (C5-9), 118.29 (C5-9), 114.69 (C13), 109.75 (C18), 108.06 (C12), 56.11 (C19/20), 56.04 
(C19/20), 55.53 (C2), 30.66 (C3). HRMS: 403.1150 [M-H]-; Tm = 159-164 °C 
General method for ester synthesis A solution of N-protected amino acid (0.62 
mmol, 1 eq) and DMAP (113.3 mg, 0.93 mmol, 1.5 eq) in DMF (5 mL) was cooled to 0 °C 
while stirring under N2 atmosphere. EDC.HCl (177.8 mg, 0.93 mmol, 1.5 eq) and uracil or 
p-cresyl based LG (0.68 mmol, 1.1 eq) were subsequently added followed by cooling for 
another hour. The reaction mixture was allowed to warm up to room temperature and left 
stirring overnight, followed by pouring the mixture in EtOAc/NaHCO3 saturated solution. 
The organic layer was washed with 1M HCl (3x) and brine (1x), followed by drying over 
anhydrous MgSO4 and evaporation in vacuo. The residue was purified by column 
chromatography. 
MATERIALS AND METHODS 
162 |  
 
(5-(Hydroxymethyl)-uracil-1-yl)methyl N-(2-nitrobenzyloxycarbonyl)-L-phenyl-
alaninate (4.53a) General method for ester synthesis, purifying by column chromatography 
(MeOH/DCM, 1:9) yielded 3% of an amorphous off-white solid as identified by 2D NMR 
(Appendix C). 
1H NMR (600 MHz, DMSO-d6, δ): 11.50 (s, 1H, NH3), 8.14 – 8.07 (m, 2H, NH18, H23), 7.81 – 
7.74 (m, 1H, H25), 7.59 (t, 3JHH = 7.8 Hz, 1H, H24), 7.57 (s, 1H, H6), 7.49 (d, 3JHH = 7.7 Hz, 
1H, H26), 7.28 – 7.17 (m, 5H, H13-17), 5.75 – 5.64 (m, 2H, H8), 5.34 (s, 2H, H20), 5.10 (t, 3JHH 
= 5.2 Hz, 1H, OH), 4.34 – 4.29 (m, 1H, H10), 4.15 (d, 3JHH = 4.8 Hz, 2H, H7), 3.04 (m, 1H, 
H11), 2.94 – 2.87 (m, 1H, H11). 13C NMR (151 MHz, DMSO-d6, δ): 171.37, 163.03, 155.55, 
150.41, 147.02, 140.88, 136.98, 134.22, 132.83, 129.20, 129.01, 128.48, 128.31, 126.65, 124.90, 
114.29, 71.01, 62.36, 55.81, 55.42, 36.40. HRMS = 497.1318 [M+H]- 
Ester 4.53b was not obtained 
 
(5-(Hydroxymethyl)-uracil-1-yl)methyl N-(4,5-dimethoxy-2-nitrobenzyloxy-
carbonyl)-L-phenylalaninate (4.53c) General method for ester synthesis, purifying by 
column chromatography (MeOH/DCM, 1:9) yielded 12% of an amorphous off-white solid as 
identified by 2D NMR (Appendix C). 
1H NMR (500 MHz, DMSO-d6, δ): 8.11 (d, 3JHH = 7.9 Hz, 1H, NH18), 7.70 (s, 1H, H23), 7.68 
(s, 1H, H26), 7.55 (s, 1H, H6), 7.21 – 7.14 (m, 5H, H13-17), 5.68 (m, 2H, H8), 5.33 (m, 2H, H20), 
5.28 – 5.21 (m, 1H, OH), 4.36 – 4.26 (m, 1H, H10), 4.14 (s, 2H, H7), 2.91 (m, 1H, H11), 2.96 – 
2.85 (m, 1H, H11). 13C NMR (126 MHz, DMSO-d6, δ): 171.50, 163.03, 155.63, 153.51, 150.41, 
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147.80, 140.87, 139.21, 136.93, 129.13, 128.30, 128.07, 127.81, 126.67, 114.28, 110.33, 108.25, 
71.02, 62.66, 56.30, 56.19, 55.80, 55.42, 36.40; HRMS = 557.1531 [M-H]- 
 
4-((Uracil-5-yl)methyl)phenyl N-(2-nitrobenzyloxycarbonyl)-L-phenylalaninate 
(4.54a) General method for ester synthesis, purifying by column chromatography 
(MeOH/DCM, 1:9) yielded 50% of an off-white solid. 
1H NMR (300 MHz, DMSO-d6, δ): 10.94 (s, 1H, NH1/3), 10.79 – 10.49 (m, 1H, NH1/3), 8.11 
(d, 3JHH = 7.8 Hz, 1H, H23), 7.97 (d, 3JHH = 8.0 Hz, 1H, H28), 7.63 – 7.50 (m, 1H, H30), 7.49 – 
7.34 (m, 2H, H29), 7.21-7.04 (m, 9H, H6,9,13,18-22), 6.71 (d, 3JHH = 8.3 Hz, 2H, H10,12), 5.24 (s, 
2H, H25), 4.43-4.29 (m, 1H, H15), 3.34 (s, 2H, H7), 3.11 – 2.99 (m, 1H, H16), 2.97 – 2.82 (m, 
1H, H16); 13C NMR (151 MHz, DMSO-d6, δ): 170.78, 164.34, 155.71, 151.44, 148.56, 147.14, 
139.11, 137.92, 137.12, 134.17, 132.77, 129.51, 129.40, 129.31, 129.08, 128.66, 128.44, 128.15, 
126.79, 124.91, 121.22, 111.54, 62.45, 55.75, 36.47, 31.17; HRMS = 469.1361 [M+H]+; Tm > 
300 °C 
 
4-((Uracil-5-yl)methyl)phenyl N-(1-(R,S)-1-(2-Nitrophenyl)ethyloxycarbonyl)-
L-phenylalaninate (4.54b) General method for ester synthesis, purifying by column 
chromatography (MeOH/DCM, 1:9) yielded 58% of an off-white solid. 
 1H NMR (600 MHz, DMSO-d6, δ): 11.07 (s, 1H, NH1/3), 10.72 (s, 1H, NH1/3), 8.18 – 8.08 (m, 
1H, H23), 7.99 – 7.94 (m, 1H, H28), 7.73 – 7.66 (m, 1H, H30), 7.58 – 7.48 (m, 2H, H29,31), 7.33 
– 7.17 (m, 12H, H6,9,13,18-22), 6.80 – 6.69 (m, 2H, H10,12), 6.02 – 5.92 (m, 1H, H25), 4.41 – 4.31 
(m, 1H, H15), 3.50 – 3.45 (m, 2H, H7), 3.16-3.08 (m, 1H, H16), 3.05 – 2.96 (m, 1H, H16), 1.57 
– 1.49 (m, 3H, H32). 13C NMR (151 MHz, DMSO-d6, δ): 170.76, 170.55, 164.34, 155.27, 155.14, 
151.44, 148.50, 147.49, 147.37, 139.09, 137.81, 137.65, 137.14, 137.05, 134.18, 134.06, 129.47, 
129.44, 129.34, 129.08, 128.94, 128.84, 128.42, 128.36, 127.16, 126.95, 126.77, 126.71, 124.26, 
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121.19, 121.13, 111.56, 67.61, 55.84, 55.56, 36.36, 36.27, 31.16, 21.88, 21.80; HRMS = 557.1683 
[M-H]-; Tm = 296-7 °C 
 
4-((Uracil-5-yl)methyl)phenyl N-(4,5-dimethoxy-2-nitrobenzyloxycarbonyl)-L-
phenylalaninate (4.54c) General method for ester synthesis, purifying by column 
chromatography using a gradient of DCM/acetone (9:1 to 5:5) resulting in a pure dark yellow 
solid (64% yield). 
1H NMR (300 MHz, DMSO-d6, δ): 11.06 (s, 1H, NH3), 10.72 (s, 1H, NH1), 8.26 (d, 3JHH = 7.6 
Hz, 1H, NH23), 7.70 (s, 1H, H28), 7.36 – 7.28 (m, 5H, H18-22,9,13), 7.27 – 7.20 (m, 3H, H18-22), 
7.13 (s, 1H, H6), 6.83 (d, 3JHH = 8.5 Hz, 2H, H10,12), 5.43 – 5.30 (m, 2H, H25), 4.55 – 4.47 (m, 
1H, H15), 3.86 (s, 3H, H32/33), 3.81 (s, 3H, H32/33), 3.48 (s, 2H, H7), 3.23 – 3.16 (m, 1H, H16), 
3.11 – 3.03 (m, 1H, H16); 13C NMR (75 MHz, DMSO-d6, δ): 170.88, 164.31, 155.73, 153.42, 
151.41, 148.50, 147.82, 139.34, 139.10, 137.91, 137.07, 129.47, 129.32, 128.41, 127.70, 126.78, 
121.16, 111.49, 110.51, 108.23, 62.71, 62.57, 56.20, 56.17, 55.74, 36.46, 31.14; HRMS: 603.1724 
[M-H]-; Tsm = 147-51 °C 
 
4-((Uracil-5-yl)ethynyl)phenyl N-(2-nitrobenzyloxycarbonyl)-L-phenylalaninate 
(4.55a) General method for ester synthesis, purifying by column chromatography 
(MeOH/DCM, 1:9) yielded 17% of an off-white solid. 
1H NMR (500MHz, DMSO-d6, δ): 11.42 (s, 1H, NH1/3), 11.38 (bs, 1H, NH1/3), 8.27 (d, 3JHH = 
7.5 Hz, 1H, NH24), 8.12 (d, 3JHH = 8.2 Hz, 1H, H29), 7.90 (s, 1H, H6), 7.73 (td, 3JHH = 7.6, 1.1 
Hz, 1H, H31), 7.62 – 7.57 (m, 1H, H30), 7.55 (d, 3JHH = 7.8 Hz, 1H, H32), 7.51 – 7.46 (m, 2H, 
H10,14), 7.34 (m, 3H, H19-23), 7.30 – 7.24 (m, 2H, H19-23), 7.02 (d, 3JHH = 8.6 Hz, 2H, H11,13), 5.40 
– 5.38 (m, 2H, H26), 4.57 – 4.49 (m, 1H, H16), 3.24 – 3.19 (m, 1H, H17), 3.12 – 3.06 (m, 1H, 
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H17). 13C NMR (126 MHz, DMSO-d6, δ):170.82, 162.91, 156.07, 150.88, 150.49, 147.52, 146.46, 
137.44, 134.49, 133.07, 132.81, 129.73, 129.46, 129.05, 128.79, 127.15, 125.26, 122.45, 120.84, 
97.12, 91.13, 83.35, 62.83, 56.12, 36.66; HRMS = 553.1364 [M-H]-; Tm = 282-4 °C 
 
4-((Uracil-5-yl)ethynyl)phenyl N-(1-(R,S)-1-(2-Nitrophenyl)ethyloxycarbonyl)-
L-phenylalaninate (4.55b) General method for ester synthesis, purifying by column 
chromatography (MeOH/DCM, 1:9) yielded 17% of an off-white solid. 
1H NMR (500 MHz, DMSO-d6, δ): 11.42 (s, 1H, NH1/3), 11.36 (s, 1H, NH1/3), 8.22 – 8.13 (m, 
1H, NH24), 8.01 – 7.94 (m, 1H, H29), 7.91 – 7.87 (m, 1H, H6), 7.75 – 7.67 (m, 2H, H29-32), 7.59 
– 7.51 (m, 2H, H10,14), 7.48 – 7.43 (m, 2H, H29-32), 7.35– 7.21 (m, 5H, H19-23), 6.95 – 6.83 (m, 
2H, H11,13), 6.03 – 5.95 (m, 1H, H26), 4.44 – 4.32 (m, 1H, H16), 3.19 – 3.10 (m, 1H, H17), 3.08 
– 2.98 (m, 1H, H17), 1.58 – 1.49 (m, 3H, H33); 13C NMR (126 MHz, DMSO-d6, δ): 170.20, 
162.53, 155.27, 155.12, 150.50, 150.06, 147.50, 147.37, 146.06, 137.73, 137.62, 137.01, 134.14, 
134.03, 132.38, 132.34, 129.29, 128.95, 128.83, 128.40, 128.34, 127.13, 126.93, 126.76, 124.22, 
122.04, 121.98, 120.42, 96.76, 90.75, 82.95, 67.62, 55.81, 55.47, 36.24, 36.10, 21.83, 21.73; 
HRMS = 567.1522 [M-H]-; Tm = 264-6 °C 
 
4-((Uracil-5-yl)ethynyl)phenyl N-(4,5-dimethoxy-2-nitrobenzyloxycarbonyl)-L-
phenylalaninate (4.55c) General method for ester synthesis, purifying by column 
chromatography using a gradient of DCM/acetone (9:1 to 5:5) resulting in a pure yellow solid 
(24% yield). 
MATERIALS AND METHODS 
166 |  
1H NMR (600 MHz, DMSO-d6, δ): 11.42 (s, 1H, NH1/3), 11.37 (s, 1H, NH1/3), 8.30 (d, 3JHH = 
7.4 Hz, 1H, H24), 7.90 (s, 1H, H29), 7.70 (s, 1H, H6), 7.48 (d, 3JHH = 8.6 Hz, 2H, H10,14), 7.36 – 
7.30 (m, 5H, H19-23), 7.28 – 7.20 (m, 2H, H19-23), 7.13 (s, 1H, H32), 6.99 (d, 3JHH = 8.6 Hz, 2H, 
H11,14), 5.43 – 5.31 (m, 2H, H26), 4.57 – 4.47 (m, 1H, H16), 3.86 (s, 3H, H33/34), 3.81 (s, 3H, 
H33/34), 3.24 – 3.15 (m, 1H, H17), 3.13 – 3.05 (m, 1H, H17); 13C NMR (151 MHz, DMSO-d6, 
δ):170.61, 162.55, 162.38, 155.78, 153.42, 150.53, 150.11, 147.84, 146.11, 139.35, 137.06, 
132.44, 129.32, 129.21, 128.42, 127.79, 127.67, 126.80, 122.05, 120.49, 110.50, 108.23, 96.76, 
90.76, 83.00, 62.75, 56.18, 55.80, 36.29, 35.86, 30.77, 29.06; HRMS = 613.1578 [M+H]+; Tm 
> 300 °C 
 
Uracil-5-yl N-(2-nitrobenzyloxycarbonyl)-L-phenylalaninate (4.56a) General 
method for ester synthesis, purifying by column chromatography (MeOH/DCM, 1:9) yielded 
38% of an off-white solid. 
1H NMR (600 MHz, DMSO-d6, δ): 8.21 (d, 3JHH = 8.6 Hz, 1H, H16), 8.11 (dd, 3JHH = 8.2, 1.2 
Hz, 1H, H21), 7.74 (td, 3JHH = 7.6, 1.2 Hz, 1H, H23), 7.61 – 7.56 (m, 1H, H24), 7.53 (s, 1H, H6), 
7.46 (d, 3JHH = 7.7 Hz, 1H, H22), 7.34 – 7.29 (m, 3H, H11-15), 7.28 – 7.17 (m, 4H, H11-15), 5.34 
(s, 2H, H18), 4.52 – 4.45 (m, 1H, H8), 3.29 – 3.23 (m, 1H, H9), 3.01 – 2.94 (m, 1H, H9); 13C 
NMR (151 MHz, DMSO-d6, δ): 170.12, 159.09, 155.58, 150.58, 146.97, 137.28, 134.21, 133.57, 
132.90, 129.30, 128.97, 128.38, 126.71, 125.80, 124.90, 120.66, 62.32, 55.24, 36.56; HRMS = 
453.1054 [M-H]-; Tm = 194-8 °C 
Esters 4.56b was not obtained 
 
Uracil-5-yl N-(4,5-dimethoxy-2-nitrobenzyloxycarbonyl)-L-phenylalaninate 
(4.56a) General method for ester synthesis, purifying by column chromatography using a 
gradient of DCM/acetone (9:1 to 5:5) yielded 59% of a yellow solid. 
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1H NMR (500 MHz, DMSO-d6, δ): 8.20 (d, 3JHH = 8.6 Hz, 1H, H16), 7.90 (s, 1H, H21), 7.70 
(td, 3JHH = 7.6, 1.2 Hz, 1H, H22), 7.61 – 7.55 (m, 1H, H23), 7.53 (s, 1H, H6), 7.46 (d, 3JHH = 
7.7 Hz, 1H), 7.34 – 7.29 (m, 3H, H11-15), 7.28 – 7.17 (m, 4H, H11-15), 7.13 (s, 1H, H24), 5.32 (s, 
2H, H18), 4.52 – 4.44 (m, 1H, H8), 3.86 (s, 3H, H33/34), 3.80 (s, 3H, H33/34),  3.29 – 3.24 (m, 1H, 
H9), 3.01 – 2.93 (m, 1H, H9); 13C NMR (151 MHz, DMSO-d6, δ): 170.31, 159.09, 155.67, 
153.51, 150.58, 147.79, 139.18, 137.28, 133.51, 129.32, 129.22, 129.14, 128.39, 128.30, 127.93, 
126.75, 125.82, 120.69, 110.16, 108.23, 62.62, 56.25, 56.19, 55.27, 36.56; HRMS = 515.1409 
[M+H]+; Tm = 257-60 °C 
 
(((Uracil-5-yl)methylene)amino)oxy N-(2-nitrobenzyloxycarbonyl)-L-phenyl-
alaninate (4.57a) General method for ester synthesis, purifying by column chromatography 
(MeOH/DCM, 1:9) yielded a minute quantity of a yellow solid. 
HRMS = 480.1157 [M+H]+ 
Esters 4.57b-c were not obtained 
 
4-((Uracil-5-yl)methyl)phenyl N-(benzyloxycarbonyl)-L-phenylalaninate (4.58) 
General method for ester synthesis, purifying by column chromatography using a gradient of 
DCM/acetone (9:1 to 5:5) yielded 56% of a white solid. 
1H NMR (300 MHz, DMSO-d6, δ): 11.07 (s, 1H, NH3), 10.75 (s, 1H, NH1), 8.05 (d, 3JHH = 7.5 
Hz, 1H, NH25), 7.43 – 7.14 (m, 12H, H9,13,17-22,26-31), 6.84 (d, 3JHH = 8.4 Hz, 2H, H10,12), 5.11 – 
4.92 (m, 2H, H25), 4.57 – 4.38 (m, 1H, H15), 3.49 (s, 2H, H7), 3.18 – 3.02 (m, 2H, H16). 13C 
NMR (75 MHz, DMSO-d6, δ): 170.98, 164.37, 156.20, 151.48, 148.62, 139.13, 137.93, 137.22, 
137.00, 129.54, 129.42, 128.47, 127.96, 127.79, 126.81, 121.25, 111.60, 65.70, 55.87, 36.55, 
31.22. HRMS: 456.1922 [M-CO2+H]+, 517.2091 [M+NH3+H]+, 522.1632 [M+Na]+; Tm = 137-
44 °C 
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p-Tolyl N-(benzyloxycarbonyl)-L-phenylalaninate (4.59) General method for ester 
synthesis, purifying by column chromatography (heptane/EtOAc, 9:1 to 6:4) yielded 33% of 
a white solid. 
1H NMR (300 MHz, DMSO-d6, δ): 8.02 (d, 3JHH = 7.4 Hz, 1H, NH17), 7.39 – 7.23 (m, 10H, H12-
16,20-25), 7.20 (d, 3JHH = 8.1 Hz, 2H, H3,7), 6.84 (d, 3JHH = 8.1 Hz, 2H, H4,6), 5.04 (s, 2H, H19), 
4.53 – 4.46 (m, 1H, H9), 3.22 – 3.14 (m, 1H, H10), 3.11 – 3.03 (m, 1H, H10), 2.30 (s, 3H, H1). 
13C NMR (75 MHz, CDCl3, δ): 170.33, 155.63, 148.01, 136.15, 135.85, 135.43, 129.97, 129.47, 
128.73, 128.55, 128.23, 128.12, 127.33, 120.88, 67.09, 54.91, 38.29, 20.85; HRMS = 346.1804 
[M-CO2-H]+, 390.1697 [M+H]+, 412.1518 [M+Na]+; Tsm = 87-90 °C 
 
p-Tolyl N-(4,5-dimethoxy-2-nitrobenzyloxycarbonyl)-L-phenylalaninate (4.60) 
General method for ester synthesis, purifying by column chromatography (heptane/EtOAc, 
9:1 to 6:4) yielded 20% of a yellow solid. 
1H NMR (300 MHz, DMSO-d6, δ): 8.27 (d, 3JHH = 7.5 Hz, 1H, NH17), 7.70 (s, 1H, H22), 7.36 
– 7.24 (m, 5H, H12-16), 7.18 (d, 3JHH = 8.3 Hz, 2H, H3,7), 7.13 (s, 1H, H25), 6.82 (d, 3JHH = 8.4 
Hz, 2H, H4,6), 5.47 – 5.26 (m, 2H, H19), 4.58 – 4.44 (m, 1H, H9), 3.86 (s, 3H, H26/27), 3.81 (s, 
3H, H26/27), 3.25 – 3.15 (m, 1H, H10), 3.13 – 3.02 (m, 1H, H10), 2.29 (s, 3H, H1); 13C NMR (126 
MHz, DMSO-d6, δ): 170.89, 155.73, 153.42, 148.09, 147.82, 139.32, 137.10, 135.25, 129.92, 
129.31, 128.39, 127.72, 126.76, 121.15, 110.47, 108.23, 62.68, 56.16, 55.74, 36.42, 20.43; HRMS: 
495.1757 [M+H]+; Tm = 169-173 °C 
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6.3.2 pKa (D2O) determination by NMR 
Stock solutions (5% m/V) of 4.8 and p-cresol (25% m/V) were prepared in 
DMSO-d6. 25 µL of the stock solution was subsequently diluted with 400 µL 
of D2O. pH for each sample was adjusted using either 0.1 N or 10 N NaOD. 
Finally, the samples were diluted to obtain a total volume of 700 µL (0.18% 
m/V and 0.9% m/V respectively). 1D 1H proton spectra were used to verify 
each sample. 2D 1H,13C HMBC spectra were used for their improved 
sensitivity over 1D 13C spectra. HMBC spectra were internally referenced to 
the DMSO signal. NMR spectra were processed using TopSpin and 
subsequently analyzed using CARA and MestReNova software. 
The chemical association constant for a typical acid base reaction is: 
: = 
;<=>?<  (1) 
And rearranging leads to the Henderson-Hasselbalch equation: 
pH = p5 + log A
;
<B (2) 
The observed chemical shift (in fast exchange) is the combination of the 
chemical shift of protonated and unprotonated form with respect to their 
molar fraction25: 
δDEF = GHIδHI + GHJδHJ  (3) 
GHI +  GHJ = 1 (4) 
Using these molar fractions, Eq. 2 can be rewritten to express the chemical 
shift δobs  in function of pH: 
δDEF = δHI + δHJ × 10
NOP;NJ
1 + 10NOP;NJ  (5) 
δA− and δAH were estimated using the value of the observed chemical shift in 
the samples with the highest and lowest pH respectively. The observed 
chemical shift was plotted in function of pH and fitted to the above equation 
using the least squares approximation. This was performed using the 
lsqcurvefit algorithm provided in the Optimization toolbox of Matlab R2015a. 
(Appendix D) 
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NMR pH titration of both LG were conducted to see if any changes in pKa 
were obtained by replacing one hydrogen on p-cresol by uracil. NMR was 
chosen for the ability to resolve all pKa values due to the narrow range of 
expected values of uracil derivative 4.8 (3 values between 9-11). HMBC 
spectra were chosen for increased sensitivity as compound 4.8 is poorly soluble 
in water and inadequate H2O-suppresion forced us to measure the spectra in 
D2O. The obtained pKa in D2O differs from those measured in H2O25 forcing 
us to obtain a reference value of p-cresol instead of relying on literature 
data.26* Table 4.3 shows the obtained values for each moiety, the phenolic 
pKa (D2O) of 4.8 was found to be more basic than p-cresol. Both acidic 
nitrogen of the uracil ring showed similar results, probably due to resonance 
forms affecting ionisation. 
6.3.3 Kinetic studies 
Pseudo first order kinetics of the aminolysis of compound 4.58 and 4.59 were 
obtained by making a 200 µL solution containing 1.6x10-4 M of respective 
compound and a given excess of benzylamine in the investigated solvent. The 
decrease of the area under the curve was quantified by HPLC through fitting 
on a pre-made calibrating curve. This method was found to be linear between 
concentrations of 0.16 mM (LOQ) - 20.02 mM for compound 4.58 and 0.05 
mM (LOQ) - 25.68 mM for compound 4.59 at 254 nm detection. Both 
calibrating curves included the intercept, allowing the use of one point 
calibrations before the determinations of each reaction constant. Periodic 
analysis (5x) per sample was carried out, measurements outside the allotted 
range were omitted. Kinetic constants were obtained by the linear fit of 
plotting the natural logarithm of compound concentration versus time. 
Constants derived from experiments with unsatisfactory fits (R2 < 0.9) were 
also omitted. Each reported value is the average of at least 3 experiments. 
  
                                      
* Herein was reported 10.27 as pKa value for p-cresol 
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6.3.4 Oligomerization experiments 
Fresh stock solutions of compound 4.54a and 4.60 (3.3x10-4 M in DMSO) were 
made every week and kept in the fridge, shielded from light. Buffer stock 
solutions (0.06M) were freshly diluted with MilliQ water from commercially 
available 1M solutions, followed by checking the pH electronically. Buffer 1 
= pH 6.0 = triethyl ammonium formate (Et3NH+ HCOO-). Buffer 2 = pH 8.4 
= triethyl ammonium bicarbonate (Et3NH+ HCO3-). Samples were prepared 
by adding 100 µL of compound stock solution in a 1.5 mL clear glass (31x5 
mm, 15 mm top) vial with center hole seal screwcap containing a micro-insert 
(maximum volume 200 µL). References were prepared in a similar fashion, 
albeit using dark vials when deemed necessary. Samples were irradiated for 2 
h unless stated otherwise; followed by addition of 100 µL of either water, 
buffer and/or a solution of the investigated product. Final concentrations 
were: buffer = 0.02 M, oligonucleotide (dA)10 = 8.25x10-6 M. LC-MS column 
was stabilized prior to analysis with 2% ACN in MilliQ water (0.1% formic 
acid) for 10 min. Samples were analyzed after a given amount of incubation 
time at given temperature, by injection of a 5 µL aliquot followed by linear 
gradient (2%-100% ACN). 
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Appendix A: The genetic code 
The universal genetic code 
1st 
base 
2nd  base 3rd 
base U C A G 
U 
UUU Phe UCU Ser UAU Tyr UGU Cys U 
UUC  UCC  UAC  UGC  C 
UUA Leu UCA  UAA Stop UGA Stop A 
UUG  UCG  UAG  UGG Trp G 
C 
CUU Leu CCU Pro CAU His CGU Arg U 
CUC  CCC  CAC  CGC  C 
CUA  CCA  CAA Gln CGA  A 
CUG  CCG  CAG  CGG  G 
A 
AUU Ile ACU Thr AAU Asn AGU Ser U 
AUC  ACC  AAC  AGC  C 
AUA  ACA  AAA Lys AGA Arg A 
AUG Met ACG  AAG  AGG  G 
G 
GUU Val GCU Ala GAU Asp GGU Gly U 
GUC  GCC  GAC  GGC  C 
GUA  GCA  GAA Glu GGA  A 
GUG  GCG  GAG  GGG  G 
Blank spaces of amino acids correspond to the above species, codons in bold have a respective 
mitochondrial tRNA  
Source: Volker A. Erdmann, Wojciech T. Markiewicz, Jan Barciszewski (eds.)-Chemical Biology of 
Nucleic Acids_ Fundamentals and Clinical Applications-(RNA Technologies) Springer-Verlag Berlin 
Heidelberg (2014) 
Exceptions to the universal code in vertebrate mitochondria  
Codon Universal Mt code 
AUA Ile Met 
UGA Stop Trp 
AGA Arg Stop 
AGG  
 
Blank spaces of amino acids correspond to the above species, codons in bold have a respective 
mitochondrial tRNA, Universal = universal code, Mt code = mitochondrial code 
Source: Elzanowski A, Ostell J (2008-04-07). "The Genetic Codes".National Center for Biotechnology 
Information (NCBI). Retrieved 2016-05-20. 
http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi?mode=c 
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Appendix B: Python file for ILG in autocatalysis 
#-*- coding: utf-8 -*- 
import scipy as sp 
from scipy.optimize import newton 
import itertools import pickle 
St_conc=1. 
#This is the standard concentration (c°) appearing in expressions  
#for equilibrium constants 
#All concentrations in mol/l (M) 
R=1.987E-3 
#Ideal gas constant, in kcal/(mol.K) 
#All energies (dG, dH or RT) in kcal/mol, entropy (dS) in kcal(mol.K) 
a=1.E-3 b=1.E-
3 c=1.E-4 
A=1.E11 
#Multiplicative constant used in the expression of k vs. T (Arrhenius law),  
#in s-1 
def func_q(K_1,a,b):     
return 1/(K_1*a*b) 
    #This is q as defined in Von Kiedrowski's schme or our scheme 
def func_q_AB(K_1,K_0,a,b): 
    Num=2*K_0**2 
    Den=K_1*(1+K_0*(a+b)-sp.sqrt(1+2*K_0*(a+b)+K_0**2*(a-b)**2))     
return Num/Den 
    #This is q as defined by Equation (35) of von Kiedrowski's original paper ... 
    #... to be used if formation of the complex AB is taken into account      
##Functions below only apply to von Kiedrowski scheme (with subscript '_vK') def 
equ_state_vK(K_2,q,c): 
    abc_equ=(sp.sqrt(8*K_2*c*q**2+(1+q)**2)-(q+1))/(4*K_2*q**2)     
c_equ=q*abc_equ     c_2_equ=K_2*c_equ**2 
    return sp.array([abc_equ,c_equ,c_2_equ]) 
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def cat_order_vK(K_2,q,c): 
    A=4*K_2*c*q**2 
    B=sp.sqrt(8*K_2*c*q**2+(1+q)**2) #    
return 1/(2+(1+q)**2/A-(1+q)*B/A)     
return A/(2*A+(1+q)**2-(1+q)*B) 
##Functions above only apply to von Kiedrowski scheme (with subscript '_vK') 
##Functions below only apply to Herdewyn_Mattelaer scheme (with subscript '_HM') 
def func_lg(abc,K_2,K_3,q,l): 
    return l/(1+K_2*K_3*(q*abc)**2+K_3*q*abc) 
#    return l/(1+K_2*K_3*(q*abc)**2) 
    #This function gives [L] as a function of [ABC], K2, K3, q and l 
    def 
func_to_be_zeroed(abc,K_2,K_3,q,c,l): 
    ll=func_lg(abc,K_2,K_3,q,l) 
    return 2*K_2*(q*abc)**2+((q+1)+K_3*q*ll)*abc+2*(K_2*K_3*(q*abc)**2)*ll-c 
#    return 2*K_2*(q*abc)**2+((q+1))*abc+2*(K_2*K_3*(q*abc)**2)*ll-c 
    def 
func_prime(abc,K_2,K_3,q,c,l): 
#    return 4*K_2*q**2*abc+(q+1)+4*l*K_2*K_3*q**2*abc/(1+K_2*K_3*(q*abc)**2)**2     
return 4*K_2*q**2*abc+(q+1)+K_3*q*l*(1+K_2*K_3*(q*abc)**2+4*K_2*q*abc)/( 
    1+K_2*K_3*(q*abc)**2)**2 
#This is the 1st derivative of func_to_be_zeroed w.r.t. the variable abc 
#Used in the scipy Newton method that is called in the function below 
    def 
equ_state_HM(K_2,K_3,q,c,l): 
    try: 
        abc_equ=newton(func_to_be_zeroed,0.,fprime=func_prime,args=(         
K_2,K_3,q,c,l),tol=1.E-20,maxiter=1000)     except RuntimeError:         
abc_equ=newton(func_to_be_zeroed,1.E-4,fprime=func_prime,args=( 
        K_2,K_3,q,c,l))  
    #This is to avoid numerical noise when solving for [ABC]     
lg_equ=func_lg(abc_equ,K_2,K_3,q,l)     c_equ=q*abc_equ     
c_2_equ=K_2*c_equ**2     d_equ=K_3*c_2_equ*lg_equ     
lc_equ=K_3*q*abc_equ*lg_equ 
    return (abc_equ,c_equ,c_2_equ,lg_equ,d_equ,lc_equ)     
#This function gives the full equilibrium state ( 
    #[ABC],[L],[C],[C2],[D],[LC])...     #... 
as a function of K2, K3, q, c and l 
def cat_order_HM(abc,K_2,K_3,q,c,l): 
    ll=func_lg(abc,K_2,K_3,q,l)     
A=K_2*K_3*(q*abc)**2     numerator=1-
A 
    denominator_1=(4*K_2*q**2*abc+(1+q))*(1+A+K_3*q*abc)     
denominator_2=4*K_2*K_3*q**2*abc*ll+K_3*q*ll*(1+A)     return 
(c/abc)*(numerator/(denominator_1+denominator_2)) 
    #This function gives the autocatalytic order p... 
    #... as a function of [ABC], [L], K2, K3, q and c 
##Functions above only apply to Herdewyn_Mattelaer scheme (with subscript '_HM') 
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   def 
func_dG(dH,dS,T):     
return dH-T*dS 
    def 
func_K_1(dG_1,T): 
    return (1/St_conc**2)*sp.exp(-dG_1/(R*T)) 
    #To be used for K1 only (termolecular equilibrium constant) 
    def 
func_K(dG,T): 
    return (1/St_conc)*sp.exp(-dG/(R*T)) 
    #To be used for K0, K2 or K3 (bimolecular equilibrium constant) 
    def 
func_k(A,Ea,T): 
    return A*sp.exp(-Ea/(R*T)) 
     
################################################ 
###########      von Kiedrowski      ###########      
################################################ 
#Generating (p,abc) data as a function of log(K_1), 
# log(K_2) for vK scheme (sanity check) 
N=50 
#N is the number of points per axis 
Max_log_K_1=12 
Max_log_K_2=12 
log_K_1=sp.array([sp.array([( 
i/float(N))*12 for j in range(N)]) for i in range(N)]) 
log_K_2=sp.array([sp.array([( 
j/float(N))*12 for j in range(N)]) for i in range(N)]) 
p_vK=sp.array([sp.array([0. for j in range(N)]) for i in range(N)]) 
abc_vK=sp.array([sp.array([0. for j in range(N)]) for i in range(N)]) 
for (i,j) in itertools.product(range(N),repeat=2): 
#    print (i,j) 
    K_1=10**((i/float(N))*Max_log_K_1) 
    K_2=10**((j/float(N))*Max_log_K_2) 
     
    q=func_q(K_1,a,b) 
     
    abc_vK[i,j]=(sp.sqrt(8*K_2*c*q**2+(1+q)**2)-(q+1))/(4*K_2*q**2) 
        if 8*K_2*c*q**2/(1+q)**2<1.E-
10: 
        p_vK[i,j]=1/(1+2*K_2*c*q**2/(1+q)**2) 
        #This is a simplification to avoid 'numerical noise' 
        #Simplification based on sp.sqrt(1+x)         
#approximately given by 1+0.5*x if x<<1     
else:         p_vK[i,j]=cat_order_vK(K_2,q,c) 
        with open('C:/Users/Henri-
Philippe/Desktop/Figures/p_vK','w') as f: 
    pickle.dump(p_vK,f) 
f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/abc_vK','w') as f: 
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    pickle.dump(abc_vK,f) 
f.closed 
#Generating (p, concentrations) data as a function of temperature T... 
#...for vK scheme (sanity check) 
N=150 
#N is the number of points per axis 
dH_0=-22.23 dS_0=-66.37*1.E-
3 dH_2=-56.45 dS_2=-
148.17*1.E-3 dS_nuc=-
12.55*1.E-3 dH_1_bc=dH_2 
dS_1_bc=dS_2+dS_nuc 
dH_1_wc=2*dH_0 
dS_1_wc=2*dS_0 
T_min_C=-50 
T_max_C=100 
T_min_K=T_min_C+273. 
T_max_K=T_max_C+273. 
T_array=T_min_K+sp.array([(float(i)/N)*(T_max_K-T_min_K) for i in range(N+1)]) 
dG_1_bc_array=func_dG(dH_1_bc,dS_1_bc,T_array) 
dG_1_wc_array=func_dG(dH_1_wc,dS_1_wc,T_array) 
K_1_bc_array=func_K_1(dG_1_bc_array,T_array) 
K_1_wc_array=func_K_1(dG_1_wc_array,T_array) dG_2_array=func_dG(dH_2,dS_2,T_array) 
dG_0_array=func_dG(dH_0,dS_0,T_array) 
#To be used if formation of complex AB is taken into account 
K_2_array=func_K(dG_2_array,T_array) 
K_0_array=func_K(dG_0_array,T_array) 
#To be used if formation of complex AB is taken into account 
q_vK_bc_array=func_q(K_1_bc_array,a,b) q_vK_wc_array=func_q(K_1_wc_array,a,b) 
q_vK_bc_array_AB=func_q_AB(K_1_bc_array,K_0_array,a,b) 
q_vK_wc_array_AB=func_q_AB(K_1_wc_array,K_0_array,a,b) #To be 
used if formation of complex AB is taken into account 
equ_state_vK_bc_array=equ_state_vK(K_2_array,q_vK_bc_array,c) 
equ_state_vK_wc_array=equ_state_vK(K_2_array,q_vK_wc_array,c) 
equ_state_vK_bc_array_AB=equ_state_vK(K_2_array,q_vK_bc_array_AB,c) 
equ_state_vK_wc_array_AB=equ_state_vK(K_2_array,q_vK_wc_array_AB,c) #To 
be used if formation of complex AB is taken into account 
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p_vK_bc_array=cat_order_vK(K_2_array,q_vK_bc_array,c) 
p_vK_wc_array=cat_order_vK(K_2_array,q_vK_wc_array,c) 
p_vK_bc_array_AB=cat_order_vK(K_2_array,q_vK_bc_array_AB,c) 
p_vK_wc_array_AB=cat_order_vK(K_2_array,q_vK_wc_array_AB,c) #To 
be used if formation of complex AB is taken into account 
with open('C:/Users/Henri-Philippe/Desktop/Figures/p_vK_bc_Tdep','w') as f: 
    pickle.dump(p_vK_bc_array,f) 
f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_vK_bc_Tdep','w') 
as f:     pickle.dump(equ_state_vK_bc_array,f) f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/p_vK_wc_Tdep','w')  
as f:     
pickle.dump(p_vK_wc_array,f) 
f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_vK_wc_Tdep','w') 
as f:     pickle.dump(equ_state_vK_wc_array,f) f.closed with 
open('C:/Users/Henri-Philippe/Desktop/Figures/p_vK_bc_Tdep_AB','w') as f: 
    pickle.dump(p_vK_bc_array_AB,f) f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_vK_bc_Tdep_AB','w') 
as f:     pickle.dump(equ_state_vK_bc_array_AB,f) f.closed with 
open('C:/Users/Henri-Philippe/Desktop/Figures/p_vK_wc_Tdep_AB','w') as f: 
    pickle.dump(p_vK_wc_array_AB,f) f.closed 
with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_vK_wc_Tdep_AB','w') 
as f:     pickle.dump(equ_state_vK_wc_array_AB,f) f.closed 
################################################ 
###########    Herdewyn-Mattelaer    ###########     
################################################ 
for l in [0*c,10*c]: 
    #Generating (p,abc) data as a function of log(K_1), 2log(K)... 
    #... assuming K_2=K_3=K for HM scheme 
     
    N=50 
    #N is the number of points per axis 
     
    Max_log_K_1=12 
    Max_log_K=6 
     
    log_K_1=sp.array([sp.array([( 
    i/float(N))*Max_log_K_1 for j in range(N)]) for i in range(N)])     
log_K=sp.array([sp.array([( 
    j/float(N))*Max_log_K for j in range(N)]) for i in range(N)]) 
     
    p_HM=sp.array([sp.array([0. for j in range(N)]) for i in range(N)])     
abc_HM=sp.array([sp.array([0. for j in range(N)]) for i in range(N)]) 
        for (i,j) in 
itertools.product(range(N),repeat=2): 
        K_1=10**((i/float(N))*Max_log_K_1) 
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        K_2=10**((j/float(N))*Max_log_K)         
K_3=10**((j/float(N))*Max_log_K)         q=func_q(K_1,a,b) 
         
        equ_state_array=equ_state_HM(K_2,K_3,q,c,l) 
         
        abc_HM[i,j]=equ_state_array[0] 
         
        p_HM[i,j]=cat_order_HM(equ_state_array[0],K_2,K_3,q,c,l) 
        with open('C:/Users/Henri-
Philippe/Desktop/Figures/p_HM_l_'     +str(int(l/c)),'w') as f: 
        pickle.dump(p_HM,f) 
    f.closed         with open('C:/Users/Henri-
Philippe/Desktop/Figures/abc_HM_l_' 
    +str(int(l/c)),'w') as f:         
pickle.dump(abc_HM,f) 
    f.closed 
     
     
    #Generating (p, concentrations) data as a function of temperature T... 
    #...for HM scheme 
     
    N=150 
    #N is the number of points per axis 
        dH_2=-22.23     
dS_2=-66.37*1.E-3 
        dH_3=-24.06     
dS_3=-69.05*1.E-3 
        dH_1_bc=-58.36     
dS_1_bc=-163.94*1.E-3 
     
    dH_1_wc=dH_2+dH_3     
dS_1_wc=dS_2+dS_3 
     
    T_min_C=-50     
T_max_C=100 
     
    T_min_K=T_min_C+273. 
    T_max_K=T_max_C+273. 
     
    T_array=T_min_K+sp.array( 
    [(float(i)/N)*(T_max_K-T_min_K) for i in range(N+1)]) 
        
dG_1_bc_array=func_dG(dH_1_bc,dS_1_bc,T_array)     
dG_1_wc_array=func_dG(dH_1_wc,dS_1_wc,T_array) 
     
    K_1_bc_array=func_K_1(dG_1_bc_array,T_array) 
    K_1_wc_array=func_K_1(dG_1_wc_array,T_array) 
        
dG_2_array=func_dG(dH_2,dS_2,T_array)     
dG_3_array=func_dG(dH_3,dS_3,T_array) 
     
    K_2_array=func_K(dG_2_array,T_array) 
    K_3_array=func_K(dG_3_array,T_array) 
     
    equ_state_HM_bc=sp.array( 
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    [sp.array([sp.nan for j in range(6)]) for i in range(N+1)])     
equ_state_HM_wc=sp.array( 
    [sp.array([sp.nan for j in range(6)]) for i in range(N+1)]) 
     
    equ_state_HM_bc_AB=sp.array( 
    [sp.array([sp.nan for j in range(6)]) for i in range(N+1)])     
equ_state_HM_wc_AB=sp.array( 
    [sp.array([sp.nan for j in range(6)]) for i in range(N+1)]) 
    #To be used if formation of complex AB is taken into account 
     
    q_HM_bc_array=func_q(K_1_bc_array,a,b)     
q_HM_wc_array=func_q(K_1_wc_array,a,b) 
     
    q_HM_bc_array_AB=func_q_AB(K_1_bc_array,K_2_array+K_3_array,a,b)     
q_HM_wc_array_AB=func_q_AB(K_1_wc_array,K_2_array+K_3_array,a,b) 
    #To be used if formation of complex AB is taken into account 
     
    equ_state_HM_bc_array=sp.transpose(sp.array([equ_state_HM(K_2_array[i] 
    ,K_3_array[i],q_HM_bc_array[i],c,l) for i in range(N+1)])) 
    equ_state_HM_wc_array=sp.transpose(sp.array([equ_state_HM(K_2_array[i] 
    ,K_3_array[i],q_HM_wc_array[i],c,l) for i in range(N+1)])) 
     
    equ_state_HM_bc_array_AB=sp.transpose(sp.array([equ_state_HM(K_2_array[i] 
    ,K_3_array[i],q_HM_bc_array_AB[i],c,l) for i in range(N+1)])) 
    equ_state_HM_wc_array_AB=sp.transpose(sp.array([equ_state_HM(K_2_array[i] 
    ,K_3_array[i],q_HM_wc_array_AB[i],c,l) for i in range(N+1)])) 
    #To be used if formation of complex AB is taken into account 
     
    p_HM_bc_array=sp.array([cat_order_HM(equ_state_HM_bc_array[0,i] 
    ,K_2_array[i] 
    ,K_3_array[i] 
    ,q_HM_bc_array[i]     ,c,l) 
for i in range(N+1)]) 
    p_HM_wc_array=sp.array([cat_order_HM(equ_state_HM_wc_array[0,i] 
    ,K_2_array[i] 
    ,K_3_array[i] 
    ,q_HM_wc_array[i] 
    ,c,l) for i in range(N+1)]) 
     
    p_HM_bc_array_AB=sp.array([cat_order_HM(equ_state_HM_bc_array_AB[0,i] 
    ,K_2_array[i] 
    ,K_3_array[i] 
    ,q_HM_bc_array_AB[i]     
,c,l) for i in range(N+1)]) 
    p_HM_wc_array_AB=sp.array([cat_order_HM(equ_state_HM_wc_array_AB[0,i] 
    ,K_2_array[i] 
    ,K_3_array[i] 
    ,q_HM_wc_array_AB[i] 
    ,c,l) for i in range(N+1)]) 
    #To be used if formation of complex AB is taken into account 
     
    with open('C:/Users/Henri-Philippe/Desktop/Figures/p_HM_bc_Tdep_l_' 
    +str(int(l/c)),'w') as f: 
        pickle.dump(p_HM_bc_array,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_HM_bc_Tdep_l_' 
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    +str(int(l/c)),'w') as f: 
        pickle.dump(equ_state_HM_bc_array,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures/p_HM_wc_Tdep_l_' 
    +str(int(l/c)),'w') as f: 
        pickle.dump(p_HM_wc_array,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures/equ_state_HM_wc_Tdep_l_' 
    +str(int(l/c)),'w') as f: 
        pickle.dump(equ_state_HM_wc_array,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures/p_HM_bc_Tdep_AB_l_' 
    +str(int(l/c)),'w') as f: 
        pickle.dump(p_HM_bc_array_AB,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures     
/equ_state_HM_bc_Tdep_AB_l_'+str(int(l/c)),'w') as f: 
        pickle.dump(equ_state_HM_bc_array_AB,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures/p_HM_wc_Tdep_AB_l_' 
    +str(int(l/c)),'w') as f: 
        pickle.dump(p_HM_wc_array_AB,f) 
    f.closed 
    with open('C:/Users/Henri-Philippe/Desktop/Figures     
/equ_state_HM_wc_Tdep_AB_l_'+str(int(l/c)),'w') as f: 
        pickle.dump(equ_state_HM_wc_array_AB,f) 
    f.closed 
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Appendix C: Supporting info for Chapter 4.2 
Nucleophilic substitution of Chloroxanthine derivatives. 
 
 
Appendix C.1. Main resonance structures of the ion of 2,6-dichloroxanthine Besides the resonance 
of N7-N9, the negative charge is delocated on C2 and C6. As the negative charge is more stabilised on 
C2, C6 is more likely to undergo nucleophilic substitution. Following this logic, introducing N-
substitution will increase the efficiency of nucleophilic substitution through avoiding the deactivating 
negative charge. This can be seen in the experimental data of Chapter 4.2.3 and has been previously 
reported on analogues structures.* 
  
                                      
* E. Y. Sutcliffe, R. K. Robins, Electron Density and Orientation of Nucleophilic Substitution in Purine 
Ring. J. Org. Chem. 28, 1662-1666 (1963). 
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Structural analysis of Chapter 4 compounds 
compound is thus also not N3-substituted. 
Compounds 4.38-39 
Problem: Two compounds isolated from the same reaction believed to be N9 and N7 regio-
isomers.  
Analysis: 
 
1H13C HMBC for compound 4.38 (blue) and 4.39 (green): horizontal = 1H, vertical = 13C; 1D 
projections are given for compound 4.38 and 4.39 in their respective colour. Acquisition parameters: 
500 Mhz, DMSO-d6, 16 scans with fid size 2048 (1H), 1024 (13C). 
 
The only proton of the purine ring (H8) makes HMBC crosspeaks with three carbons (red 
cross): C8 (red horizontal line), C5 and C4. The CH2 of the N-substitution of compound 4.38 
has besides the C8 also C4 in HMBC range (black arrow). This in contrast to compound 4.39 
(HMBC in green) who makes contact with C5 (dotted lines) and in so confirming subsequent 
structures. 
 
 
Compound 4.36-37 and 4.40-41 
Structures were determined by the same logic as compound 4.38-39. 
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Compound 4.42 
Problem: One compound obtained in low yield from a complex mixture, which was expected 
due to multiple reactive moieties. 
Analysis: 
 
1H13C HMBC for compound 4.42: horizontal = 1H, vertical = 13C; 1D projections for 1H is internally 
referenced. Acquisition parameters: 500 Mhz, DMSO-d6, 16 scans with fid size 2048 (1H), 1024 (13C). 
 
From the 1D proton NMR, it was already clear that a product was obtained as the result of 
the reaction of one xanthine and two benzylbromide 4.25 molecules. One of the two CH2 
groups so obtained shows the same pattern as for compound 4.37, indicating N7-substitution 
(black arrow). The other CH2 group has an HMBC crosspeak with C4 (green arrow), as N9-
substitution would also, but also a signal with another quaternary carbon (dotted green line). 
The chemical shift of that carbon indicates either a carbonyl group or another equivalently 
deshielded carbon. In the light of all possibilities, taken into account the already identified 
N7-substituent, this can only be the C2, thus indicating N3-substitution. This evidence 
supports the following structure. 
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Compound 4.47 
Problem: Partial deprotection of methoxy groups on dimethoxypurine 4.47 and difficult 
determination of the regiochemistry of those methoxy groups as only a very weak HMBC 
(borderline signal to noise) signal can be found between one of the methoxygroups and C5. 
Furthermore the chemical shift between the C2 and C6 is negligible. 
Analysis: 
 
 
Overlay of 1H NMR of 4.43, 4.45 and 4.47 spectra and chemical structure in matching colour. 
Acquisition parameters: 500 Mhz, DMSO-d6, 32 scans 
 
Comparing the different substitution patterns, indicates that deprotection of the methoxy 
groups proceeds in the same order as their nucleophilic addition on N-protected 
dichloropurine. 
 
Compound 4.48 
Problem: Compound 4.48 isolated in trace amounts, 1H NMR integration indicated the 
formation of a dimerised compound as it was also pure on TLC.  
Analysis: Following the logic of the structural analysis on compounds 4.36-37, it could 
already be determined that the two xanthine moieties in the molecule were both N7-
substituted (red crosses, HMBC below). Prior synthesis of 4.33 (Method A) in the same 
conditions explained the additional 6-methoxy group found in the 1H NMR (not shown). 
Same reasoning was used to assume that also the free phenolic group of the compound in 
question could partake in nucleophilic substitution, and thus result in a dimer. The acidic 
hydrogen (OH) was used to distinguish both parts of the dimer (green pathway) 
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1H13C HMBC for compound 4.48: horizontal = 1H, vertical = 13C Acquisition parameters: 500 Mhz, 
DMSO-d6, 16 scans with fid size 2048 (1H), 1024 (13C). 
 
 
Compound 4.53a 
Problem: Compound 4.53a isolated in low yield (3%), 1H NMR gave an extra signal 
integrating for 2 protons, comparing to the expected compound according to reaction scheme 
below. 
 
Analysis: HRMS = 497.1318 [M+H-], predicted Chemical Formula: C23H22N4O9 indicating an 
extra CH2O,  
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1H13C HSQC-HMBC overlay for compound 4.53a: horizontal = 1H, vertical = 13C; HSQC: positive 
signals in blue, negative signal in red; HMBC in green Acquisition parameters: 600 Mhz, DMSO-d6, 
HMBC = 8 scans with fid size 4096 (1H), 1024 (13C), HSQC = 8 scans with fid size 1024 (1H), 1024 
(13C). 
 
Besides the signal for the β protons of phenylalanine (not shown), there are three CH2 signals 
as indicated by the HSQC. Our reference point to analyse is the cross given by H6 and C6 
(black dotted lines). The 6-position of uracil is easily recognized as the only singlet in the 
aromatic region in the 1H-spectrum, plus gives a distinct pattern for identifying quaternary 
carbons C2, C4 and C5 (weak signal, encircled for emphasis). The HMBC pattern for the 6 
position indicates the vicinity of only two CH2 groups. One of these, shows HMBC (and 
COSY) crosspeaks with an unidentified triplet without HSQC signal, suspected to be an OH. 
The HMBC crosspeaks of OH with C5 and respective CH2 with C5 and C4 confirms an 
unreacted 5-hydromethyluracil. The remainder CH2 position gave no crosspeaks on COSY 
(not shown), and the signals on HMBC with C2, C6 (yellow vertical line) indicate N1-
substitution of uracil ring. An extra signal with the carbonyl-group of phenylalanine (yellow 
cross), indicates ester formation. The hemi-aminal thus formed accounts also for its downfield 
shift, in regard to the 5-hydroxymethyl group. Thus leading the final conclusion as depicted 
below due to possible contamination of 5-hydroxymethyluracil (Chapter 4): 
 
Compound 4.53c 
Structure was determined by the same logic as compound 4.53a. 
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Compound 4.54-58 
Problem: The different uracil derived LG synthesized in this work, bear different nucleophilic 
moieties that could react with the N-protected amino acid under carbodiimide mediated 
esterification conditions. Identifying which connection between LG and carboxylic acid was 
made was necessary. 
Analysis: Example compound 4.54c 
 
1H13C HMBC for compound 4.54c: horizontal = 1H, vertical = 13C. Acquisition parameters: 500 Mhz, 
DMSO-d6, 16 scans with fid size 2048 (1H), 1024 (13C). 
Although two proton signals higher than 10 ppm are seen, correlating with the imino and 
amide protons, an HMBC was recorded to rule out the possibility that one of these acidic 
signals would be an OH instead. The two carbonyls (C14,24) of the N-protected amino acid 
were identified by the signals indicated by the full, green and red arrows. The lack of cross 
peaks between C14 and H6, rules out N1-substitution. The dotted arrows show signals seen by 
one of the acidic protons. That protons sees two carbons that also give signals with the H7 
proton, the only possibilities to assign these carbons are either C4,5 or C5,6. This would 
correlate the acidic proton either with H3 or H1 respectively. The green dotted line’s chemical 
shift indicates a carbonyl group (C4) and thus by retrospective logic, the acidic proton is 
identified as H3. The compound is thus also not N3-substituted. 
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Appendix D: Supporting Information for Chapter 4.3 and 4.4 
Measuring pKa in D2O of uracil derivatives 
Experimental NMR results and fits of pH titration of compound 4.8, for more 
details on the calculations see Chapter 6 
 
 
Figure D.1: plotting 13C chemical shift of carbons nearby the acidic moieties of interest versus the 
pH value measured in D2O:  calculated plot added in dotted lines 
Table 4.3 expanded with error values and without rounding the numbers 
Expanded table 4.3. pKa values determined in D2Oa 
Compound  pKa1a SEb pKaNc SE 
p-cresol 10.409 0.062 -  
4.8 10.943 0.061 10.535 0.051 
a phenolic group; b Standard Error; c acidic nitrogens of uracil ring, the average of the 
two values is reported. 
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Measuring the kinetic influence of uracil on aminolysis 
 
Figure D.2. Representative example of one experiment of pseudo first order kinetics determination 
for compound 4.58 (red) and compound 4.59 (blue).  Reagents and conditions: 1.6x10-4 M of ester; 
50 eq of benzylamine; solvent: ACN 
 
 
Figure D.3. Plot of pseudo first order kinetics in function of benzylamine concentration for 
compound 4.58 (red) and compound 4.59 (blue):  K1 pseudo/[benzylamine] in function of [benzylamine] 
with linear fit (left). K1 pseudo/[benzylamine] in function of [benzylamine] with quadratic fit for compound 
4.58 and the same linear fit for compound 4.59 (right). Solvent ACN.  
Pseudo first order kinetics for amide formation usually result in a linear fit 
when plotting K1 pseudo/[amine] in function of [amine] when using primary 
amines in organic solvents. The fact that for compound 4.58 the plot shows a 
better quadratic fit might indicate the presence of an extra term in the rate 
equation, derived from the presence of an uracil moiety. Equations 1-3 show 
the derivation of a linear fit from the given rate equation for an amine 
catalysed aminolysis of esters. 
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S = %24T$UV0WXYU +  %34T$UV0WXYU2      (1) 
    = 4T$UV0WXYU [%2 +  %30WXYU\     (1) 
 
  %(TU]-^ =  0WXYU [%2 +  %30WXYU\     (2) 
 
%(TU]-^
0WXYU  =   %2 +  %30WXYU       (3) 
 
  
Retention time analysis 
 
Figure D.4. Retention time (tR) analysis of oligomers of phenylalanine (blue) and UBnOPhen (red) 
Phenylalanine oligomers were commercially obtained references, results are according to literature*, tR 
values for UBnOPhen were experimentally obtained. 
 
  
                                      
* J. L. Meek, Prediction of Peptide Retention Times in High-Pressure Liquid-Chromatography on the 
Basis of Amino-Acid-Composition. Proc. Natl. Acad. Sci. USA 77, 1632-1636 (1980). 
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Photolysis experiments 
 
Figure D.5. Photolytic reaction of 4.54c, result with (red) or without (blue) a priori addition of 
oligonucleotide:  Reaction conditions: compound 6 in DMSO  and equal volume of water (blue) or 
oligonucleotide solution (dA)10, final concentration = 5 mol%, followed by 2 h 368 nm. Incubation time 
1 h RT before analysis 
 
 
 
Figure D.6. Photolytic reaction of 4.54c, effect of alkaline pH versus blank:  general reaction and 
analysis conditions see Figure 4.7 and Chapter 6 (blue) no oligonucleotide, no buffering; (red) no 
oligonucleotide, pH 8.4. 
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Figure D.7. Photolytic reaction of 4.54c, effect of oligonucleotide at pH 8.4: general reaction and 
analysis conditions see Figure 4.7 and Chapter 6 (blue) no oligonucleotide, pH 8.4; (red) (dA)10, pH 8.4 
 
 
.  
Figure D.8. Photolytic reaction of 4.60, result with (red) or without (blue) a posteriori addition 
of oligonucleotide: general reaction and analysis conditions see Figure 4.7 and Chapter 6. LG = p-
cresol 
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Figure D.9. Photolytic reaction of 4.54c, result after 1 h (blue) and 2 d (red) of incubation with 
oligonucleotide: Reaction conditions: compound 4.54c in DMSO 2 h 368 nm, followed by addition of 
an equal volume of water or oligonucleotide solution (dA)10 , final concentration = 5 mol%. Incubation 
1 h RT (blue) or 2 d RT (red) before analysis. 
 
 
 
Figure D.10. Photolytic reaction of 4.54c, result after 1 h (blue) and 2 d (red) of incubation with 
oligonucleotide at pH 6.0: Reaction conditions: compound 4.54c in DMSO 2 h 368 nm, followed by 
addition of an equal volume of oligonucleotide solution (dA)10 , final concentration = 5 mol% and/or 
buffer at pH 6.0 . Incubation: 1 h RT (blue) or 2 d RT (red) before analysis. 
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Appendix E: The photoreactor used in Chapter 4.4.2 
 
Figure E.1 Outside view of photoreactor Frontview with controls for stirring plate and UV lamps 
(left), Sideview illustrating the perforations for fan powered airflow cooling (right). 
 
 
Figure E.2 Casing removed to illustrate fan cooling mounted under grating  
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Figure E.3. Inside view of photoreactor 16 UV lamps can be placed in 4 parallel circuits, that can be 
independently controlled, reflective panelling ensures maximum efficiency of irradiation towards the 
reaction centre (top). Top cover and protective cover for the stirring plate removed for better visibility 
and to expose the latter (bottom). Grating under the lamps allow for airflow/cooling from fans mounted 
below (Figure E.2). 
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Appendix F: Safety Information 
Although this dissertation contains theoretical and analytical research, the 
main occupation was synthetic chemistry. To this end, important remarks 
regarding safety and handling of frequently used (or high risk) chemicals in 
this work will be discussed. 
General: Good Laboratory Practices should always be respected, the use of 
personal protective equipment (labcoat, goggles, gloves,…) and collective 
protective equipment (fumehood, ventilation, waste containers,…) is 
imperative and the quality of this equipment should be assessed regularly.  
Photoreactions: The reactor was shielded in order to ensure no UV light 
escaped the reactor. Exposure to UV-light causes burns to skin and eyes and 
should be avoided at all cost. As this reactor (Appendix E) included warning 
lights when in use, there is no reason to open the reactor when in use. A 
defective lamp will break the circuit, killing the light. If for any other reason 
the reactor should be opened while in use (for example maintenance testing) 
special goggles for strong UV light should be used (not sunglasses!!). When 
using shorter wavelength UV irradiation (<300 nm) the reaction should take 
place in a well vented environment, the reactor should be opened and vented 
before accessing it. Short wavelength UV irradiation produces ozone, which is 
dangerous (corrosive) when inhaled. 
Silylation: Silylation reagents such as HDMS, BSA and TMS-Cl are very 
volatile, flammable and reactive towards nucleophiles (corrosive to lungs, eye 
and skin). They react violently with water (hydroscopic!) and acid, reactions 
are quenched by pouring the mixture in (acetic) acid/ice mixtures. Although 
mostly used as intermediates in one pot reactions, silylated compounds can 
be isolated but are also volatile hazards. Hydrolytic stability of silylated 
compounds can be increased by using bulkier alkyl substituents. 
Phenolic compounds: A variety of phenolic compounds have been used and 
prepared in this research. Phenols are corrosive compounds causing 
discoloration of clothing and skin, while the latter can undergo severe chemical 
burns as phenolic compounds penetrate and dissolve the epidermal barrier 
with great efficiency. Any exposure should be rinsed superfluously with water. 
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Phenolic compounds are mutagenic due to aromatic intercalation in nucleic 
acids, the risk depending on the substitution pattern. Amines increase the risk 
by providing additional interactions between the protonated species and the 
negative phosphate backbone. Presence of hydroxyl-groups increase options 
for phase II metabolism (conjugation with glucuronic acid, sulfate etc.) 
increasing hydrophilicity and thus rapid elimination of the compound from 
body through urinary excretion. Alkyl substituents also decrease the risk, 
either by providing a handle for phase I metabolism (benzylic oxidation) or 
by steric hindrance of bulky substituents. 
Uracil derivatives (or more in general nucleobase derivatives): Although 
no safety information on the newly synthesized species is available, the fact 
remains that many of these compounds might express pharmacological 
properties such as antiviral or anticancer activity. The mode of action mostly 
concerns incorporation in nucleic acids or as anti-metabolites. All compounds 
were thus treated as such, avoiding skin and mucosal contact to limit 
exposure. 
Solvents: Practising chemistry without solvents is unthinkable but one most 
take special consideration to avoid carelessness due to frequent use. An inert 
solvent does not exist, it is advisable to review compatibility charts before 
setting up a “new” reaction. 
Et2O is a volatile, flammable liquid with low boiling point (34.6 °C) and may 
form peroxides due to oxidation. The peroxides are an explosion hazard after 
evaporation results in polymeric species (thus beware old, opened bottles). 
Dioxane, as cyclic ether, may know the same hazard although the higher 
boiling point (>100 °C) reduces the risk of spontaneous formation of peroxides 
but forced evaporation under high temperatures (rotovapor!) should be 
carried out carefully. It is also known as a possible carcinogenic agent. 
Chlorinated solvents such as CCl4, CHCl3 and DCM are volatile and are 
known to cause liver problems (cirrhosis, cancer) due to oxidative metabolism 
to phosgene (like species), with CCl4 as main hazard. The proton of CHCl3 
can be considered to be acidic, precautions should be taken when combining 
with a strong base such as hydroxide salts or alkaline metals; especially in the 
presence of a nucleophilic acceptor (acetone!), an exothermic reaction can be 
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expected. Combining DCM and CCl4 and alkaline metals should also be 
avoided (radical Wurtz-type reactions, explosion hazard). High boiling 
solvents with good dissolution capacity (DMSO, DMF) should be handled 
with care as they potentially facilitate the delivery of toxins through skin, 
gloves or labcoat. 
Acids and Bases: Corrosive materials with concentrated (inorganic) bases 
generally the strongest and faster acting species. Any exposure should be 
rinsed superfluously with water for a prolonged period to avoid chemical 
burns.  
Pyridine has a characteristic odour, is a possibly carcinogenic and known as 
possible effector in (male) fertility loss. NaH and other metal hydrides should 
be handled with care as they react violently with water (hygroscopic!) when 
used as powder. 
The following concerns specific hazards used frequently in this research. 
POCl3 is a clear liquid with boiling point of 105.8 °C, it is a multifunctional 
reagent for dehydration and chlorination of functional groups. Chlorination of 
the amides and imines of nucleobases is usually performed using a large excess. 
The reaction is quenched by pouring the hot solution (heat resistant gloves!) 
onto ice (10x volume). The quenching starts slowly due to slow 
dissolution/reaction of POCl3 and water, pouring the hot solution reduces lag 
time. Keep adding ice until a cool, clear solution is obtained; even then it is 
advisable to wait an hour more especially when dealing with large amounts 
to rule out further reaction, otherwise the subsequent extraction with organic 
solvent and the following (base) washing might result in expansive eruption 
of solvent from the extraction funnel. In this case, damage control by adding 
ice into the funnel over pouring it into ice is preferred as handling the funnel 
mixes the reaction mixture and stirs it up. 
Sodium metal is a soft metal kept in mineral oil. Using it to make a freshly 
prepared solution of sodium methoxide, was experimentally preferred over 
available commercial sources of the latter which is quite hygroscopic and led 
to inconsistent results. To obtain a specific amount of the metal, the following 
procedure was used. A piece of sodium was taken from the slightly viscous 
mineral oil and put onto a glass plate, subsequently pieces were cut and dried 
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carefully with a tissue followed by dropping it in a tared beaker containing 
heptane. Adding the sodium to methanol was done at room temperature with 
an open reflux set-up (H2 gas formation!) using small pieces, one at a time, 
after drying the heptane with a tissue. The dissolution is slow and a run-away 
reaction must be avoided when a large amount of sodium starts to dissolve 
more rapidly by the heat generated of the reaction. 
CAN or Ceric(IV) Ammonium Nitrate is a strong oxidant, contact with other 
material may cause a fire. It causes eye, skin, and respiratory tract irritation 
and can be harmful if swallowed. 
NaN3 is self-reactive, explosive and will decompose at temperatures above 275 
°C or under pressure. Empty containers containing residue might be 
dangerous. Quench with nitrous acid before disposing. Fortunately, in azide 
formation reactions starting from an amine and the in situ formation of a 
diazonium species, this is already present. Avoid the use of metals such as 
copper (in situ CuAAC!), it forms a highly explosive salt. 
BPO or BenzoylPerOxide is used as initiator in radical reactions after thermal 
dissociation. It is a possible fire and explosion hazard when dry, it is therefore 
provided in a 70% pure powder containing water. Used in 5-10% solutions or 
ointments for the treatment of acne, it is known to discolour clothing and can 
cause irritation to eyes, skin and mucosal tissue. 
BTC or (Bis(Trichloromethyl) Carbonate is also known under the trivial 
name of triphosgene. It has been investigated as a safer and more easily 
handled analogue or precursor for phosgene as it is a solid at room 
temperature and not a gas. BTC should always be handled under a fumehood, 
even when weighing as it reacts slowly with ambient water to produce 
phosgene and hydrogen chloride (possible overpressure when opening vial!). 
The formation of large amounts of HCl gas during reactions should be taken 
into account as it can slow down the reaction, corrode parts of the setup (inert 
gas balloon!) or machinery (rotovapor!), pose a safety hazard when working 
with the reaction mixture and contaminate the end product as it cannot 
always be washed with an extraction. Therefore, it is recommended to flush 
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the reaction mixture frequently with inert gas, monitoring the gas outlet by 
a piece of damp pH paper. 
EDC or 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide is a watersoluble 
carbodiimide coupling reagent, the corresponding urea after reaction can 
easily be removed by aqueous  washing. Carbodiimides are known for causing 
skin and eye irritation, even allergic reactions. EDC is a very hygroscopic, 
fluffy powder making handling (of old, open vials) difficult, thus extra 
precaution should be taken when weighing the compound to avoid aerosolising 
the flakes. 
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